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Abstract 
Introduction 
Obstructive Sleep Apnoea Hypopnoea Syndrome (OSAHS) is estimated to 
affect one billion people globally, carrying a substantial risk of road traffic 
accidents due to daytime sleepiness with additional other adverse health 
impacts. Continuous positive airway pressure (CPAP) is an effective treatment 
but requires long-term adherence. Regular clinical review of CPAP therapy 
users is important to address any problems, assess symptom relief, and 
specifically to review implications for driving. Reviews can be face-to-face, by 
telephone, or via teleconsultation with remote telemonitoring of CPAP usage. 
My PhD addresses the mode of delivery and content of CPAP reviews for 
people with OSAHS in three distinct but interlinked projects. 
Aims and objectives: 
1) Systematic review:    
To review the evidence for the effectiveness of teleconsultation combined 
with telemonitoring in the review of people with OSAHS receiving CPAP 
therapy compared to face-to-face care. 
2) e-Delphi: 
i) To reach consensus amongst a panel of international sleep 
clinicians, academics, and CPAP users on the most important 
components to include in a CPAP review, and how often a review 
should take place. 
ii) To develop a structured sleep medicine review template that 
records the important components identified by the e-Delphi 
consensus panel. 
 
3) Implementation study 
 To introduce the template in three diverse sleep medicine Centres for use 
in face-to-face or remote consultations and observe implementation 
using mixed methods. 
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Systematic review 
I followed Cochrane methodology and I searched ten electronic databases, 
trial registries, and reference lists for studies that included interventions that 
combined remote consultations with telemonitoring of CPAP usage. Outcome 
measures were: the proportion of CPAP users who had a review, adherence 
to CPAP, symptom control, satisfaction / acceptability, and cost-effectiveness.  
From 362 potentially relevant papers, I identified four randomised controlled 
trials and one controlled clinical trial (including 269 patients). The risk of bias 
was moderate in one, and moderate to high in four trials. Two trials reported 
the number and duration of reviews with inconsistent results. The 
teleconsultation / telemonitoring improved CPAP adherence in two trials; two 
reported no between-groups differences. Two trials, both at moderate to high 
risk of bias, showed no between-group differences in the Epworth Sleepiness 
Scale. Satisfaction was generally positive in all five trials; one trial reported that 
the teleconsultation / telemonitoring patients were ‘more likely to continue’ with 
CPAP therapy and one trial reported that CPAP teleconsultation / 
telemonitoring was cost-effective.  
e - Delphi and template development 
I recruited an international expert panel to identify the core components of a 
CPAP review derived from thirteen OSAHS guidelines and asked participants 
to score components (scale of one to five) over three rounds. Consensus was 
defined as ≥75% agreement for scores of ≥4. Free-text comments were 
analysed thematically.  
 
40 participants completed all three scoring rounds. Of 36 potential 
components, 17 achieved consensus: treatment acceptability, sleep quality, 
symptom resolution (including reduction in apnoea-hypopnoea index), 
assessment of sleepiness (including when driving), technical issues (mask fit 
/ humidification / cleaning / filters), CPAP adherence, and quality of life. 
Participants suggested reviews should be 12 to 18 monthly (more frequent 
when in early treatment) or “on demand / request.” Free text comments 
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emphasised that reviews should be multidisciplinary, flexible (including 
telehealth), and focus on symptom control.  
 
Based on the consensus findings I devised a CPAP review template that 
included the core components suggested by the participants. 
Implementation study 
I recruited three Centres: City, Urban / Rural, and Rural to a mixed-methods 
implementation study. There were four stages: 





Effectiveness of the implementation strategy was assessed by template 
uptake, feasibility of use, and fields completed. Analysis of the quantitative 
data was descriptive. Nine clinicians participated in final semi-structured 
interviews which were analysed thematically. 
 
219 anonymised templates were returned for analysis; all were completed 
voluntarily by nursing staff. The average completion time was 14 minutes; with 
six of the eight fields completed in over 90% of reviews. Six themes emerged 
from nine interviews. The template: 
 
1) Facilitated a structured, standardised review, reducing variation in practice. 
2) Was not perceived to affect clinical autonomy or person-centred care. 
3) The decision to participate was made at organisational level and individuals 
in the departments were free to decide whether, or not, to use the template in 
any / all of their consultations. 
4) Use of the template did not impact on how the review was conducted though 
template completion extended review time in one Centre where double data 
entry was required. 
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5) From a service perspective, the template was perceived as improving 
efficiency and promoting better patient outcomes whether in face-to-face 
reviews or teleconsultations. 
6) The template was seen as potentially contributing to multidisciplinary team 
working. 
With the rapid deployment of Microsoft Teams and NHS Near Me during the 
COVID -19 pandemic, the template supported remote consultations and might 
be useful for education and training purposes. Adaptations (structure, content, 
and layout) were highlighted. An electronic template was suggested, 
integrated with the electronic health record, obviating the requirement to 
dictate letters and reducing administrative processes.   
 
Conclusions and context  
The three studies add to the evidence base on the regular review of CPAP 
users. Telemedicine is an option for CPAP reviews for people with OSAHS.  
The international consensus group identified important components that 
should be recorded in a CPAP review informing development of a structured 
review template. Implementation of the template was achieved in three 
Centres and was considered to provide structure to both face-to-face reviews 
and teleconsultations with a potentially important role in training staff and 
standardising care.  
 
Teleconsultation has come of age in the midst of a global pandemic for routine 
CPAP reviews, and electronic templates adapted to the local setting could 
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Lay summary 
Background 
Obstructive Sleep Apnoea Hypopnoea Syndrome (OSAHS) is a condition 
where a person may stop breathing numerous times throughout the night. This 
can result in excessive daytime sleepiness or tiredness and reduced quality of 
life, and an increased risk of road traffic accidents. OSAHS can also have other 
important health consequences such as an increased risk of heart-related and 
circulation-related problems. The treatment for this condition is to wear a mask 
over the nose or mouth that provides positive pressure to keep the airway open 
during sleep, and this treatment is called CPAP therapy. People who use this 
treatment require regular review, and this can be either face-to-face or using 
video-assisted calls or telephone review.  
 
What did I want to find out and what did I do?: 
1. What was the evidence for using video-assisted or telephone review 
combined with electronic monitoring of CPAP use overnight? 
 
I reviewed research papers that looked at combining real-time video or 
telephone reviews combined with remote monitoring compared to face-to-face 
traditional care of people using CPAP therapy. I found five papers that 
concluded that there was no difference in the number of hours that people use 
CPAP each night when they were reviewed remotely compared to a face-to-
face review. Patient satisfaction was generally reported positively in all five 
papers; one paper reported that a video review combined with overnight 
monitoring of patients were ‘more likely to continue’ with CPAP therapy and 
one paper reported that CPAP teleconsultation / telemonitoring was cost-
effective. There were no safety concerns identified in any of the papers.  
 
2. What were the most important components to include in a CPAP review, 
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I carried out an international study by email to gain an understanding of 
participants collective views on the most important components to include in a 
review. I was then able to establish what were the most important components 
to include in a CPAP clinic review. I then developed a review template that 
could be used to support a CPAP review. 
 
3. What were the opinions of the sleep clinic staff on the use of the 
template in clinical reviews? and how many templates were completed 
during the study period?. 
 
I then implemented this template in three sleep clinics in the UK. I asked clinical 
teams to use the template for two months and provide me with copies of their 
completed templates to see how they had used them, and what they thought 
of them by asking them to take part in recorded interviews. The nurses that 
participated in the study found the review template to be useful and suggested 
some alterations and are keen to see a revised version of the template. 
Conclusion 
The three studies I have carried out support the use of telemedicine as an 
option for review in people using CPAP therapy, and the importance of having 
a regular review and suggested core components to include in a review. Using 
a structured template that includes these core components can guide a review 
and is a tool to assist the healthcare professional with ensuring the most 
important components to include in a review are covered. However, the review 
should be about what matters to the patient and what they want to discuss in 
a review and this should not be overlooked. Using telemedicine as an option 
for review in the midst of a global pandemic for routine CPAP reviews and 
using templates adapted to the local setting could support safe and effective 
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Chapter 1 General overview of thesis 
1.1 Clinical context of thesis 
Obstructive Sleep Apnoea Hypopnoea Syndrome (OSAHS) is a common 
condition that occurs in all age groups where a person may have repeated 
complete or partial collapse of the of the upper airway resulting in reduced 
respiratory effort, intermittent dips in the oxygen saturation level leading to 
hypoxaemia and disrupted sleep resulting in excessive daytime sleepiness 
and reduced quality of life (1-3). The gold standard treatment for this condition 
is Continuous Positive Airway Pressure (CPAP) therapy, although there are 
other treatment options for those that may not tolerate CPAP (4, 5). Current 
guidelines recommend regular review of CPAP users however there is no 
collective agreement regarding the content or components of the review and 
how often a review should take place (4-9). The mode of consultation may be 
adapted to the clinical context setting (face-to-face or teleconsultation).  
 
In Chapter 2, I summarise the clinical features of OSAHS, the options for 
management, and the different modes of consultation used.   
1.2 Program of Research and presentation of the thesis 
In this thesis, I will explore both the content of a clinical review and mode 
of delivery and how often this should take place.  
• In Chapter 3, I describe my aims and methods. 
• In Chapter 4, I will describe the evidence base for use of teleconsultation 
combined with telemonitoring in the review of CPAP users compared to 
traditional face-to-face care. 
• In Chapter 5, I will describe the findings of an international e-Delphi 
consensus study and how this has facilitated the formation of a novel 
structured sleep medicine review template that contains the most important 
core components suggested by the e - Delphi participants (10). 
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• In Chapter 6, I will describe the findings of the Implementation study of the 
use of this template in the clinical setting in three diverse sleep medicine 
Centres in the UK.  
 
1.3 Relevance of this research  
In Chapter 7, I discuss the findings of my thesis in terms of the clinical, 
healthcare, and policy context. 
 
This work will be of interest and have potential relevance for sleep medicine 
service providers / policymakers both nationally and internationally. 
Particularly within the current Coronavirus global pandemic where 
telemedicine solutions for delivering healthcare services are critically important 
to remobilisation and the continuation of services and for the longer term.  This 
work may also inform future healthcare guidelines regarding the most 
important components to consider / include in a clinical review in CPAP therapy 
users, how often a review should be undertaken and what a review template 




Doctor of Philosophy - University of Edinburgh 2021 
Chapter 2 Obstructive Sleep Apnoea Hypopnoea 
Syndrome 
2.1 History of OSAHS 
The evolution of the history of sleep medicine from ancient to modern times 
makes for captivating reading for 21st-century practicing sleep medicine 
clinicians, particularly in this era of the SARS-CoV-2 global pandemic where 
the modern-day history of the delivery of sleep medicine services globally is 
being redefined.  
2.1.1 Ancient history of OSAHS 
Some surviving ancient Egyptian medical papyri dating back to 4000 BC 
include a reference to sleep disorders that include descriptions of sleep 
problems like insomnia, and treatments for sleep disorders such as 
narcolepsy, insomnia, and snoring (11).  
 
Hippocrates “The Father of Medicine” may have identified the origins of 
OSAHS. Hippocrates lived between 460-377 BC and is possibly the first to 
describe the existence of OSAHS in the literature where he writes about 
abnormal sleep patterns: ‘Others, when their diet bares too great a proportion 
to their exercise, not only sleep well at night, but are likewise drowsy in the 
day; the repletion still increases, and their nights begin to grow restless; their 
sleep afterwards becomes disturbed with frightful dreams of battles’ (12). 
 
A condition that could be described as possible OSAHS is reported in the 
literature by Aelianus et al in 1666 when Dionysius ‘a Greek ruler’ in 360 AD is 
described as having several features that suggest that he may have suffered 
from sleep apnoea, notably obesity, breathing problems, sleepiness, and that 
he was difficult to waken (13). Another reference by Athenaeus in 1863 in the 
same publication by Krieger et al reports that Magas, King of Cyrene 
(deceased in 258 BC) ‘was weighted down with monstrous masses of flesh in 
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2.1.2 Modern history of OSAHS 
The Surgeon Extraordinary to the King was William Wadd, and in 1816 is 
reported to have written a monograph regarding his observations on obesity 
and how this could impede exercise and breathing and increase sleepiness. 
He writes about a case where the individual regularly fell asleep while eating 
in the company of others (14). The first contemporary descriptions of OSAHS 
emerge from the 1960s with reports from Lugaresi et al and Gastaut et al both 
describing cases where they saw an association between obesity and 
hypersomnolence (15, 16), however, the discovery of OSAHS has been 
attributed to Jung in 1965.  Lavie et al’s publication in 2008 does describe 
reported cases of suspected OSAHS some 50 years earlier with the 
publication of Burwell et al’s paper in 1956 – titled ‘Extreme Obesity Associated 
with Alveolar Ventilation - A Pickwickian Syndrome’ (17). Although the first 
description of OSAHS is generally attributed to Charles Dickens’ The Pickwick 
Papers. In the last 40 years and more recent times, the ground breaking work 
of Sullivan et al published in 1981 has positioned OSAHS as an important 
respiratory condition that deserves the full attention of respiratory clinicians 
globally (18).  
 
2.2 Obstructive Sleep Apnoea Hypopnoea Syndrome - 
definition 
The National Institute for Health and Excellence (NICE) defines OSAHS as the 
coexistence of excessive daytime sleepiness with irregular breathing at night 
(9). This quotes the British Thoracic Society (BTS) who use the term OSAHS 
for people with repetitive apnoeas and symptoms of sleep fragmentation with 
excessive daytime sleepiness (9). The American Academy of Sleep Medicine 
(AASM) has defined OSAHS as a sleep-related breathing disorder where there 
is upper airway narrowing that can impair normal sleep-related ventilation (19). 
The European Respiratory Society (ERS) similarly defines this condition as 
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An obstructive apnoea is the cessation of airflow for at least ten seconds with 
persistent respiratory effort while the term hypopnoea refers to a reduction in 
inspiratory airflow (by at least 30%) lasting greater than ten seconds, with 
associated oxygen desaturation or arousal from sleep (20). The 
pathophysiology of OSAHS is described in more detail in section 2.2.7.  It is a 
common, treatable condition and a major public health problem for healthcare 
providers globally with a reported prevalence of 3 – 12.5 % of middle-aged 
men and 2 – 5.9 % of women (4, 6, 21-24). The prevalence of OSAHS is 
discussed in more detail in section 2.2.2. It has been recognised as an 
important cause of morbidity and mortality for almost four decades. People 
present to health care services with a range of complaints; loud disruptive 
snoring, witnessed cyclical breathing cessation during sleep, a sensation of 
nocturnal choking in some cases, and consequent excessive daytime 
tiredness and often falling asleep in inappropriate situations (23, 25, 26). 
2.2.1 Contributing factors to OSAHS 
OSAHS is present in all age groups and there are a number of risk factors that 
increase the likelihood of this condition developing: being overweight or obese 
(2, 24, 26), having a large collar size (>17 inches), (27), increasing age and 
male gender (male to female ratio estimated to be 2:1 in the general 
population) (25, 28), post-menopausal women, existing hypertension (29, 30), 
a family history of OSAHS (31), a small lower jaw and certain other facial 
configurations or abnormalities (32, 33), enlarged tonsillar tissue (34, 35), 
increased alcohol consumption, sedative medications and smoking (29, 36), 
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2.2.2 Prevalence of OSAHS 
One reason for the wide divergence in the reported prevalence of OSAHS over 
time is that there have been substantial variations in methodological reporting 
of diagnostic tests and thresholds for reporting sleep studies (38). The current 
accepted metric for diagnosing OSAHS is the Apnoea Hypopnoea Index (AHI), 
(the number of apnoeic and hyponoeic events recorded per hour of sleep).  
Section 2.2.6 (Table 1) defines diagnostic thresholds for the AHI (27). 
 
Recent epidemiological data from the United States and Europe have 
suggested that between 14% and 49% of middle-aged men have clinically 
significant OSAHS (30). Senaratna conducted a systematic review in 2017 and 
reports that the prevalence of OSAHS ranged from 9% to 38% in the adult 
population, from 13% to 33% in men, 6% to 19% in women, with much higher 
prevalence in the elderly (38). A further recent publication from a European 
epidemiological study reports the overall prevalence of OSAHS as 44 % in the 
general population and 22.7% in moderate to severe OSAHS cases (39). The 
reported rising prevalence of OSAHS is in line with the ‘epidemic’ of obesity 
and is a clear indication of the significant disease burden this condition places 
on health care systems globally. 
 
2.2.3 Economic impact of OSAHS 
OSAHS also represents a significant economic burden on healthcare systems 
and society globally. The overall healthcare costs related to OSAHS include 
the direct costs of diagnostic testing and the ongoing costs of treating the 
condition and the indirect costs associated with other co-morbid conditions 
(obesity, diabetes, cardiovascular and cerebrovascular disease), (30). People 
with poorly controlled or untreated OSAHS may be less productive in the work 
environment, with a higher level of absenteeism due to daytime fatigue / 
somnolence, impaired workplace vigilance / performance, mood disturbances, 
neurobehavioral impairments, and general malaise (40). OSAHS also impacts 
occupational safety at work; people with OSAHS have a twofold increase in 
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work accidents and more commonly suffer work-related injuries (41). OSAHS 
is a well-documented cause of increased road traffic incidents resulting in 
serious injury and fatalities which has financial implications for society as a 
whole and already overstretched and underfunded healthcare systems (41-
44). It has been estimated that up to 7% of road traffic accidents for a 
population of male drivers can be attributed to OSAHS (45). With proper 
management of OSAHS, significant improvements to an individual’s health 
and public safety will benefit healthcare systems and society as a whole.  
 
2.2.4 Medico-legal implications of OSAHS 
With the expanding evidence base of the impact of increased work-related 
incidents and road traffic accidents in people with OSAHS, there are medico-
legal implications for the individual as well as healthcare providers of sleep 
medicine services globally (40). This has important driving and vehicle 
licensing implications for people with this condition as well as a major public 
safety concern as accidents involving people with OSAHS can be 
accompanied by serious injuries (46). Driving issues and OSAHS are 
discussed in more detail in section 3.2. 
2.2.5 Diagnosis of OSAHS 
The diagnosis of OSAHS can only be confirmed by objective tests that are 
carried out during sleep and the gold standard diagnostic test is considered to 
be laboratory-based polysomnography (PSG).  Home Sleep Apnoea Testing 
(HSAT) is now considered an alternative option due to the rising prevalence of 
OSAHS. This has particular relevance due to the increased demand for limited 
laboratory-based PSG (4, 19, 47).  
• A full PSG measures multiple sleep parameters including brain activity 
(EEG), eye movements (EOG), muscle activity or skeletal muscle 
activation (EMG), and heart rhythm (ECG), respiratory airflow, and 
respiratory effort indicators with pulse oximetry to measure oxygen 
saturation (19).  
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• HSAT can be conducted in the place of residence as well as any health 
care setting and is an accepted test for suspected OSAHS. It is a more 
convenient diagnostic option,  it is less expensive than formal PSG, 
however, there is the disadvantage that HSAT measures fewer 
parameters and has the potential for misdiagnosis (47). HSAT is poised 
to become the most prevalent diagnostic test in the current COVID 19 
pandemic, and for the longer term with full-in lab PSG testing being 
paused in many services to reduce the need for face-to-face inpatient 
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2.2.6 Measurement of severity of OSAHS 
The measurement of the severity of OSAHS has traditionally been defined by 
the number of breathing pauses that occur during sleep and the AHI has been 
the most commonly used means of defining the severity of this condition (19).  
The AHI is derived from the total number of apnoeas and hypopnoeas divided 
by the total sleep time (Table 1).  
 





Very severe >50 
Table 1 Apnoea Hypopnoea Index (AHI) and Severity of OSAHS 
 
However, controversy exists about the AHI score and its link to the severity of 
OSAHS and this is related to differences in the way that PSG and HSAT 
scoring criteria have changed and evolved over time (23). A study that 
explored three scoring criteria methods in a population of 2,162 people with 
OSAHS was able to demonstrate wide variation in the AHI and this resulted in 
almost one-third of individuals being misdiagnosed  (48). This may be resolved 
in the future by sleep medicine services adopting a more standardised or 
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2.2.7 Pathophysiology of OSAHS 
The pathophysiology of OSAHS has been widely studied and numerous 
anatomical and pathophysiological abnormalities within the upper airway give 
rise to the occurrence of OSAHS (Figure 1). Other contributory factors are 
enlarged tongue / tonsillar tissue, excess pharyngeal soft tissue, and retro - or 
micrognathia (50). Quality of life (QoL) is adversely affected by OSAHS 
sufferers (6, 50). The underlying mechanism of OSAHS is the repeated 
intermittent collapse of the pharyngeal airway dilator muscles due to the loss 
of the sleep-induced compensatory muscle tone resulting in intermittent 
nocturnal hypoxaemia and sleep fragmentation (51-53). The maintenance of a 
patent upper airway during sleep is essential for effective nocturnal alveolar 
ventilation. 
 
Figure 1 Mechanism of airway obstruction OSAHS 
 
 
An apnoeic event is the episodic absence or cessation of breathing and 
OSAHS occurs where an individual experiences repeated episodes of 
breathing cessation as a result of partial narrowing (hypopnoea) or collapse of 
the pharyngeal airway during sleep (2, 54). The decrease in the airway muscle 
tone supporting the airway during sleep is the cause of these 
apnoeic/hyponoeic events. Complete airway closure (obstruction) stops 
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airflow and is defined as ‘apnoea’ whereas partial obstruction decreases 
airflow and is defined as ‘hypopnoea’. OSAHS results in periodic episodes of 
brief arousal from sleep to restore normal breathing and airway patency (9, 
55).  
 
Intermittent hypoxaemic events, numerous sleep arousal events, changes in 
intrathoracic pressure, and elevated nocturnal blood pressure are considered 
to be the most likely causal pathway through which OSAHS leads to 
cardiovascular disease (56). Increased deposition of fat in the tissues 
surrounding the upper airway and central adiposity can lead to increased 
upper airway collapse, by increased mechanical loading around the upper 
airway, reduced tracheal traction on the pharynx, and reduced neuromuscular 
activity, particularly during sleep (57). Craniofacial abnormalities such as a 
small maxilla and mandible are common features found in OSAHS (33).  The 
anatomical structures of the upper airway also impact significantly on an 
individual’s predisposition to have an increased risk of OSAHS (58-60), and 
more recent research has focused on craniofacial and upper airway 
morphology as contributing mechanisms in OSAHS in adults (60). Neelapu et 
al in 2017 conducted a systematic review and meta-analysis of cephalometric 
studies in people with OSAHS and concluded that there is good evidence to 
support a reduction in pharyngeal airway space as a causative factor, the 
inferior position of the hyphoid bone and an increase in the anterior facial 
height is also implicated (32). 
 
2.3 Treatment options in OSAHS 
2.3.1 Weight loss 
Obesity is a problem of global epidemic proportions as evidenced by a recent 
report by the World Health Organisation suggesting that over 600 million 
people have a body mass index (BMI) greater than 30 kg/m2 (26). The rising 
prevalence of obesity is directly associated with the increasing incidence of 
OSAHS and is recognised as the key reversible risk factor in this condition (21, 
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61-64). Significant and sustained weight loss is arguably the gold standard of 
treatment for OSAHS where this can be achieved (65, 66), although minorities 
of individuals are non-obese (6, 21, 67). The AASM makes recommendations 
for weight reduction by modifying lifestyle factors such as increasing exercise 
and dietary modifications that promote weight loss (71). Advising on lifestyle 
changes and weight reduction strategies should be addressed in every 
OSAHS clinical discussion (22, 63-66). A randomised controlled trial by Lopes-
Padros et al in 2020 has shown that an intensive weight loss program in obese 
patients with severe OSAHS is effective in both reducing weight and the 
severity of OSAHS and also improved lipid profiles, glycaemic control, and 
inflammatory markers (68). 
 
2.3.2 Treatment of OSAHS with CPAP 
In 1981 Sullivan et al published their seminal paper in the Lancet describing 
their experience of using CPAP therapy in five patients with severe OSAHS in 
an inpatient setting. They described the effective reversal of sleep-induced 
upper airway collapse with the application of CPAP. They concluded that the 
safety and simplicity of their CPAP apparatus suggested that this could be 
replicated in the home environment (18). CPAP therapy is now accepted 
globally as the treatment of choice in the management of OSAHS, however 
until the later 1990s the effectiveness of CPAP therapy had yet to be firmly 
established (69). Since then a plethora of research, national and international 
guidelines, and consensus documents have confirmed the benefits of CPAP 
therapy as the gold standard in the treatment and long term management of 
the symptoms associated with OSAHS (3-5, 8, 9, 70-72). CPAP machines 
have evolved to become very small portable, quiet devices with the capacity 
to remotely monitor users’ adherence to therapy, mask fit, mask leak, efficacy 
of therapy in treating sleep-disordered breathing, and record oxygen saturation 
monitoring via mobile networks. Web-based technology may offer the options 
for reduced clinical review and remote review via teleconsultation(73-75).  
CPAP therapy is the most common treatment that is now offered on a global 
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scale and is recommended by all national and international guidelines (6, 8, 9, 
67, 76).  Figure 2 is a device that is used in the local sleep medicine service 




Figure 2 An example of a CPAP device (Airsense Elite 10 CPAP unit) 
 
Following diagnosis, the majority of individuals are established on fixed CPAP 
therapy, usually following auto-titration to establish therapeutic pressure 
settings. CPAP therapy works by generating a positive continuous flow of air 
from an electronic flow generator that is delivered to the user via a hose and 
nasal or full face mask attached to the face (62, 69). The positive airway 
pressure generated by the CPAP unit acts to keep the upper airway open 
during sleep and thus abolish the episodic breathing pauses that occur during 
sleep (Figure 3), (77). Traditionally the pressure required to prevent upper 
airway collapse is assessed by manually titrating increased CPAP pressure 
over time (9, 24, 67). In contrast, Automatic positive airway pressure (APAP) 
therapy automatically calculates the pressure required to overcome airway 
obstruction during an apnoeic or hyponoeic episode. The method used to 
determine the required pressure has been shown to make no difference to 
longer-term clinical outcomes of therapy (78).  
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Figure 3 Mechanism of action of CPAP 
 
Since the design of the first CPAP therapy device by Sullivan et at in 1981 
(18), CPAP machines have evolved and become smaller and quieter to 
increase treatment acceptability and adherence rates (62). Newer CPAP 
devices provide some expiratory relief by reducing the pressure on the 
expiratory phase of breathing to make exhalation against the positive pressure 
more comfortable (3). APAP devices can be used where there are difficulties 
encountered in adhering to a fixed CPAP pressure. These devices work out 
the 95th percentile pressure required to abolish the apnoeic events and a fixed 
CPAP pressure can then be prescribed for individual patients or they can 
continue with the APAP device.  
 
The CPAP pressure required to treat nocturnal events can change over time 
with weight loss and weight gain and patients need to be advised that they 
should contact their CPAP service provider if presenting symptoms reoccur 
such as snoring, nocturnal breathing pauses, or increasing daytime 
somnolence (79-81). Some sleep medicine Centres provide all patients with 
an APAP device for long-term treatment, the rationale being that this can 
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reduce the number of clinical reviews needed over time and are equally 
effective as CPAP devices. This is an important consideration during COVID 
19 for sleep services as APAP devices can reduce the number of face-to-face 
visits (8, 82, 83).  
 
More sophisticated breathing support device options are also available as 
Non-Invasive Ventilation (NIV) devices for those with complex sleep-
disordered breathing, and some people tolerate NIV therapy better than fixed 
CPAP if poor adherence is an ongoing problem (83). NIV devices can deliver 
more modes of ventilation and are often used where people have OSAHS and 
obesity hypoventilation syndrome (84). 
 
The latest development in recent years in CPAP and other breathing support 
devices is the ability to remotely monitor therapy adherence and other 
parameters of interest to the clinical teams such as efficacy of treatment and 
mask fit information, and the ability to adjust CPAP settings remotely (85-88). 
The latest CPAP units are so small that they can be fit into the palm of a hand, 
are much lighter and more portable for those with OSAHS who have to travel 
for their business or employment purposes.  
 
CPAP therapy can have some side effects and oro-nasal dryness and nasal 
congestion can be relieved by the addition of humidification (89). Other 
common side effects reported by users are claustrophobia and mask 
discomfort which may result in poor adherence. This can be alleviated in some 
cases by good and responsive sleep clinician support and ensuring the 
appropriate mask is fitted (79, 89, 90). These factors are discussed in more 
detail in 2.3.3.  
  
Current guidelines recommend that patients using CPAP should be reviewed 
regularly to assess adherence, replace disposables such as masks, filters, and 
hoses, manage side effects, and maintain CPAP devices (3, 8, 9, 23, 67). 
Although routine review and maintenance are clinically important (87, 90, 91), 
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this is an on-going resource-intense and time-consuming factor globally and 
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2.3.3 CPAP adherence and challenges 
CPAP adherence is problematic for several reasons such as mask fit, comfort, 
prescribed CPAP pressure intolerance, oral-nasal dryness, claustrophobia, 
abdominal bloating, psychological and social factors. A NICE technology 
review reported CPAP adherence as 71% (range 64–83%), in the first year of 
use and 79% (range 68–90%), in those that used it for > than 12 months (9). 
However, a systematic review by Rotenberg et al in 2016 identified that over a 
20-year time frame CPAP use of greater than 7 hours per night was 34% (92). 
An explanation for this wide variation in adherence rates may lie in the fact that 
the definition of CPAP adherence is inconsistent leading to reports of CPAP 
adherence ranging from as low as 28% to more than 83% in more recent 
studies (72, 93). Both of these studies defined adherence as 4 hours per night 
for 70% of nights used.   
 
Modern CPAP devices can measure CPAP wear time and efficacy at effective 
pressure and provide remote monitoring (72). Low adherence to CPAP limits 
its therapeutic benefit (72, 74), and encouraging optimal CPAP use is an 
ongoing challenge for users and service providers. A review by Bakker et al 
2019 sought to understand two important unanswered questions regarding 
CPAP adherence: 1) How many hours of CPAP use are necessary to improve 
daytime symptoms and reduce cardiovascular risk and 2) What strategies 
could be implemented to optimise adherence in clinical settings. They found a 
dose-response relationship between CPAP use and a range of outcomes, 
including daytime sleepiness, functional status, and blood pressure. They also 
noted that current data suggests that optimal adherence rates differ depending 
on the outcome measures of interest. Following this review, the authors were 
unable to come to a definitive answer regarding their first question and 
recommended further RCTs are needed to define this. Regarding their second 
question, they suggested that combining theory-driven behavioural 
interventions with telemedicine could be the answer to improving CPAP 
adherence rates in the real-life clinical setting, and they recommend that 
further randomised studies are required to explore this theory (94). 
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The results of the Sleep Apnea Cardiovascular Endpoints (SAVE) study by Qui 
et at 2019 confirmed that CPAP treatment is beneficial in improving daytime 
somnolence and quality of life and it provided evidence that CPAP therapy in 
OSAHS can reduce depression and improve work place productivity even 
when adherence was < 4 hours per night (95). The MERGE study published 
in 2020 by Kelly et al also showed that there was a beneficial effect of CPAP 
in quality of life in people with  mild OSAHS when used for up to 4 hours per 
night (96).  
2.3.4 Mandibular Advancement Devices (MADs) 
Other treatment modalities beyond CPAP therapy are available such as 
custom-made MADs, (Figure 4) which can be successful in managing the 
symptoms of mild, moderate, and severe OSAHS  (36) (97-99). The evidence 
base for the use of MADs to treat OSAHS is well established (98, 99), however, 
these devices can result in side effects such as temporomandibular joint stress 
and pain and changes in dental morphology over time and it is recommended 
that users should be monitored routinely (100, 101).  
 
 
Figure 4 Mandibular Advancement Device 
 
A MADs mechanism of action is to advance or protrude the length of the 
mandible while simultaneously increasing the space in the upper airway (35, 
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99, 101). CPAP therapy can be difficult to tolerate in some individuals for 
several reasons as listed previously and may result in sub-optimal adherence 
to treatment so referral to an orthodontic service for consideration of a MAD 
may be a better or more aesthetic option for some individuals. 
2.3.5 Bariatric surgery 
Bariatric surgery is recognised nationally and internationally as a therapeutic 
treatment option for morbid obesity and can offer suitable individuals a more 
permanent weight reduction solution that can also convey beneficial effects on 
diabetes, hyperlipidaemia, hypertension, and the severity of OSAHS although 
critical complications of bariatric surgery for OSAHS have been reported (66, 
102-104). Wong et al in 2018 conducted a systematic review and meta-
analysis of the effect of bariatric surgery in people with OSAHS and concluded 
that surgical weight loss reduces the severity of OSAHS and improves 
symptoms (26). The successful outcomes of permanent weight loss post-
bariatric surgery is an attractive long-term treatment option however it should 
be acknowledged that people with OSAHS are at high risk from serious post-
surgical complications including death (104). 
2.3.6 Palatal surgery and other surgical options 
A systematic review by Rotenberg et al 2016 suggests that some individuals 
with OSAHS may be managed more effectively with palatal surgery than 
CPAP, avoiding the need for long term treatment adherence (92), and Yu Li 
2019 advocates hybrid palatial surgery techniques for treatment of OSAHS in 
individuals who cannot tolerate CPAP therapy (105). Nasal surgery 
interventions such as septoplasty may have some beneficial effects in selected 
cases in terms of reducing the severity of the OSAHS, respiratory disturbance, 
reducing snoring, improving subjective daytime somnolence, quality of life, and 
improving nasal airway patency to improve CPAP adherence although in 
isolation does not have a consistent effect in people with OSAHS (106, 107). 
Other anatomical abnormalities can be surgically corrected with good 
outcomes and there is a growing evidence base for some surgical options.  
Facial examination can identify retrognathia of maxillary retrusion which may 
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be amenable to corrective maxillary / facial procedures. Obvious external nasal 
septal deviation may also reveal other proximal nasal defects of the nasal 
septum contributing to symptoms that may improve symptoms of OSAHS with 
corrective surgery (108). 
2.3.7 Positional therapy 
Positional therapy has emerged in the last decade as a simple and easy-to-
use therapy to manage positional related OSAHS although its use is not widely 
used by the sleep medicine community due to a paucity of evidence regarding 
its effectiveness (109). It works by providing a vibrating feedback mechanism 
in a position sensor worn around the chest that alerts a person when they are 
lying supine to change position. A recent systematic review by Ravesloot 2017 
provides good quality evidence that newer generation positional therapy 
devices can be an effective means in reducing the severity of OSAHS (110). 
A Cochrane review in 2019 concluded that CPAP is the most effective 
treatment for OSAHS in terms of reducing the AHI, however long-term 
adherence is problematic. Positional therapy user’s self-reported adherence 
was better, but with less effect compared to CPAP on measures like the AHI. 
Future studies should record objective adherence to positional therapy and 
also establish its effect on other important outcomes like quality of life and 
clinical outcomes like cardiovascular events (111). The Cochrane review 2019 
findings are further supported by Mok et al’s publication in 2020 where they 
conducted the first RCT crossover study of its kind comparing positional 
therapy versus CPAP therapy in 40 somnolent patients who were suspected 
of having OSAHS. The non-inferiority primary endpoint for positional therapy 
was not met and their results were inconclusive (112).  
2.3.8 Hypoglossal nerve stimulation 
There is emerging evidence beyond clinical trials that hypoglossal nerve 
stimulation (HNS) implant surgery may be a successful alternative option for 
treating OSAHS (113-115), and has been approved by several health care 
systems. Weeks et al in 2018 reported that upper airway stimulation by 
hypoglossal nerve implant can be successfully implemented in non - academic 
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hospital and clinic settings (116). A systematic review by Kompelli et al in 2018 
concluded that HNS is a safe and effective treatment for OSAHS in those who 
find CPAP therapy difficult to tolerate. It was associated with good adherence 
and significantly improved subjective and objective outcomes of sleep with 
minimal adverse effects (117), however, further trials are needed to compare 




2.4 Consequences and Complications of OSAHS 
2.4.1 Cardiovascular consequences of OSAHS 
The underlying mechanisms of cardiovascular injury are multifactorial with 
frequent intermittent hypoxaemia, surges in elevated blood pressure following 
apnoeic spells, and oxidative stress, triggering an inflammatory cascade of 
events that results in repetitive injury to the vascular endothelial system with 
subsequent inflammation, accelerated atherosclerosis, hypercoagulation, and 
activation of the sympathetic nervous system (118, 119). The cardiovascular 
consequences of OSAHS have been extensively studied over the last three 
decades. OSAHS is considered to be an independent risk factor for many 
forms of cardiovascular disease. It is associated with increases in the 
incidence and progression of coronary heart disease, heart failure, stroke, 
hypertension, and atrial fibrillation and the potential for sudden cardiac death 
(5, 20, 61, 118-121). Eighteen years ago Stradling et al established that 
OSAHS is an independent risk factor for diurnal hypertension (122), and in 
subsequent years numerous studies have firmly established an association 
between OSAHS and hypertension, independently of age, weight, and other 
confounding factors (20, 118, 123-125).  
 
2.4.2 Cardiovascular effects of adherence to CPAP therapy 
Despite a clear association between cardiovascular disease and OSAHS, 
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prospective observational studies and RCTs have disappointingly not been 
able to show that cardiovascular outcomes are improved by adhering to CPAP 
therapy. This is a controversial subject that remains to be clarified in future 
research (126-129). A recent meta-analysis by Abuzaid et al in 2017 has been 
more promising in that they found a cardiovascular protective effect when 
CPAP use was greater than four hours per night (129). Quan et al 2018 
reanalysed data for the SAVE study and their results have suggested that 
CPAP therapy may offer protective cardiovascular effects in people with 
OSAHS and diabetes, and improved adherence should be encouraged in 
these individuals (130). There is a push to study physiological and clinical 
phenotypes in people with OSAHS and precision medicine is entering the 
arena in recent publications (131-133). There are still unanswered questions 
regarding the true effects of CPAP therapy on cardiovascular outcomes and 
the sleep medicine world is waiting in anticipation of definitive answers to these 
questions.  
2.4.3 Other Specific complications of OSAHS 
2.4.3.1 Heart failure in OSAHS 
 
Another manifestation of cardiovascular disease in OSAHS is the development 
of heart failure and these conditions commonly co-exist with the prevalence of 
heart failure in the general population greater in people with OSAHS, 
estimated to be as high as 50-70% (21, 134, 135).  
2.4.3.2 Resistant Hypertension and OSAHS 
 
The relationship between hypertension and OSAHS has been known since 
2001 and since then numerous observational studies have confirmed this 
association (20, 127). OSAHS prevalence has been reported to be as much 
as 100% in patients with refractory hypertension (uncontrolled hypertension 
despite treatment with at least five antihypertensive drugs), (136, 137). The 
Wisconsin Sleep Cohort study followed 709 patients with OSAHS and found a 
linear, dose-dependent relationship between the severity of OSAHS at 
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baseline and the risk of developing hypertension during follow-up (137).  
2.4.3.3 Atrial fibrillation and OSAHS 
 
The prevalence of atrial fibrillation in people with OSAHS is reported as 40 to 
50% and significantly impacts increased morbidity and mortality and is an 
independent predictor of stroke (137-143). Evidence points to OSAHS also 
being an independent risk factor for atrial fibrillation however its role in new-
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2.4.3.4 Cerebrovascular consequences of OSAHS 
 
Multiple studies have shown that OSAHS is an independent risk factor for 
stroke disease and ischaemic stroke, and the severity of OSAHS also 
increases stroke incidence (146, 147).  People presenting with a stroke or a 
transient ischaemic attack are three to four times more likely to have OSAHS 
than the general population and OSAHS is prevalent in up to 50% of people 
affected by stroke (148). Undiagnosed and untreated OSAHS also 
exacerbates the damage produced by a stroke once it has occurred and 
increases the risk for a subsequent stroke.  
2.4.3.5 Metabolic consequences of OSAHS 
 
Metabolic Syndrome is a collection of metabolic and cardiovascular 
abnormities such as impaired fasting glucose, type-II diabetes, hypertension, 
dyslipidaemia, and central obesity (147, 149, 150). The reported global 
prevalence of metabolic syndrome is between 20 - 40% and a systematic 
review by Xu et al in 2015 has confirmed a positive association between 
OSAHS and metabolic syndrome (150, 151). Although causality is not proven, 
there is evidence that in people with moderate to severe OSAHS, three months 
of CPAP treatment lowers blood pressure and partially reverses metabolic 
abnormalities (152).  
2.4.4 Assessing excessive daytime somnolence in OSAHS 
Untreated OSAHS fragments the sleep pattern and is known to have a 
negative impact on the physical and psycho-social aspects of life (29, 40, 42, 
43, 151). Excessive daytime somnolence or sleepiness is commonly reported 
by people presenting to their health care provider with a suspected diagnosis 
of OSAHS. Simple screening tools that can assist in early detection of OSAHS 
are currently in use in clinical services that may support a decision for referral 
for diagnostic testing. There are several scales or scoring tools that can be 
used to measure the level of daytime sleepiness however the evidence base 
regarding their use as a diagnostic tool are controversial (153).  
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2.4.4.1 The Epworth Sleepiness Scale (ESS) 
 
The ESS developed by Johns in 1991 is popular and used in many clinical 
settings (154). Despite the limitation of inaccurate reporting of daytime 
sleepiness, a score greater than ten is generally considered to be abnormally 
sleepy. The ESS sleepiness scale is intended to be a self-administered 
questionnaire regarding the likelihood of falling asleep in certain situations and 
provides a numerical measurement of an individual’s general level of daytime 
somnolence or sleepiness. It was validated in 30 adult control subjects and 
150 adults with sleep disorders, and the total ESS score significantly 
distinguished normal people from those with OSAHS, narcolepsy, and 
idiopathic hypersomnia. A more recent pictorial ESS was developed in 2011 
to address any misunderstandings on how to use the scale, and the validation 
study found that a pictorial version of the ESS was comparable with the 
traditional ESS and may be a suitable alternative in cases with limited literacy 
(155).   
2.4.4.2 STOP-Bang Questionnaire (SBQ) 
 
In 2008 Chung et al developed the snoring, tiredness, observed apnoea, high 
BP, BMI, age, neck circumference, and male gender (STOP-Bang) 
questionnaire as a tool to screen individuals for possible OSAHS (156). The 
tool contains eight dichotomous (yes / no) items related to the clinical features 
of OSAHS and the total score range is zero to eight with the individual risk of 
OSAHS being greater with higher scores (157). A recent meta-analysis by 
Chiu et al in 2017 concluded that compared with the Berlin questionnaire, 
STOP questionnaire, and Epworth sleepiness scale, the STOP-Bang 
questionnaire is a more accurate assessment tool with both a higher sensitivity 
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2.4.4.3 STOP questionnaire (SQ) 
 
The snoring, tiredness during the daytime, observed apnoea and high blood 
pressure (STOP) questionnaire includes four questions and was developed 
and validated by Chung et al in 2008 as a tool to screen for possible OSAHS 
in preoperative surgical patients (157). It is a shortened version of the STOP-
Bang questionnaire.  It was found to be quick, concise, and easy to use and 
shows a moderately high level of sensitivity and specificity in detecting OSAHS 
in surgical patients (156). 
2.4.4.4 Berlin Questionnaire (BQ) 
 
The Berlin questionnaire (BQ) is a useful, brief, and clinically validated 
screening tool that identifies persons who are at high risk for OSAHS.  It is 
used in some sleep medicine Centres and includes questions about snoring, 
daytime sleepiness, body mass index (BMI), and hypertension (158). 
Ramakant et al 2018 recently compared the ESS and the BQ and concluded 
that the ESS is a less sensitive tool in predicting OSAHS compared to the BQ 
(159).  
2.4.5 Impact of sedative medication and alcohol on OSAHS 
The role of sedative medications as a predisposing factor in OSAHS has been 
raised and there is concern that the administration of these drugs to people 
with co‐existing OSAHS may worsen the condition. However, a Cochrane 
review in 2015 reviewed 14 studies that investigated ten sedative drugs and 
did not find convincing evidence that sedatives increased the severity of 
OSAHS, though they concluded that more studies in a larger cohort for a 
longer duration were needed (160). A metanalysis by Nigam et al in 2019 did 
not find that the use of non-benzodiazepine sedating drugs worsened the 
severity of existing OSAHS in the majority of participants (161).  
 
 
In contrast to these findings, there is evidence that sedative and opioid-
 
27 
Doctor of Philosophy - University of Edinburgh 2021 
containing drugs worsen central sleep apnoea which has a prevalence as high 
as 24% in chronic opioid use (162), and is reversible on discontinuation of 
opioid medication (163). Central sleep apnoea co-exists with OSAHS in 
methadone replacement programmes (164, 165).  
 
There is sparse literature on alcohol consumption and its effects on OSAHS 
however a systematic review by Simou et at in 2018 concluded that alcohol 
consumption is associated with an increased risk of OSAHS and this could be 
explained as alcohol consumption reduces airway muscle tone, predisposing 
to upper airway collapse and generally increasing upper airway resistance 
(36).   
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2.5 Driving and OSAHS 
The recognition of OSAHS as a causative factor in Road Traffic Accidents 
(RTA’s) has been known for 40 years and a meta-analysis by Bioulac in 2017 
estimated a twofold increased risk of RTA’s due to sleepiness whilst driving 
(166).  The costs to society and healthcare systems of RTA’s are significant 
(40), and it has been estimated that 7% of RTA’s for a population of male 
drivers can be attributable to OSAHS (44).   
 
2.5.1 European Union Regulations 
In 2016 the European Union directive 2014/85/EU - New rules on driver 
licensing for patients with obstructive sleep apnoea were published (167). The 
directive states the following:   
• Applicants or drivers where moderate or severe obstructive sleep apnoea 
syndrome is suspected shall be referred for further authorised medical 
advice before a driving licence is issued or renewed. They may be 
advised not to drive until confirmation of the diagnosis. 
• A driving licence may be issued to applicants or drivers with moderate to 
severe obstructive sleep apnoea syndrome who show adequate control 
of their condition and compliance with appropriate treatment and 
improvement of sleepiness, if any, confirmed by authorised medical 
opinion. 
• Applicants or drivers with moderate to severe OSAHS under treatment 
shall be subject to a periodic medical review, at intervals not exceeding 
three years for drivers of group 1 (non-commercial drivers) and one year 
for drivers of group 2 (commercial drivers), to establish the level of 
compliance with the treatment, the need for continuing the treatment and 
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A European Respiratory Society task force Statement published in 2020 on 
Sleep Apnoea, Sleepiness, and Driving Risk provides a collective statement 
for clinicians advising on fitness to drive in people with OSAHS (45). All 
clinicians undertaking CPAP reviews regardless of the mode of consultation 
need to take all of these four factors into account when assessing people’s 
fitness to drive safely. The key messages of this statement are: 
• Sleep apnoea severity as assessed by the AHI alone does not predict 
fitness to drive in people with obstructive sleep apnoea.  
• Excessive sleepiness is a major factor in determining accident risk in 
Obstructive sleep apnoea but does not relate to the AHI and may be 
partly due to other non-related sleep apnoea factors.  
• Where doubt exists regarding the validity of self-reported sleepiness, 
further investigation such as maintenance of wakefulness test is 
warranted, especially in professional drivers. 
• Effective and compliant treatment of obstructive sleep apnoea with  
CPAP largely reverses the increased accident risk and driving can 
resume once demonstrated. 
2.5.2 United Kingdom Driving regulations 
In 2018 the British Thoracic Society published a position statement advising 
medical practitioners and specialist sleep medicine teams of their roles and 
responsibilities regarding advice to be given to individuals who are suspected 
of having OSAHS and have excessive daytime sleepiness that may affect their 
ability to drive safely (90). The roles and responsibilities of the clinicians 
involved in the care of people with OSAHS are outlined below: 
 
A general practitioner or other referring healthcare practitioner should: 
• Recommend that a patient does not drive if excessive sleepiness is 
having or likely to have an adverse effect on driving, whatever the cause.  
• Arrange onwards referral for specialist review if indicated and ensure 
prioritisation of cases as urgent where patients report an impact on 
 
30 
Doctor of Philosophy - University of Edinburgh 2021 
vigilant critical activities such as driving, flying, or operating dangerous 
machinery.  
 
The sleep specialist team member (clinician, sleep nurse, sleep physiologist) 
should: 
• Advise the patient that if they hold a driving licence, they must follow the 
Driver and Vehicle Licensing Authority (DVLA) guidance.  
• Help the patient to assess the likely impact of their symptoms on their 
safety to drive with a detailed driving history including distances driven, 
episodes of drowsiness whilst driving, and information from family 
members, identifying any crashes or near misses which could be 
attributed to sleepiness or inattention.  
• Advise the patient whether they have just OSA (no need to contact 
DVLA), or OSA plus sleepiness (need to contact the DVLA). The DVLA’s 
specific forms give options for “Which condition have you been diagnosed 
with?” including “Sleep Apnoea (with excessive sleepiness during normal 
waking hours), or OSAS or other sleep condition”. The clinician should 
record the discussion and recommendations about driving, and whether 
the DVLA should be notified, in the patient’s notes. 
 
The Patient: 
• Report their symptoms honestly to their clinicians. 
• Notify the DVLA regarding a diagnosed medical condition when required 
to do so, including OSA which affects their ability to drive safely. 
• Comply with the instructions of the DVLA 
 
The DVLA website A-Z page provides a link to the forms that need to be 
completed. On receipt of the appropriate form, the DVLA opens enquiries for 
car / motorcycle license holders and for lorry and bus licence holders, which 
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2.6 Organisation and delivery of care in OSAHS 
2.6.1 Clinical review 
National and international guidelines recommend regular review of people with 
OSAHS who are using CPAP therapy however there is no consensus on the 
frequency and modality of the clinical review (3, 24, 168). Long-term follow-up 
may vary in frequency, or potentially be “on-demand / or request,” and can be 
conducted by a range of healthcare clinicians with the option of using 
telemonitoring and teleconsultation (168, 169). A practice guideline by the 
American Academy of Sleep Medicine recommends review should include 
monitoring and troubleshooting of objective effectiveness of CPAP therapy 
including usage data to ensure adequate treatment and adherence is being 
achieved. This review should be delivered by a qualified clinician (e.g., 
physician or advanced practice provider, trained healthcare provider), 
following CPAP initiation and during treatment of OSAHS (67).  
 
2.6.2 Who conducts the clinical review 
A variety of healthcare clinicians can undertake a review of people who are 
using CPAP therapy. Physicians, respiratory scientists and therapists, sleep 
technologists, specialist nurses, and other sleep specialists may all be involved 
in the early clinical review and longer-term review of CPAP users (3, 169, 170). 
Given the increased prevalence of OSAHS and the number of people requiring 
CPAP therapy, overstretched sleep medicine services need to rethink their 
service delivery and design pathways and by whom, and where will future 
services be delivered to meet the rising demand for the service with no 
increased capacity.  
 
There is evidence that a nurse‐led service for home diagnosis, CPAP 
treatment initiation, and ongoing management of selected patients with 
OSAHS is feasible and cost‐effective, with outcomes comparable to 
conventional inpatient services (169, 171-174). Comer 2017 concluded that a 
nurse-led respiratory sleep medicine service for diagnosis and initiation of 
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CPAP therapy was fit for purpose and was well received by patients (169). A 
study in 2015 also concluded that a simplified nurse-led model of care has 
demonstrated non-inferior results to physician-directed care in the 
management of symptomatic moderate-severe OSAHS while being less costly 
(61). An internet search reveals that many Centres across the UK offer 
specialist nurse and specialist respiratory physiologist-led CPAP review with 
respiratory consultant oversight, thus freeing up the physicians to see more 
complex cases.  
 
In the USA, there is a major concern regarding the rapid decline in board-
certified sleep medicine specialists and some solutions that have been 
suggested are increased training for generalist clinicians, including non-
physicians, in the diagnosis and management of symptomatic, uncomplicated 
OSAHS (175-178). An RCT conducted in Europe in 2015 provided evidence 
that follow-up in primary care following suitable training showed no worsening 
CPAP compliance compared with a specialist model and was a cost-effective 
alternative (174).  
 
Chakrabarti et al 2020 concluded that an intelligent computer-guided 
consultation programme creates opportunities in sleep medicine management 
pathways to utilise non-specialists working effectively and safely under 
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2.6.3 Method of Clinical review 
2.6.3.1 Traditional face-to-face review 
 
The review of people using CPAP therapy has traditionally been face-to-face 
in a secondary care clinic setting. There are advantages to this model of care 
as the clinician and patient can interact directly and any physical or clinical 
examination or required tests can be conducted at this review (182). The 
clinician can stay in the same place and avoid travel, and this may be time-
efficient for clinical service provision. However, there are also some 
disadvantages of face-to-face review for CPAP users, such as time taken off 
work and the distance to travel to tertiary Centres, increased fossil fuel 
consumption, and dealing with traffic congestion which has a negative 
environmental impact in terms of increased carbon emissions. There is also 
the potential for increased road traffic incidents (168, 180, 181).  
2.6.3.2 Teleconsultation clinical review 
 
The introduction of telemedicine to the stage in the last two decades has driven 
a revolution in OSAHS management and changed the landscape for the 
treatment and long-term management of this condition (181-185). There are 
several potential ways in which technology can support CPAP reviews: (168, 
185-188).  
 
• Facilitation of remote reviews  
Telemedicine can support remote reviews and this can have benefits for 
both clinicians and patients and may be a more convenient mode of 
service delivery. 
 
• Telemonitoring of CPAP adherence 
Adherence to CPAP therapy can be overseen remotely and important 
parameters such as CPAP hours of use, reduction in the AHI, and mask 
leak can also be monitored, reducing the need for face-to-face clinic 
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reviews. CPAP settings can also be changed remotely reducing the need 
for face-to-face reviews. 
 
• Reducing Carbon footprint 
By obviating the need to travel to satellite clinics for clinicians and 
reducing face-to-face visits for CPAP users, the miles travelled for review 
can be significantly reduced with the beneficial effects of reduced fossil 
fuel consumption and reduced carbon emissions. 
 
• Improved access to care 
Telemedicine can improve access to care, particularly where there are 
large geographical distances to travel to main sleep medicine Centres. It 
can help to reduce waiting time for investigations and treatment and 
improve patient-clinician safety and deliver more person-centred care. 
 
• Reduced traffic congestion and work productivity 
Traffic congestion can also be avoided, of particular importance in 
densely populated cities. It can also reduce the loss of work productivity 
in terms of time taken off work to travel for face-to-face reviews. 
 
2.7 Summary of chapter 2 
OSAHS is a common and increasingly prevalent condition that is being driven 
by the global obesity epidemic. Weight reduction is the first treatment 
recommendation and may reverse this condition, however, CPAP therapy 
remains the gold standard therapy of choice for most people. Other treatment 
options are discussed, and research is beginning to identify phenotypes of 
OSAHS that may lead to a precision-medicine approach to the diagnosis and 
treatment of this OSAHS in the future. This introductory chapter outlines the 
increased risk of accidents and cardiovascular, cerebrovascular, and 
metabolic complications of having a diagnosis of untreated OSAHS and the 
impact that some sedative medication and alcohol can contribute to the 
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severity of OSAHS. The various assessment tools that are available in clinical 
practice to assess the level of daytime somnolence are described, as this is 
directly related to assessing an individual’s fitness to drive until their symptoms 
are controlled on CPAP therapy. The vehicle and licensing agencies rules and 
reporting regulations for clinicians and people with OSAHS to maintain 
individual and societal safety by avoiding RTA’s in sleepy drivers are 
presented.  
 
The importance of comprehensive reviews of people with OSAHS is discussed 
and the current lack of consensus about what this should include.  With the 
rapid deployment of telemonitoring and teleconsultation options for CPAP 
therapy users, there are many opportunities to streamline and provide more 
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Chapter 3: Aims and objectives of PhD 
 
In the last chapter, I outlined the history of OSAHS and its contributing factors, 
its prevalence, economic impact, medicolegal implications, diagnostic options, 
measuring its severity, the pathophysiology of this condition, and its treatment 
options. I outlined the consequences and complications of OSAHS, tools to 
assist with assessing the level of daytime somnolence, UK and European 
driving regulations, the organisation and delivery of care, and the options 
available for current reviews including telehealth. Current guidelines 
recommend regular review of CPAP users however there is no collective 
agreement regarding the content or components of the review and how often 
a review should take place. In this thesis, I will explore both the content of a 
clinical review and mode of delivery and how often this should take place. 
 
Aims and objectives: 
I aimed to inform the mode of delivery and content of CPAP reviews for people 
with OSAHS in three distinct but interlinked projects: 
I.       Systematic review:    
To systematically review the literature on the effectiveness, acceptability, 
and health service resource implications of using the combination of real-
time telemonitoring of CPAP usage data plus remote consultations to 
undertake routine reviews of patients using CPAP compared to face-to-
face care.  
II. e-Delphi:     
a) To reach consensus amongst a panel of international sleep clinicians, 
academics, and CPAP users on the most important components to 
include in a CPAP review and how often a review should take place.  
b)  To develop a structured sleep medicine review template that records 
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III.      Implementation study 
To introduce the template in three diverse sleep apnoea Centres for use 
in face-to-face or remote consultations and observe implementation 
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Chapter 4: Systematic review 
There is increasing interest in telehealth as an option for the clinical review and 
longer-term management of CPAP users in sleep medicine services. In this 
chapter, I will explore the evidence base for the role of telehealth 
(teleconsultation and telemonitoring), in CPAP therapy users.  
 
The systematic review is published: 
• Phyllis Murphie (PM), Stuart Little (SL), Brian McKinstry (BMcK), Hilary 
Pinnock (HP). Remote consulting with telemonitoring of continuous 
positive airway pressure usage data for the routine review of people with 
obstructive sleep apnoea hypopnoea syndrome: A systematic review. J 
Telemed Telecare 2019;25:17-25 
4.1 Rationale for the systematic review 
Technology-enabled care is rapidly evolving and transforming healthcare on a 
global scale and telemedicine and telemonitoring in sleep medicine have 
emerged as additional options in diverse health care settings in this specialty 
over the last few decades. Telehealth methods to support the clinical review of 
CPAP users have the potential to deliver cost-effective and convenient care 
(87-89, 185, 186, 189). Potential benefits include increased therapy 
adherence, user satisfaction (184), and reduced loss of workforce by not 
attending for a face-to-face review, avoidance of traffic congestion in urban 
Centres, and consequent positive effects on the environment with reduced 
fossil fuel consumption and carbon emissions (87, 181, 187, 189). Recent 
evidence has suggested that the use of CPAP telemonitoring may improve 90-
day treatment adherence, however, the literature regarding combining both 
telemonitoring with teleconsultation is limited (187), and longer-term studies 
are needed to assess the duration of the effect on adherence (75). There is 
also evidence to support teleconsultation as an acceptable alternative to face-
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The AASM in 2015 published a position statement on the use of telemedicine 
for the diagnosis and treatment of OSAHS (4). They convened a task force 
that recommended clinical standards of care for sleep telemedicine services 
should be comparable to face-to-face review, including all aspects of 
diagnostic and therapeutic treatment plans compared to usual care. My 
specific interest was in routine reviews as the increasing prevalence of OSAHS 
is straining limited healthcare resources and viable alternatives are needed 
that can deliver safe, effective, and person-centred care closer to their place 
of residence. 
 
Aims and objectives of the systematic review 
I aimed to systematically review the literature on the effectiveness, 
acceptability, and health service resource implications of using the 
combination of real-time telemonitoring of CPAP usage data plus remote 
consultations to undertake routine reviews of patients using CPAP compared 
to face-to-face care in any healthcare setting.   
4.2 Methods 
The systematic review protocol is registered with the international prospective 
register of systematic reviews (Appendix 2 – PROSPERO registration: 
CRD42015019455). I did not make any changes to the protocol. 
 
An ethics self-audit checklist was submitted to the University of Edinburgh, 
Centre for Population Health Sciences Research Ethics Group for this 
systematic review (Appendix 1). The systematic review is reported according 
to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses 
(PRISMA) statement for reporting on systematic reviews (190). PRISMA is an 
evidence-based minimum set of items for reporting in systematic reviews and 
meta-analyses that focuses on the reporting of reviews evaluating randomised 
trials.  The PRISMA checklist is in Appendix 3. I followed the methodology 
described in the Cochrane Handbook (190-192). 
 
40 
Doctor of Philosophy - University of Edinburgh 2021 
4.2.1 Inclusion and exclusion criteria 
  Definitions 
Population Adults with a diagnosis of 
OSAHS on CPAP therapy 
Sleep apnoea is defined as a condition in 
which a person experiences repeated 
episode of apnoea because of a narrowing or 
closure of the pharyngeal airway during sleep  
Intervention The application of telehealth to 
review people with a diagnosis 
of OSAHS and using CPAP 
This was defined as the use of telehealth to: 
review patients remotely (e.g. telephone or 
video consultation) and telemonitoring of 
CPAP usage  
I excluded telephone calls without 
telemonitoring and also telemonitoring 
without remote consultation 
Comparator Usual clinical care without 
telehealth  
Normally delivered face-to-face but may 
include some telephone calls (but without 
telemonitoring of CPAP data) 
Outcomes Primary outcome: 
Primary outcomes of 
interest were: 
• the proportion of patients 
who had received a 
telehealth review 





Secondary outcomes of 
interest included current 
control of symptoms of 
OSAHS, patient and 
clinician acceptability and 
satisfaction with the 
telehealth review, and 
health service resource 
use/cost implications 
compared to face-to-face 
care 
CPAP adherence which is typically defined 
as recorded use of CPAP therapy for > 4 











Clinical symptoms include validated 
measures of sleepiness, quality of sleep, and 
quality of life 
 
Setting Any setting Typically, the patient will be in the 
community, but the healthcare practitioner 
may be based in primary or secondary care  
Study design Randomised controlled trials (RCTs), quasi-RCTs, and controlled clinical trials 
(CCT). 
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4.2.1.1 Reason for my decisions on inclusion and exclusion criteria    
• Population  
My interest was in adults with a diagnosis of OSAHS who were using CPAP 
therapy. 
• Intervention 
I chose to only include interventions that had both a consultation remote to 
the main health-care facility (video or telephone consultation) and the facility 
for reviewing real-time telemonitoring of data from the CPAP device (defined 
as data transmitted and monitored by, or available to the reviewing clinical 
team via a web-based platform at any time). I excluded telephone calls 
without telemonitoring and also telemonitoring without remote consultation.  
This decision was based on my interest in published research that provided 
access to almost identical CPAP review care with the same real-time face-
to-face teleconsultation and access to real-time adherence data. 
• Comparator 
The comparator was the usual face-to-face review of CPAP therapy users 
who did not use telehealth. 
• Outcomes 
My primary outcome of interest was the proportion of patients who had 
received a telehealth review and adherence with prescribed CPAP therapy. 
My Secondary outcomes of interest included current control of symptoms of 
OSAHS, patient and clinician acceptability and satisfaction with the telehealth 
review, and health service resource use / cost implications compared to face-
to-face care. 
• Setting 
Any healthcare setting was included with typically, the patient being in the 
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• Study design 
I searched for randomised controlled trials (RCTs), quasi-RCTs and 
controlled clinical trials (CCTs) in CPAP therapy users that compared 
teleconsultation combined with daily telemonitoring of CPAP data with face-
to-face care. I chose to only include these types of studies as I considered 
these would provide the most reliable evidence on the effectiveness of any 
telehealth intervention compared to usual care and minimise the risk of bias.   
My interest was in routine reviews of people established on CPAP, as 
opposed to the coaching and additional support associated with the initiation 
of treatment. 
4.2.2 Search strategy 
I searched ten electronic databases; Allied and Complementary Medicine 
(AMED); British Nursing  Index (BNI); Cumulative Index of Nursing and Allied 
Health Literature (CINAHL);  Cochrane  Library; Database of Abstracts of 
Reviews of Effects (DARE); Excerpta Medica dataBASE (EMBASE); Latin 
American and Caribbean Health Sciences Literature (LILACS); Medical 
Literature Analysis and Retrieval System Online (MEDLINE); Web of Science 
and Z Electronic Table of Contents (ZETOC) (Table 3).  The bibliographies of 
included studies were scrutinised to identify possible additional studies and I 
also hand searched relevant sleep medicine and respiratory journals (Sleep 
Medicine, Journal of Clinical Sleep Medicine, Sleep, Sleep Medicine Reviews, 
Thorax, European Respiratory Journal, Breathe, British Medical Journal Open 
Respiratory Research, Respiratory care, American Journal of Respiratory and  
Critical  Care  Medicine, Chest, European Respiratory  Review, Respiratory  
Medicine, Nature Partner Journals Primary Care Respiratory Medicine). 
Search dates were not limited as the literature review identified possible 
research of the use of telemedicine in sleep medicine over the last 20 years.  I 
only included studies published in English as I did not have access to the 
resources to permit translation. The search was carried out in November 2015.  
 
43 




Search strategies for MEDLINE, EMBASE, AMED  
 
1. Sleep apnea syndromes/ or sleep apnoea, obstructive/ 
2. Sleep-disordered breathing. mp. or Sleep apnea Syndromes/ 
3. Continuous positive airway pressure/  
4. CPAP therapy. mp. 
5. Nasal CPAP.mp. 
6. Sleep apnoea syndrome. mp. 
7. 1 or 2 or 3 or 4 or 5 or 6 
8. Obstructive sleep apnoea hypopnoea syndrome. mp. 
9. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 
10. telemedicine/ or teleconsultation/ 
11. (Telehealth* or ehealth or telemonitoring*).mp. 
12. 10 or 11 
13. Clinical trial/ or controlled clinical trial/ or randomised controlled trial/ 
14. quasi-randomised. mp. 
15. 13 or 14 
16. 9 and 12 and 15 
17. adherence.mp. 
18. compliance.mp. 
19. exp "patient acceptance of health care"/ 
20. Satisf*.mp. 
21. 17 or 18 or 19 or 20 
22. 9 and 12 and 21 
 
Search strategy for The Cochrane Library, ISI Web of Science, CINAHL, LILACS, ZETOC, DARE 
and British Nursing Index 
1. Sleep apnea syndromes/ or sleep apnoea, obstructive/ 
2. Sleep-disordered breathing. mp. or Sleep Apnea Syndromes/  
3. Continuous positive airway pressure/ 
4. CPAP therapy 
5. Nasal CPAP 
6. Sleep apnoea syndrome 
7. S1 OR S2 OR S3 OR S4 OR S5 OR S6 
8. Obstructive sleep apnoea hypopnoea syndrome 
9. telemedicine/ or teleconsultation/ 
10. telehealth or e-health or telemonitoring 
11. S9 OR S10 
12. Clinical trial/ or controlled clinical trial/ or randomised controlled trial/ 
13. quasi randomised  
14. S12 OR S13  
15. S7 AND S11 AND S14  
16. adherence or compliance 
17. exp "patient acceptance of healthcare" 
18. patient acceptance of healthcare 
19. satisfaction 
20. S16 OR S17 OR S18 OR S19  
21. S7 AND S11 AND S20 
 
Table 3 Search strategies   
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4.2.3 Selection of studies 
Selection was carried out in three stages: 
• I carried out an initial sift of the papers that had been retrieved and 
rejected any obviously unrelated abstracts. The reason for this 
preliminary step was the time and resource restraints of undertaking this 
part-time PhD whilst working in my NHS role.  
• I adhered to the principles of this methodology and included the study 
setting and quasi-RCTs and controlled clinical trials as some non RCTs 
warranted inclusion in the review.   
• I then screened the titles and abstracts with 25% checked by HP or BMcK 
(agreement 100%). This was also a practical decision based on time 
constraints however, to ensure that I did not overlook potentially eligible 
trials, I included all abstracts in which any form of telehealth and OSAHS 
and / or CPAP were mentioned. I included interventions that had both a 
teleconsultation remote to the main health-care facility (video or 
telephone consultation), and the facility for reviewing real-time 
telemonitoring of data from the CPAP device (defined as data transmitted 
and monitored by, or available to the reviewing clinical team via a web-
based platform at any time).  
• The full text of all potentially eligible studies was retrieved and 
independently assessed against the inclusion criteria by two reviewers 
(PM, and SL or HP); any disagreements were resolved by team 
discussion. The selection process was summarised using a PRISMA flow 
diagram (Figure 5). 
 
4.2.4 Quality assessment 
The methodological quality of included studies was assessed (by PM and HP) 
using the Cochrane Risk of Bias (ROB) tool (192) and the Cochrane 
Effectiveness and Practice Organisation of Care (EPOC) guidelines (190). The 
Cochrane risk of bias tool covers six domains of bias: selection bias, 
performance bias, attrition bias, detection bias, reporting bias, and other 
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biases. The following seven domain-based parameters were used to assess 
bias in the systematic review: adequate sequence generation, allocation 
concealment, blinding of participants and personnel, blinding of outcomes, 
how incomplete outcome data were addressed, completeness of reporting, 
and freedom from other sources of bias. Included studies were given an overall 
risk of bias by PM and HP and any differences of opinion were resolved by 
discussion with BMcK and SL.  
4.2.5 Dealing with lack of information 
If, after full-text assessment, it was still unclear whether a study fulfilled the 
inclusion criteria, or if I required clarification of any details relating to the 
intervention, study reporting, or outcome data, I contacted authors by email for 
further relevant information.  
4.2.6 Data extraction 
I used a piloted data extraction sheet to extract characteristics of included 
studies under the headings; author and study year, country, risk of bias, type 
of trial, number of participants, follow up, setting, intervention, and comparator, 
patient demographics, personnel, arrangements for remote consultation, 
telemonitoring of CPAP adherence, aspects of care addressed, duration and 
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4.2.7 Outcomes of Interest 
The primary outcomes of interest were: 
• The proportion of patients that received both a teleconsultation and 
telemonitoring review.  
• Adherence with prescribed CPAP therapy that was recorded by 
telemetric data transmission.  
The Secondary outcomes of interest were: 
• Current symptom control using a validated score (e.g. the Epworth 
sleepiness scale or the Functional Outcomes of Sleep Questionnaire).  
• Patient and clinician acceptability and satisfaction with the 
teleconsultation / telemonitoring model of clinical review. 
• The health service resource use / cost compared to face-to-face care. 
 
4.2.8 Data synthesis 
I expected that I would identify a limited number of eligible studies (based on 
my preliminary scoping work).  I, therefore, planned to undertake a narrative 
synthesis of the data. The heterogeneity or variation in the data reporting in 
the included studies in this systematic review would be assessed using 
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4.3 Results 
362 potentially relevant publications were identified from the literature search, 
from which 17 full-text articles were reviewed with 12 being excluded (71, 86, 
87, 184, 186, 193-199), as they did not match my inclusion criteria. Table 4 – 





Figure 5 PRISMA diagram 
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   Reference 
Country 







     
Reason for exclusion 
Abreu et al 2013 
(193) 
Portugal 
RCT n=51 FU: 1m Telemonitoring of CPAP compliance and efficacy 
data compared with active phone call care or usual 
care 
Adults with OSAHS 
Mean age 54 
% male 82 
Abstract only published 
 
No teleconsultation used in study 
Dellaca et al 2011 
(194) 
Spain 
Pilot observational study 
n= 20 FU: 1 week 
Remote CPAP pressure titration with TM system in 
the patient’s home by a sleep lab technician 
No comparator 
Adults with OSAHS 
Mean age 56 yrs 
% male not reported 
No control group and no 
teleconsultation 
DeMolles et al 2004 
(195) 
USA 
Pilot RCT n=30 FU: 2m Use of TLC technology system in addition to UC 
 
Comparator - UC 
Adults with OSAHS 
Mean age 50 yrs 
% male not reported 




Editorial   Journal editorial 




study n=90 FU: not reported 
Feasibility of CPAP telemonitoring 
No comparator 
Adults initiating CPAP for OSAHS No results published to date 
Isetta et al 
2014 (86) 
Spain 
Study 1 - prospective 
observational study 
n= 50 FU: same day 
Study 1- Patient satisfaction with teleconsultation 
No comparator 
People with OSAHS 
Mean age 62 
% male 64 
Study 1- no comparator 
Isetta et al  2014 (86) 
Spain 
Study 2- RCT: n=40 FU: 
same day 
Study 2 
CPAP training application via teleconference 
Comparator- usual care 
People with OSAHS being 
commenced on CPAP therapy 
Mean age 59 
% male 80 
Study 2- no daily telemonitoring 
Isetta et al 
2015 (87) Spain 
Multicentre RCT: n=139 
FU: 1,3 6 m 
Bayesian cost-effectiveness analysis of a 
Telemedicine- based CPAP strategy for 
follow-up 
Comparator face-to-face follow up 
People with OSAHS 
requiring CPAP 
therapy Mean age 49 
% male 86 
No telemonitoring of CPAP data  
 
Data were downloaded via the data 
card at the end of the study (not for 
review purposes) 
Kwiatkowska 2009 (199) 
Canada 
Proposed framework for 
development of a telehealth 
support system 
Proposed Telehealth - Framework for 
Supporting the Treatment of OSA 
People with OSAHS living remotely 
from specialist sleep clinics 
No study 
Description of a framework  
Kwiatkowska 2010 (198) 
Canada 
Editorial   Journal editorial 
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Table 4 Reasons for excluding studies 
 
Nilius et al 2012 (71) 
Germany 
RCT: n=84 FU:3m Weekly telephone support re CPAP use for 12 
weeks 
Comparator- usual care 
Adults with OSAH new to CPAP 
therapy 
Mean age 50 
% male 62 
No telemonitoring of CPAP data 
usage 
Parikh et al 2011 (184) 
USA 
Prospective survey of patient 
satisfaction 
n=90 
FU: 2 weeks 
Teleconsultation review remotely 
 
Comparator- usual care 
Adults with OSAHS 
prescribed CPAP 
therapy Mean age 51 
% male 43 
No telemonitoring of CPAP data 
usage 
Sparrow et al 
2010 (186) USA 
RCT n=250 FU: 12 m Theory-driven interactive voice response system 
designed to improve 
CPAP adherence 
using a telephone-linked communications system 
Comparator- 
educational control TLC system 
Provided general health education via a TLC 
system 




Mean age 55 
% male 82 
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4.3.1 Five papers fulfilled our inclusion criteria 
Table 5 describes the characteristics of the studies included and Table 6 
describes the aspects of care addressed in these studies.  
 
Four studies were from North America: A Large private hospital in San Diego 
(200), The University of Kansas /  St Francis Hospital (201), The University of 
British Columbia, Vancouver, Canada (202), The  Walter Reed Army Medical 
Centre in Washington (203) and one from Europe, Burgos in Spain (204). All 
the telehealth-based interventions were delivered in the community setting. 
The five studies included a total of 269 participants and all included real-time 
telemonitoring of CPAP adherence; three studies utilised telephone 
consultations as a means of communication with participants (202, 204), and 
the other two utilised teleconsultation for remote consultations (201, 203). 
 
The heterogeneity or variation in the data reporting in the included studies in 
this systematic review was assessed using Cochrane methodology (192). The 
only homogenous data reported in all five included studies were that all 
participants were newly diagnosed with OSAHS before commencing CPAP 
therapy and all the studies reported that adherence data was transmitted 
telemetrically. There was significant heterogeneity in other outcomes of 
interest: one of five included studies was a CCT (204), two had very small 
sample sizes (201, 204), and there was wide variation in the length of follow 
up between one to six months in all studies. The proportion of people reviewed 
was only reported in two studies, only two included the Epworth sleepiness 
scale (200, 202), with only two reporting on the cost of the interventions (201, 
204),  and patient / clinician acceptability was not reported in four studies (200, 
201, 203, 204). This level of heterogeneity in the included studies allowed me 




































n = 16 





CPAP usage) v 

















v UC 85% 
(significance not 
reported) 
Not measured The visual analogue 
scale used (1–10) 
reported as 9.5 for 
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with the TH 
patients: 
TH: 210 min 
(SD 42) - vs 
UC: 143 min 
(SD 48) p< 
0.0001 
Adherence 
greater in TH 
group: mean 
hours /night: TH 










Not measured Not measured TH may 
improve 
adherence 
to CPAP at 
initiation of 
therapy 






n = 19 
FU: 3 m 
 




























use rate. TH 
(CPAP 
support): 90% 
vs TH (W-B): 
44% 
(p = 0.033) 
Not measured Proportion rating 
service ‘positively’ 
TH (CPAP support) 






were less than 
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support): 
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higher in TH than UC 
group on a score of 
1 to 5 
(4.8 vs 4.3: p = 0.05) 
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(SD 1.8) vs UC: 
2.8 (SD 2.2) 
(p = 0.07) 
 
difference TH 
9.2 (SD 6.6) 
v UC 9.9 (SD 
5.2) 













n = 114 
FU: 1 m 
 
TH via Health 
Buddy with daily 
automated 



























(SD 2.15) v UC: 
4.22 





(reported - no 
differences 
between TM 
and UC group 
No between group 




(SD 3.1) v UC 28.0 
(SD 3.5) p=0.43 
Not measured Very short 
follow-up (28 
days) 
ROB- Risk of bias, FU- follow up, CCT- controlled clinical trial, n-number, m-month, TH-telehealth, v-verses, UC- Usual care, RCT-randomised controlled trial, SD- standard deviation, 
WB-wellbeing, $-dollar  
 
Table 5 Characteristics of included studies
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Study year Country, Setting Patient demographics Description of delivery of Intervention Aspects of care 
addressed 
Duration and intensity Control 
Coma del Corral 




study led from main 
site to nurse 
supported remote 
site 
New diagnosis of OSAHS 
commenced on CPAP 
therapy 
Demographics of those 
randomised not reported. 
16 randomised and 7 
received intervention, 9 
controls 
Central-based sleep research unit and distant 
centre 80Km away. Team members included 
physicians at central unit and nurses at remote 
site 
Face-to-face consultation for commencement 
of CPAP at central unit and via nurse assisted 
videoconference remotely 
3 of 5 outcomes of interest 
addressed 
Compliance/Adherence - 
reported as CPAP therapy 
for > 4 hours per night for 5 
nights per week reported 
Control of symptoms- not 
reported  
Patient/clinician 
acceptability - not reported  
 
Patient satisfaction - 
reported in both groups  
 
Clinician satisfaction- not 
reported  
Cost of telemedicine - 
reported versus usual face-
to-face care 
Interventions conducted by 
a physician based centrally 
and nurse assisted remote 
teleconsultation arm 
Duration of intervention 6 
months. All received at least 







Fox et al 2012 
(202) 
Sleep disorders 





Patients with new 
diagnosis of OSAHS 
commenced on CPAP 
therapy.  
Demographics 
80% male, mean age 53.5 
39 received intervention, 
36 controls 
 
Introductory CPAP session conducted for all 
patients by trained respiratory therapists, 




3 out of 5 outcomes of 
interest reported. 
Adherence-reported as 
number of minutes of use 
per day  
Control of symptoms – 
Epworth sleepiness score 
used  
Patient/Clinician 
acceptability - not reported 
Patient satisfaction - 
measured using a visual 
analogue scale  
Clinician Satisfaction - not 
reported  





Interventions delivered by 
trained respiratory 
therapists, face-to-face and 
telemedicine review 
conducted by a physician 
and respiratory therapist 
Standard care group 
contacted at day 2 to 
assess progress /adherence 
and discuss any problems 
Further face-to-face review 
at 4-6 weeks with physician 
/ CPAP coordinator.  CPAP 
adherence/efficacy 
information downloaded at 
this visit, week 8-and 3-
month clinic visits 
Telemedicine group data 
sent daily via modem 









database monitored by 
research co-ordinator. 
Contacted by a research co-
ordinator at day 2 and at 
other times if needed to 
discuss compliance and any 
problems. Review by 
physician 4-6 weeks and at 
3 months with adherence 
data 





Kansas/ St Francis 





Patients with new 
diagnosis of OSAHS (had 
been non-adherent across 
3 months) recommenced 
on CPAP therapy 
Mean age 63 
No difference in severity 
of OSAHS. % male - not 
reported. 10 received 
intervention, 9 controls 
Nurse-led study in patient’s homes using 
telehealth equipment with built-in two-way 
cameras 
2-way telehealth sessions over the 12-week 
period regarding adherence to CPAP therapy 
and how to manage any problems 
encountered in the intervention group and in 
the control group the 12-week health care 
sessions provided information on importance 
of daily vitamin intake 
4 of 5 outcomes of interest 
addressed. 
Compliance/Adherence- 
reported adherence of > 4 
hours/night for 9 of 14 
nights 
Control of symptoms- not 
reported  
Patient acceptability - 
reported by both groups 
Clinician acceptability - not 
reported  
Patient satisfaction -
reported using evaluation 
survey  
Cost of telemedicine- 
reported 
Study interventions 
delivered in patient’s homes 
by nurses familiar with 
CPAP and clinical trial 
research. Duration of 
intervention was 12 weeks 
(3 x 30 min telehealth visits 
in first week and 
subsequent 1 x 30 min 





CPAP therapy but 
only one group 
received coaching 
in importance of 
CPAP adherence 
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Stepnowsky et 
al 2007 (200) 
Veterans Affairs San 
Diego Healthcare 
System (VASDHS), 
San Diego, CA, USA.  
CPAP clinical staff 
and research team at 
a large private 
hospital 
Patients with new 
diagnosis of OSA 
commenced on CPAP.  
Demographics 
98% male, mean age 59, 
20 received the 
intervention, 20 controls 
CPAP therapists (non-blinded) delivered all 
study interventions, 
Initial face-to-face start-up visit for all 
participants 
Other team members were research 
physicians and statisticians 
3 out of 5 outcomes of 
interest were addressed 
Compliance/Adherence – 
reported as percentage of 
use 
Control of Symptoms – 
Epworth sleepiness score 
used 
Patient /Clinician 
acceptability - not reported 
Patient satisfaction -not 
reported  
Clinician Satisfaction - not 
reported  
Cost of telemedicine - not 
reported 
Study interventions 
conducted by CPAP 
therapists /research staff. 
Usual care group -1-week 
telephone follow-up then 1-
month face-to-face review. 
Helpline number in the event 
of problems. CPAP 
compliance data downloaded 
manually at 1 month 
Telemonitored group had 
CPAP compliance/ efficacy 
data nightly monitored for 2 
months via secure website. 
Participant interactions were 




Taylor et al 2006  
(203) 
 
Walter Reed Army 
Medical Centre, 
Washington DC, USA. 
 Sleep medicine 
practitioners based at 
the Sleep disorders 
centre 
Patients diagnosed with 
OSAHS prescribed CPAP 
therapy 
Demographics 
71% male, mean age 45, 
56 received intervention, 
58 controls 
Sleep medicine practitioners delivered initial 





2 out of 5 outcomes of 
interest were addressed 
Adherence – measured in 
average hours of CPAP use 
Control of Symptoms - Not 
reported  
Patient/Clinician 
acceptability - not reported 
Patient Satisfaction -reported 
Clinician satisfaction - not 
reported  
Cost of Telemedicine- not 
reported 
 
Sleep medicine practitioners 
delivered face-to-face care 
and reviewed the data daily 
Usual care group, one-month 
review and subsequent 
review as needed. Telephone 
support/walk-in clinic visits 
provided for both groups 
Intervention group received 
prescheduled CPAP-related 
questions they entered daily 
in a home computer-based 
telehealth system for 30 days. 
Guidelines used to advise on 
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4.3.2 Description of the study characteristics 
Four of the included studies were RCTs;  (201-203), the other was a CCT    
(204). The follow-up period in the studies ranged from one to six months. Two 
of the studies reported the proportion of reviews achieved. The outcome 
measures included CPAP adherence in all five studies, (200-202, 204), and 
ESS in two studies (200, 202). Patient satisfaction and acceptability were 
reported in all five studies (200-204), but clinician satisfaction and acceptability 
were not reported in any of the studies. The costs of providing the 
telemonitoring / teleconsultation intervention were reported in two studies (201, 
204). The setting for the studies varied with the main sleep Centres either 
being hospital or university-based and the telehealth interventions being 
delivered remotely in people’s homes (200-202), and in one study via 
teleconsultation at a district general hospital, 80 km’s from the main research 
Centre (204). The characteristics of included studies are described in Table 5 
and the aspects of care addressed are described in Table 6. 
4.3.3 Methodological quality 
The results of the methodological quality assessment are detailed in Table 7. 
One study was assessed as a moderate risk of bias (203), and four were at a 
moderate-to-high risk of bias (200-202, 204). The commonest sources of bias 
were lack of information regarding sequence generation, allocation 
concealment, completeness of reporting, no published study protocol, and the 
inability to blind the study personnel to the study intervention. The risk of bias 
in the included studies is represented in Table  8.
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C    Corral et al 
2013 {Coma-D 




  CCT Not reported Not reported No (not 
possible) 







Yes - loss of data 





data in 1 patient 





or statement about 
deviations from 
protocol) 
Yes Small sample size - underpowered 
Included participants with Apnoea 
hypopnoea index > 10 but no further details 
given on severity of OSAHS 
Fox et al 
2012 {Fox N, 
 2012 #617} 
 
High ROB 






















Not reported Unclear (no 
published protocol, 
or statement about 
deviations from 
protocol) 
Yes Single centre study in only patients with 
moderate to severe OSAHS included so 
results relate to this group only 
Low adherence rate in usual care group 
No sham telemonitoring device used as 
control 
Smith et al 
2006 (201) 
High ROB 
RCT Not reported Not reported No Not reported Yes Yes No Small sample size - underpowered 
Participants had been non-adherent to 
CPAP across 3 months following 
diagnosis before enrolment 
Severity of OSAHS not reported 
Stepnowsky 
et al 2007 
(200) 
High ROB 






















1/21 in control  









Yes No published protocol 
Included only those with moderate to 
severe OSAHS 
100% accuracy of wireless data 
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Taylor et al 
2006 (203) 






































Not reported Yes – attrition 
was 9 in the 
control group 




















Telephonic communication delays 
reported, and delay in delivery of 
equipment may have resulted in failure to 
demonstrate benefit of telemedicine 
? 30 days follow up not adequate time to 
measure adherence to treatment 
7 in intervention group withdrawn 
because they did not activate the Health 
Buddy, those left will have been more 
compliant which may have introduced 
bias 
Severity of OSAHS reported 
CCT- controlled clinical trial,  RCT- randomised controlled trial. 
Table 7 Methodological quality of included Studies
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Free of selective 
reporting 
(reporting bias) 




        
Fox et al 2012 
 
        
Smith et al 2006 
 
        
Stepnowsky et 
al 2007 
        
Taylor 2006 
 
        
Table 8 Risk of bias 
Key:      High ROB                      Moderate ROB                          Low ROB     
        
 
The main areas of bias were lack of information regarding sequence generation, allocation concealment, and completeness of 
reporting, no published study protocol, and the inability to blind study personnel to the study intervention.
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4.3.4 Description of the interventions 
The characteristics of the included studies are described in detail in Table 5. 
All of the interventions were conducted by physicians, trained nurses, 
respiratory clinicians, researchers, or CPAP therapists. All of the participants 
in the five included studies had received a face-to-face consultation by a 
respiratory clinician to initiate the introduction of CPAP therapy before entry to 
the study. 
4.3.5 Telemonitoring of CPAP usage data 
Real-time telemonitoring (via a modem) of CPAP adherence and efficacy was 
included in three studies (200, 202, 204). Fox et al also transmitted the CPAP 
adherence data via an attached modem (EncoreAnywhere®, Philips 
Respironics Inc.), (202). Stepnowsky et al used CPAP flow generators that 
were fitted with a ResTraxx wireless transmitter (ResMed Corp, Poway, CA), 
(200). Two studies used a home web-connected telemonitoring system 
(participant activated), with telephone support (201, 203). In all the included 
studies, clinical personnel could access and monitor participants and intervene 
were indicated using predefined pathways that could assist with problems 
where encountered. Stepnowsky et al used a clinician intervention 
management matrix in the telemonitored group that could assist with identified 
problems associated with the mask fit, leak, CPAP pressure issues, and other 
encountered side effects (200). Fox et al used daily telemetric monitoring of 
the participants and data were transmitted daily via modem for review by the 
research co-coordinator regarding adherence, pressure delivery, mask leak, 
and residual respiratory events. Participants were contacted after two days by 
the research coordinator to enquire regarding progress and adherence, and to 
troubleshoot problems with CPAP therapy. The research coordinator reviewed 
the data every working day and made contact with the participant if problems 
were identified:  a detected mask leak > 40 Litre/min for > than 30% of the 
night, < 4 hr of CPAP use for two consecutive nights, observed AHI > 10 
events/hr, and the 90th percentile of pressure > 16 cm water pressure (202).   
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4.3.6 Teleconsultation for remote review 
Additional telephone support by the clinical research staff was used to 
recommend appropriate action where necessary in four studies (200, 201, 
203). Coma-del- Corral et al used a video conference system at a remote site 
hospital, 80 km distant to the central base of the sleep research unit to provide 
the teleconsultation intervention (204). Smith et al used a home-based 
telemedicine system with a built-in modem and two-way camera to allow the 
study nurses to deliver a structured 12 week CPAP education / support 
program (201). Both groups were commenced on CPAP therapy but only one 
group received coaching in importance of CPAP adherence and monitoring of 
problems encountered on treatment.  
4.3.7 Effectiveness of interventions 
The main findings and interpretation of the studies are summarised in Table 9.   
Below is a description of the findings of each included study, and section 4.3.8 
-  and 4.3.12 presents the findings according to the primary and secondary 
outcomes of interest.  
 
Comma-del-Corral found some evidence that teleconsultation combined with 
telemonitoring from the main sleep medicine Centres to a distant site was 
feasible and could potentially provide specialised sleep medicine services to a 
geographically distant population. There was 85% adherence to CPAP therapy 
for greater than four hours per night in the usual care group compared to 75% 
in the telemonitored group. Participants in both groups were satisfied with the 
intervention they received; however, clinician satisfaction and costs of the 
telemedicine intervention were not reported. This model of sleep medicine 
review may reduce the service user’s travel / expenses and improve efficacy 
and optimisation of specialist services with better use of community-based 
hospital beds and be more environmentally friendly (204). 
 
Fox et al found some evidence that adherence to CPAP is improved with the 
use of telemonitoring / teleconsultation at the time of the initiation of CPAP 
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therapy. The adherence / compliance time was defined as minutes per day 
used in this study however there was significantly greater adherence in the 
telemedicine arm (3.2 hours / day), versus the usual care group (1.8 hours per 
day), hours over 3 months (p = 0.006). There were no significant between-
group differences in the ESS or participant satisfaction and cost implications 
were not reported (202). 
  
Smith found some evidence that a structured telehealth / teleconsultation 
intervention delivered over 12 weeks had the potential to improve CPAP 
adherence, facilitate problem-solving strategies via direct visual camera 
observation, and overcome barriers to adherence. There was a higher 
percentage adhering to CPAP therapy in the telemedicine group compared to 
the usual care group: 90% (n = 9 out of 10), compared to 44% (n = 4 out of 9), 
(p = 0.03). Participant satisfaction in the telemedicine group was 100% and 
75% in the usual care group. The total costs of the telemedicine intervention 
per patient were reported as $420 versus $1,500 in the usual care group 
providing some evidence that a telehealth / teleconsultation model may be 
more cost-effective than face-to-face care (201).  
 
Stepnowsky et al found some evidence that telemonitoring of CPAP 
adherence and efficacy with rapid clinician support to guide collaborative 
management was as effective as usual care in improving adherence and 
patient satisfaction. The telemedicine group adhered to CPAP on 78% of 
possible nights compared to 60% in the usual care group (p = 0.07), however, 
adherence was not defined by hours of night-time use in this study. No 
between-group differences were reported in the ESS and participant 
satisfaction was rated highly in the telemonitored group and the likelihood of 
continuing CPAP treatment was higher than the usual care group (4.8 vs 4.3: 
p = 0.05). The telemedicine costs were not reported (200). 
 
Taylor et al found no differences in adherence to CPAP therapy, functional 
status, and client satisfaction in the telemedicine versus usual care group. 
Adherence was reported telemetrically via the Health Buddy computer system 
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and via an automated data recorder at the end of the study. Adherence was 
defined as CPAP use ≥ 4 hours over 30 days with the telemedicine group 
reporting 4.29 hours versus 4.22 hours in the usual care group (p = 0.87). 
There were no between-group differences in participant satisfaction with the 
telemedicine intervention (69%) versus usual care (71%). The costs of the 
telemedicine intervention were not reported (203). 
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 Adherence/Compliance Symptom control 
of OSAHS 




Monitored telematically in both 
groups 
Reported as use of 
CPAP therapy > 4 hours per 
night 
For 5 days per week. 
85% adherence in UC compared 
to 75% in TM arm 
Not reported Measured using visual 
analogue scale (1-10), 
reported as 9.5 for both 
groups 




Some evidence that teleconsultation and telemonitoring from main 
sleep medicine centres to remote sites feasible and can potentially 
provide specialised sleep medicine services to a geographically 
distant population 
 
May also reduce service user’s travel / expenses and improve 
efficacy and optimisation of specialist services with better use of 
community-based hospital beds 
Fox et al 
2012 (202) 
Adherence reported 
telemetrically via attached 
modem in the telemonitoring 
group 
Not defined as ≥ 4 hours use 
Significantly greater in 
telemedicine arm (321mins 
per day) v standard arm (207 
mins per day) 
UC arm 1.8 hrs. v 3. 2 hours 
over 3 months- (p= 0.006) 
Epworth sleep 
score measured in 









score. (TH 5.1 vs 
UC 5.2) 
No significant differences 
between intervention and  
UC measured using a 
visual analogue scale (0 -
10) larger number 
representing more 
favorable response 
regarding subjective sleep 
quality, 5.13 in intervention 
and 6.4 in controls 
Not reported Some evidence that adherence to CPAP is improved with use of 
telemonitoring / teleconsultation at initiation or therapy 
Smith et al 
2006 (201) 
Measured by CPAP unit timer 
recorder. Reported as ≥ 4 
hour’s use of nightly CPAP / 9 
out of 14 days 
Higher percentage adhering to 
CPAP therapy in TM 
compared to the UC group. 
90% (n =9 out of 10) 
compared to 44%. (n= 4 out of 
9) (p = 0.03) 
Not reported. Patient satisfaction 
measured by evaluation 
survey 
 
100% of surveys in TM 
and 75% in UC group 
rated the telehealth 
sessions positively (n =17) 
Total costs of the TM 
intervention per 
patient reported as 
$420 v $1,500 usual 
care 
Some evidence that structured telehealth / teleconsultation over 12 
weeks has the potential to improve CPAP adherence, facilitate 
problem-solving strategies via visual camera observation and 
overcome barriers to adherence 
 
Some evidence that telehealth/teleconsultation model is more cost-
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Stepnowsky 
et al 2007 
(200) 
Adherence reported via 
telemetry to a secure website 
– but not defined by ≥ 4 hours 
of use per night 
 
TM arm used CPAP on 78% of 
possible nights compared to 
60% in UC arm (p = 0.07) 
Epworth sleep 
scale measured in 





scale -  no 
significant between-
group differences 
TH 9.2 (SD 6.6) vs 







quality of life, and 
psychological 
factors at baseline 
and post-
intervention 
Patient and clinician 
satisfaction assessed 
using questionnaires that 
included both Likert – type 
items and open-ended 
questions 
 
Participants asked to rate 
satisfaction with care using 
scale (1 = poor; 5 = 
excellent) 
 
TM arm rated satisfaction 
highly and likelihood of 
continuing CPAP 
treatment higher than UC 
group (4.8 vs 4.3: p = 
0.05) 
 
Both groups reported not 
being concerned with 
being telemonitored 
Not reported Some evidence that telemonitoring of CPAP adherence and 
efficacy with rapid clinician support to guide collaborative 
management as effective as usual care in improving adherence 
and patient satisfaction 
Taylor et al 
2006 (203) 
Adherence reported 
telemetrically via Health 
Buddy system and via 
automated data recorder 
Defined as CPAP use ≥ 4 
hours over 30 days 
UC arm 4.22 hours v 4.29 in 
TM arm (p=0.87) 
Modified 
Functional 
Outcome of Sleep 
Quality   
(reported - no 
differences 
between TM 





No difference between UC 
and TM groups 
69% in intervention and 
71% in control 
Not reported Evidence that no differences in adherence to CPAP therapy, 
functional status, and client satisfaction observed in TM v UC 
group 
TM-telemedicine, UC- usual care, v-versus, $-dollar, n-number, SD- standard deviation. 






4.3.8 Proportion reviewed 
Two studies reported on the number and / or duration of participants reviewed. 
Fox et al found that on average an additional hour over the three-month trial 
was spent with the telehealth patients compared with the usual care group 
(202). In contrast, the teleconsultation / telemonitoring patients in Taylor et al’s 
study in new users of CPAP had one ‘walk-in visit’ per week compared to the 
usual care group who had three per week (203).  
4.3.9 Adherence to CPAP 
The Taylor et al study (at moderate risk of bias) recruited patients with a range 
of OSAHS severity.  Adherence to CPAP with teleconsultation / telemonitoring 
was similar to usual care TH 4.29 hours per night v UC 4.22 hours per night 
(p=0.89).The proportion  of nights used in the TH intervention was 47% v 50% 
in UC group (p=0.61) (203). Three studies of a lower quality reported improved 
CPAP adherence after the teleconsultation / telemonitoring intervention, 
although two were relatively small pilot studies. Fox et al reported adherence 
to CPAP were greater in the telehealth group: mean hours per night: with 
telehealth 3.2 versus usual care: 1.8 (p=0.006), (202). Smith reported 
telehealth (CPAP support) improved the proportion achieving  80% use. 
Telehealth CPAP support: 90% vs telehealth wellbeing : 44% (p=0.033), (201). 
Stepnowsky et al reported a non-significant trend to greater adherence in the 
telehealth group. Hours of CPAP use per night : 4.1hrs (SD 1.8) versus usual 
care: 2.8hrs (SD 2.2) (p=0.07), (204). Coma del Corral reported adherence as 
75% in the teleconsultation / telemonitoring intervention versus 85% in those 






4.3.10 Control of symptoms 
Two studies (both at moderate to high risk of bias) used the ESS to record 
symptom control (200, 202). Fox et al reported the ESS - no significant 
between-group differences with telehealth (5.1hrs ) versus usual care (5.2hrs). 
Stepnowsky et al reported the ESS as no significant between-group 
differences with telehealth  9.2hrs (SD 6.6), versus usual care 9.9hrs (SD 5.2), 
(p=0.72). One study also used the Functional Outcome of Sleep Questionnaire 
(FOSQ) and found no statistically significant differences between the 
intervention and usual care group for any of the component measures of this 
tool (203). Two of the included studies did not measure symptom control (201, 
204). Table 9 - page 63. 
 
4.3.11 Patient / clinician acceptability / satisfaction 
All five studies reported on participant satisfaction with teleconsultation / 
telemonitoring versus face-to-face care. Four studies using visual analogue 
scales (200, 202-204), or questionnaire ratings (201, 203), found no difference 
in satisfaction between teleconsultation / telemonitoring and usual care. One 
study (at moderate / high risk of bias) reported on patient acceptability and 
satisfaction of telemonitoring compared to the control group (201). The authors 
undertook a thematic analysis of the free-text comments on their satisfaction 
survey; 100% of the surveys in teleconsultation / telemonitoring and 75% in 
usual care group rated the telehealth sessions positively (no statistical analysis 
reported); a key theme was that teleconsultation / telemonitoring helped 
reinforce the importance of CPAP adherence and participants felt more 
supported with this intervention. None of the studies reported on acceptability 
to clinicians. Table 9. 
4.3.12 Costs of telehealth intervention 
Smith et al reported that the cost of delivering 14 teleconsultations / 
telemonitoring sessions for a single participant was United states $420  





on the overall teleconsultation / telemonitoring costs (which included 
diagnostic testing) but did not report the direct costs associated with delivering 
the CPAP telehealth review component of the study (204). Table 9. 
4.4 Discussion 
4.4.1 Summary of findings 
The evidence base for the clinical effectiveness of the combined interventions 
of remote consultations plus telemonitoring in the clinical review of adults who 
are using CPAP therapy was limited to five studies.  The findings of two small 
studies (201, 204), and three larger studies (200, 202, 203), four of which were 
assessed as being at moderate to high risk of bias (200-202, 204), and one at 
moderate risk of bias (203), are reported. Collectively these studies do not 
provide definitive evidence of the effectiveness (in terms of adherence and 
symptom control), of teleconsultation combined with telemonitoring in CPAP 
users; however, there is no suggestion of any adverse harm to people who are 
using CPAP therapy from the telemedicine / teleconsultation interventions. The 
free-text comments from a single study suggest that teleconsultation combined 
with telemonitoring was well received and perceived as being supportive (201).  
4.4.2 Strengths and limitations 
In conducting this systematic review, I searched a wide range of databases 
and kept the search strategies broad, but there is the risk that I may have 
missed some potentially relevant studies. I had access to limited resources in 
the conduct of the systematic review and this meant I was unable to arrange a 
duplicate independent screening at all stages of the selection process of 
excluded studies, but I undertook duplicate screening of 25% of the excluded 
abstracts with my co-authors and after discussion achieved 100% agreement.  
 
A key challenge for the systematic review was my definition of telehealth. 
Published studies on the use of telehealth in the clinical review of people with 
OSAHS who are using CPAP therapy utilise a wide variety of terms to describe 





systematic review as an intervention that included both remote consultation 
either by telephone or videoconferencing, and also the capability for real-time 
telemonitoring of CPAP adherence using a web-based platform to transmit 
CPAP adherence data to the main sleep medicine Centre clinical research 
teams. This meant that I rejected interventions (for example) that used remote 
data on CPAP usage but expected the patient to travel to follow-up face-to-
face consultations. However, I recognise that by including the dual 
requirements of the provision for real-time telemonitoring and remote 
consultations in combination in my review that I have excluded a number of 
important studies that have utilised other aspects of telehealth in their study. I 
regarded both telemonitoring and teleconsultation as important components in 
maximising the benefits of telehealth solutions in the delivery of future OSAHS 
healthcare services. Nevertheless, I recognise that the studies that I rejected 
may have some significant lessons of relevance to this review. I have 
described the characteristics of the twelve excluded studies in Table 5.  
 
The main reasons for excluding these studies were: Abreu et al only published 
an abstract of their telemonitoring study that did not include a teleconsultation 
intervention (193). Dellaca et al did not include teleconsultation or a control 
group (194). De-Molles et al’s study did not use daily telemonitoring or 
teleconsultation (195). Farre was a journal editorial (205). Fraysse et al 
conducted a feasibility study that included telemonitoring but there was no 
comparator and there are no published results to date (197). Isetta et al 
reported two studies and the first one measured satisfaction with 
teleconsultation but there was no comparator (86), their second study used 
teleconsultation for CPAP initiation but not telemonitoring (86). The same 
authors published a study in 2015 which did not utilise daily telemonitoring of 
CPAP adherence (87).  
 
In summary, six of the excluded studies did not have the capacity to enable 
real-time telemonitoring of CPAP adherence (71, 86, 87, 184, 186, 197), 





a data card to download this information to include in healthcare records. Not 
having access to real-time telemonitoring CPAP adherence and efficacy data 
may have reduced the potential for the clinicians to detect real-time problems 
in remotely monitored participants such as poor adherence, poor mask fit / 
leak, and  elevated AHI that could have facilitated early clinician intervention 
to resolve any detected problems with the continuous remote monitoring. The 
remote consultations in the excluded studies were generally well-received, (86, 
87, 184) and one trial found the teleconsultations to be cost-effective (travel 
costs and lost work time were the most important sources of savings), (87).   
 
Adherence remains a major and important clinical issue for users of CPAP 
therapy. Echoing the findings of this systematic review, three of the excluded 
RCTs that used a teleconsultation approach showed no benefit in terms of 
adherence, (71, 87, 184), daytime sleepiness, or quality of life (87).  In contrast, 
the excluded study by Sparrow et al tested a telephone-delivered, theoretically 
based, motivational intervention and showed a significant improvement in 
adherence, symptoms, and functional status (186).  
 
The reasons for non-adherence to CPAP therapy are extremely complex and 
in an overview of the many factors that influence adherence to CPAP therapy, 
Shapiro et al cite features of the actual CPAP device; treatment side effects; 
individual patient factors (such as clinical condition / co-existing comorbidity, 
family / home support context, socio-economic status, personality and 
cognitive functioning), the attitude and communication skills of healthcare 
professionals; availability and efficiency of healthcare services; and the 
national policy and the funding of sleep medicine services (93).   
 
An important factor in the long-term adherence of CPAP therapy users is that 
they need to demonstrate to driver and vehicle licensing agencies that they 
meet the driving standards of these agencies and this may have a significant 
and important impact on adherence (52). Sleep medicine clinicians need to 





patients on the benefits of long-term CPAP adherence, and reinforce this 
education at every clinical review. Access to real-time telemetric CPAP 
adherence usage data is a tool to inform and facilitate clinical review 
discussions regarding long-term CPAP treatment benefits as well as meeting 
the requirements of local and national driving and vehicle licensing agency's 
regulations. 
 
An overview of the collective findings of these five studies suggests that a 
combined remote monitoring and teleconsultation model of clinical review for 
people with OSAHS who are using CPAP therapy is worth pursuing. Higher 
quality, larger trials with a low risk of bias in their design are needed.  They 
need to explore the effect of this intervention on adherence, symptom control, 
service user and clinician satisfaction, socio-economic and environmental cost 
/ benefits on an individual and population basis in terms of reduced travel, 
reduced loss of work-based productivity, reduced fossil fuel consumption, and 
reduced carbon emissions for service users and clinicians. 
 
4.5 Interpretation in the light of published literature 
 
Telehealthcare-enabled solutions in the delivery of clinical services are a 
rapidly developing field in sleep medicine and the AASM have recently 
published their systematic review, meta-analysis, and grade assessment of 
treatment of Adult Obstructive Sleep Apnoea with Positive Airway Pressure 
2019. They reported a clinically significant improvement in CPAP adherence 
in adults where telemonitoring was utilised compared to usual care with a high 
quality of evidence for adherence (3). Since I undertook the initial searches at 
the outset of this systematic review, several further relevant studies have been 







The first is a three month prospective parallel group pilot RCT by Fields et al 
(85), which randomised 60 participants to telehealth (real-time telemonitoring 
and teleconsultation with telephone review at one week, one month, and three 
months after CPAP initiation) or usual (face-to-face) care. They found no 
statistical between-group differences in CPAP adherence, patient satisfaction, 
functional outcomes, and dropout rates, although those randomised to 
telemedicine showed greater improvements in mental health scores. The 
participants formal and verbal feedback with all parts of the study was 
overwhelmingly positive. Fields et al’s results reinforce the findings of this 
systematic review, with their conclusions suggesting that larger-scale trials are 
warranted to establish the benefits (or not) of a combined telemonitoring and 
teleconsultation approach for the review for CPAP therapy users. 
 
The second study published in 2017 that would have met the systematic review 
inclusion criteria is a one month non-blinded prospective RCT by Munafo et al 
that included 122 CPAP therapy users that compared a telehealth web-based 
coaching program that also included real-time telemonitoring and telephone 
support from clinicians triggered by responses to automated texts / e-mails 
compared to usual care in people newly diagnosed with OSAHS (88). Again, 
reflecting the findings of my systematic review, there were no statistical 
between-group differences in adherence to CPAP therapy or change in ESS 
with the combined telehealth intervention versus usual care. However, the 
telehealth intervention did significantly reduce the time spent providing 
education and coaching making it a more time-efficient clinical service delivery 
option which is noteworthy and of added value to services. 
 
The third study published in 2018, that would have met the systematic review 
inclusion criteria is a three month RCT by Hwang et al 2018 (187). They 
studied the effect of telemedicine education and telemonitoring on CPAP 
adherence. This four-arm study recruited 556 participants who were 
prescribed CPAP to treat OSAHS. Two telemedicine interventions were 





telemonitoring initiated with an automated patient feedback intervention. 
Patients were randomised to receive 1) usual care, 2) usual care plus tele-
education 3) usual care plus telemonitoring and 4) usual care plus tele-
education and telemonitoring. The primary endpoint in this study was 90 day 
CPAP adherence rates with secondary endpoints being CPAP clinic 
attendance rates and change in ESS.  This study concluded that the 
combination of the use of CPAP telemonitoring with automated feedback 
messaging improved the 90 day adherence rates in CPAP therapy users. The 
telemedicine-based education intervention did not significantly improve CPAP 
adherence but did increase the clinic attendance rates for service users. 
 
The fourth study published by Schoch et al in 2019 was a six month large 
randomised, controlled phase III trial that collected data on the use of 
telemedicine in the CPAP treatment adherence of 240 patients with OSAHS 
over a six-month follow-up period. Participants were randomised to a 
telemedicine or control arm with the telemedicine arm also receiving 
teleconsultation via phone calls during the first month of treatment where poor 
adherence or excessive mask leakage was identified via the remote CPAP 
telemonitoring system. The primary outcome of interest was adherence to 
CPAP therapy at six months with a secondary outcome being the 
measurement of sleep-related quality of life. The study established that the 
telemonitoring triggered intervention in the first month of CPAP use did not 
increase adherence in the study population, however, it had a beneficial effect 
in those with milder OSAS and improved in sleep-related quality of life (206). 
 
The fifth study by Lugo et al 2019 was an open three-month follow-up RCT in 
186 patients that compared routine review with a virtual sleep unit review in 
review of CPAP users. They aimed to compare any clinical improvement and 
cost-effectiveness in a non-inferiority analysis. The virtual sleep unit review 
included teleconsultation and telemonitoring. The virtual sleep unit offered a 
more cost-effective option of improving quality-adjusted life years (QALY’s), 





that a virtual sleep unit could assist with the management of CPAP therapy 
users and adherence was similar in both groups at > five hours per night (207). 
 
Taking into consideration the above studies published since I undertook the 
systematic review that collectively included 1164 participants (85, 88, 187, 
206, 207), all of these studies would have met the inclusion criteria for the 
systematic review. Four of these studies showed no differences in the 
recorded CPAP adherence rates between those randomised to telemedicine / 
teleconsultation versus usual care (85, 88, 206, 207), which mirrors the 
findings of my review where the included studies showed no benefit of 
teleconsultation combined with telemonitoring versus usual care but with no 
observed safety concerns. Only one of these studies showed an increased 90 
day CPAP adherence rate in the participants and this study included CPAP 
telemonitoring initiated with an automated patient feedback messaging 
intervention which may have added additional support and encouragement to 
new CPAP therapy users (187). Regarding other secondary outcomes of 
interest, only one study reported a statistically significant increase in reported 
quality of life at one month in the telemonitoring / teleconsultation group (206), 
however, this was not found to be significant at six months follow up. One study 
reported that virtual sleep unit review compared to hospital review was more 
cost-effective in both in terms of QALY’s and overall service delivery (207). 
 
The follow up period in all the studies included in the systematic review ranged 
from one to six months and the five subsequent studies that have been 
published since my systematic review was conducted also had a follow up 
period of one to six months.  This may not be a long enough period of time in 
order to address the outcomes of interest such as longer term adherence rates 
to CPAP therapy and the effects of telemonitoring and teleconsultation and 
patient and clinician satisfaction with this model of CPAP review. A longer 
follow up period such as 12 - 24 months in future studies may allow more 
confidence in the findings of the outcomes of interest in my systematic review. 





may be problematic due to drop out rates with patients being unwilling to 
participate in extended RCT’s rates. There is also the issue of obtaining 
funding for conducting lengthy RCT’s to consider.  Perhaps prospective 
observation studies over a longer period of time may be an option to conduct 
future research on these outcomes and add to the evidence base and the 




When combining the results of these recently published studies with my 
systematic review findings published in 2017 it would appear that there is a 
consistent message emerging.   Combined telemonitoring and teleconsultation 
results in similar adherence to CPAP and clinical outcomes to traditionally 
delivered face-to-face care but is generally acceptable to patients and may 







4.6 Implications for research and future practice 
The technology to implement this combined model of sleep medicine service 
delivery has been available for more than a decade and is evolving at pace 
globally (particularly in relation to the sleep medicine specialties response to 
the global pandemic). It is becoming widely available and being utilised in 
many healthcare settings and driving more research in this area. Sarmiento et 
al 2019 are leading the field in the national expansion of sleep telemedicine for 
veterans in the USA (208), and many more services are now adopting this 
technology.  
 
Based on the results of the five trials included in the systematic review the 
evidence for remote teleconsultation with daily telemonitoring of CPAP usage 
in OSAHS was far from clear at the time of conducting the systematic review 
and I had originally maintained that well-designed, adequately powered 
studies were required to clarify the role of teleconsultation combined with real-
time telemonitoring in the routine clinical review of people using CPAP therapy.  
 
When considering the combined findings of the five studies that have been 
published since my systematic review was conducted (85, 88, 187, 206, 207), 
and reflecting on the free-text comments in one of the studies, telemonitoring 
was perceived as reinforcing the importance of adherence, whilst remote 
consulting has the potential to facilitate convenient reviews especially for those 
living at a greater distance from sleep Centres. With the emergence of new 
technologies that enable remote teleconsultation, and real-time telemonitoring 
capability in-built into newer CPAP units, there is an opportunity for trials to 
build on the current evidence base and inform future practice (189). A recent 
meta-analysis that included 18 studies and investigated the effectiveness of a 
range of telehealth interventions in improving CPAP adherence concluded that 
a broad range of electronic telehealth interventions in adults with OSAHS can 
improve CPAP adherence early in treatment initiation, increasing the night time 





the duration, timing, intensity, and methods of telehealth delivery that are most 
effective using technology-enabled healthcare (74). 
 
The impact of the arrival of the SARS-CoV-2 pandemic in early 2020 has had 
a huge impact on the delivery of sleep medicine services globally, with many 
services being completely suspended as respiratory clinicians were 
redeployed to the front line to assist acute services during this pandemic. 
Services were just beginning to explore ways to remobilise as the second wave 
of the pandemic appeared, and the use of innovative teleconsultation and 
telemonitoring solutions in the diagnosis and the review of CPAP therapy users 
is at the forefront of all current services.   
 
These technologies are not new and despite this, there has been a slow uptake 
in some services before the pandemic. It is now absolutely necessary to 
continue to develop and utilise these technologies moving forward beyond the 
pandemic as services have adapted rapidly to deliver as many clinical review 
options using non face-to-face telehealth solutions. Incorporating telehealth 
into the diagnosis, treatment, and review pathways for CPAP therapy users 
need to be delivered at the same standard level for face-to-face reviews using 
guideline-based care. The current COVID 19 pandemic although a global 
disaster with catastrophic loss of lives continues, however does force sleep 
medicine services to redesign service pathways using already proven 
telehealth solutions that can help transform health care and people's lives on 
a global scale. 
 
The positive environmental impacts of delivering more remote consultations 
using telehealth solutions are already an important factor in healthcare 
delivery. It reduces the time taken away from the place of employment, also 
reducing the travel time from the place of work to attend a centrally based 
sleep medicine service, and the associated subsequent reduced fossil fuel 
consumption, and is more environmentally friendly than traditional face-to-face 





by vehicles by reducing the number of journeys made for face-to-face visits 
and thus contributes to environmental sustainability. Globally there is an ever-
increasing drive to reduce greenhouse gas emissions with Scotland having an 
ambitious target of an 80% reduction in emissions by 2050. If these targets are 
to be realised, then sleep medicine providers nationally and internationally 
need to develop their telemedicine / teleconsultation services at pace to keep 
up with the growing body of research in this technology-enabled care driven 
environment.  A widespread paradigm shift in the sleep medicine community 
is needed where telehealth solutions are viewed as an essential component of 
health care delivery and not just considered for those who lack access to care 
due to geography, or other constraints. The pandemic may be the catalyst for 




The combination of a remote consulting service and continuous real-time 
telemonitoring of CPAP therapy use has the potential to offer efficient, 
acceptable, and convenient care that has similar outcomes in terms of 
promoting adherence to CPAP and symptom control.  Recent trials corroborate 
these conclusions. Future research needs to include other secondary outcome 
measures beyond adherence, treatment efficacy, symptom control, and patient 
and clinician satisfaction. They need to include the impact of teleconsultation 
and telemonitoring on travel reduction, reduction in lost time in terms of work 
productivity, reduced fuel consumption, and carbon emissions.  In the light of 
the increasing prevalence of OSAHS globally, specialist sleep medicine 
service clinicians and providers should consider investing in telehealth 
services as a strategy to manage the rising demand within the limited capacity 
of this specialist area of respiratory medicine.  The global pandemic has added 





4.8 Summary of Chapter 4 
This chapter reports the findings of a systematic review of the literature 
published in 2015 and also summarises a number of trials published shortly 
after the completion of my review. It is clear that, although some unanswered 
questions remain, teleconsultations / telemonitoring now has an established 
place in the routine management of people using CPAP for OSAHS.  
     
My initial plan was to conduct a pilot RCT comparing telemonitoring and 
teleconsultation with usual face-to-face care however in combining the findings 
of my review and the subsequent publication of several large trials I concluded 
that this was no longer required. During my VIVA I reflected on the five studies 
included in my Systematic review and their collective relatively small sample 
size and their moderate to high risk of bias. My current thinking around this has 
now changed and I would no longer make this assertion. I will consider 
updating my systematic review and include the five studies that have been 
published since then and any more recent studies published since submission 
of this thesis. I would define usual care as a routine face-to-face consultation 
usually in a hospital clinic or outreach clinic that requires the clinician and the 
individual to attend in person for a review and include both teleconsultation 
and real time telemonitoring as the comparator in an updated systematic 
review.   
 
I turned my attention from the mode of delivery to the content of a clinical 
review of CPAP therapy users and how often such a review should take place. 
National and international guidelines recommend regular reviews but do not 
provide clarity on what components should be included in a clinical review and 
the frequency. 
 
In the next chapter, I will describe an e-Delphi study that established an 
international consensus on the most important components and frequency of 





Chapter 5: International e - Delphi study and design of 
Sleep Medicine review template 
In the previous chapter, I conducted a systematic review and established that 
telehealth is an effective and alternative mode of conducting a clinical review 
with some advantages for CPAP therapy users, reducing the need for travel 
for face-to-face reviews, with benefits in terms of reduced time taken off work 
and thus being more convenient and environmentally friendly. 
 
In this chapter, I describe an international e-Delphi in which I reached a 
consensus on the core components of a CPAP review which would be 
applicable in all routine reviews of people with OSAHS.  
 
The e-Delphi is published: 
Murphie P (PM), Little S (SL), Paton R (RP), McKinstry B (BMcK), Pinnock H 
(HP).   Defining the Core Components of a Clinical Review of People Using 
Continuous Positive Airway Pressure Therapy to Treat Obstructive Sleep 
Apnea: An International e-Delphi Study 
 J Clin Sleep Med 2018;14:1679–1687 
 
5.1 Introduction and rationale for the e-Delphi 
5.1.1 OSAHS as a lifelong condition 
OSAHS is usually a lifelong condition that requires long-term treatment such 
as CPAP therapy to relieve symptoms, and the potentially serious impact of 
disturbed sleep and daytime sleepiness and reduced quality of life (9, 67, 209).  
5.1.2 Arrangements for CPAP review in the UK 
In the UK CPAP review and frequency varies amongst Centres with some 
seeing people on an annual basis and some providing open access or on 
request review. A recent publication in the BMJ best practice recommends a 
time interval of 6 - 12 monthly review, however, this has not been firmly 





DVLA requirements (209)(212). Stradling in 2016 reported there were 
approximately 230 000 patients on CPAP in the UK (210). A recent editorial in 
the Lancet estimates that around 8 million people aged 30–69 years might be 
affected by OSAHS in the UK alone, which represents a huge burden to the 
NHS, and already overwhelmed sleep medicine services across the country 
(211). There has been a shift to nurse-led, physiologist and clinical scientist 
review services across the UK to free up respiratory physicians to see more 
complex cases, and there is evidence that this is an effective way of delivering 
services with similar outcomes to nurse versus consultant reviews (171, 212). 
An internet search has identified many services across the UK that work in an 
organised and multidisciplinary team with the oversight of a consultant. 
5.1.3 Frequency and components of a CPAP review 
At the time of developing the International e-Delphi study, the published 
guidelines and best practice statements recommended regular clinical review 
for people who are using CPAP therapy. They suggested a range of 
components that could be included such as subjective assessment of 
sleepiness and other symptoms, adherence to CPAP therapy, practical issues 
with mask fit, equipment issues, pressure settings, guidance on driving license 
advice, and weight and blood pressure monitoring. However, the guidelines 
gave conflicting advice, and some did not offer any advice regarding the core 
content of a clinical review (Table 10), and how often this should take place. I 
felt that this represented a gap in the evidence base regarding the core content 
of a clinical review and there was, therefore, a need to reach a consensus. I 
decided to conduct an international e-Delphi study that included the views of 
respiratory clinicians, specialist nurses, physiologists, physician academics, 
and CPAP therapy users, with the objective being that this method would allow 






5.2 e-Delphi methodology 
Stemming from the RAND Corporation in the 1950s (213), a Delphi study 
delivers a series of questionnaires over (typically) three rounds in which expert 
panellists contribute their ideas independently, and in subsequent rounds 
individual responses may be influenced by feedback of the collective 
participant responses from previous rounds, facilitating arrival at a consensus. 
The e-Delphi is an electronic structured research method that can be used for 
reaching a common viewpoint or consensus among a panel of experts where 
there is limited evidence on the priority attached to a range of items (214, 215). 
It has been used extensively within a health and social care research setting 
to aid the decision-making process regarding health care practices and to 
assist with developing guidelines based on the consensus outcomes. 
Communication can take place by email, enabling participation both nationally 
and internationally over a short timeframe. With the use of the e-Delphi 
technique, experts participate in different periods, at their own pace within the 
set timescales of the research project (213, 215).  
 
5.2.1 Other Consensus methodology options 
5.2.1.1 Nominal group technique 
 
The nominal group technique (also known as the expert panel method), is a 
moderated and structured group activity that encompasses identification of the 
problem, developing solutions to facilitate decision making. Groups of different 
numbers can participate, with the aim being to arrive at a consensus decision 
in a timely manner, by a group vote with all attendees opinions being heard. It 
requires face-to-face meetings and the method aims to prevent the domination 
of the discussion by a single person, encouraging all members to contribute, 
aiming to arrive at an agreed set of solutions or recommendations that 
represent the group’s views or preferences (216). This method is popular and 
has been used to scrutinise the suitability of healthcare interventions that may 





(217). It has advantages in that groups can meet face-to-face and 
disadvantages with the main disadvantage being the travel time and economic 
cost involved with a face-to-face meeting. 
 
5.2.1.2 RAND-UCLA appropriateness method (RAM) 
 
The RAM - also developed by the RAND Corporation and the University of 
California - Los Angeles was developed in the mid-1980s, primarily as a 
method to quantify the overuse and underuse of healthcare procedures.  It is 
an internationally recognised technique that applies a combination of expert 
opinion and current evidence to arrive at a consensus. The consensus 
between participants is then applied to inform the content of guidelines or 
policies under development. This method is used when the evidence base 
underpinning guidelines or practices may need to be refined for a particular 
setting or group, before being introduced or when there is incomplete evidence 
to support decision making. It is a modified Delphi technique that aims to 
precisely find out participants own experiences and views to assist with 
informing the relevance of different healthcare practices. Again its main 
disadvantages are that it requires a face-to-face meeting with the added travel 
and economic costs incurred and it can take a long time to reach consensus 
(218). 
5.2.1.3 Consensus development conference method 
 
This method is intended to assist in the development of a guideline that reflects 
the views of the expert panel that has examined and discussed the scientific 
data, with the aim being to create a multidisciplinary approach to the subject 
of interest. A consensus development conference can be national or 
international with the aim being to gather a large group of healthcare 
professionals and others to meet, and jointly interact to evaluate an existing 
technology or evidence base regarding healthcare policies or guidelines. 





deliberation and consensus of priority issues, and they can be helpful where 
there are conflicting opinions among participants. The method has some 
advantages in facilitating both the creation of the best available information 
and supports the reaching of consensus and validation between participants, 
for whom this work will have the most relevance for this consensus process 
(219, 220). However, the disadvantages are that the process of interactions 
with participants is less structured and there is also the requirement for travel 
and time take from work activities.  
 
5.2.2 Why did I choose an e-Delphi 
I chose to use an e-Delphi research technique for this study to be able to 
include an international audience of participants from different healthcare 
settings and disciplines who were living in different parts of the world. I 
considered this was the best and most practical method in which to obtain or 
achieve consensus,  as it would have been difficult to arrange to conduct three 
rounds either face-to-face or via telemedicine due to the differing time zones 
of participants globally from different continents. 
 
5.2.3 Aims and objectives of the e-Delphi study 
a)  To reach consensus amongst a panel of international sleep clinicians, 
academics, and CPAP users on the most important components to include in 
a CPAP review and how often a review should take place.  
b)  To develop a structured sleep medicine review template that records the 









I obtained ethical approval for the International e-Delphi study from the Usher 
Institute of Population Health Sciences and Informatics, University of 
Edinburgh (application number 1700), (Appendix 3). All participants provided 
electronic written consent to participate in the study. The e-Delphi study 
protocol is described in Appendix  6. 
 
5.3.3 Developing the initial list of components 
5.3.3.1 Guideline review 
 
I identified current national and international guidelines for the management of 
people with OSAHS therapy, searching  Medline, Turning Research Into 
Practice (TRIP), databases and Google Scholar using the following search 
terms ‘sleep apnoea/apnoea syndrome’, ‘CPAP therapy’, ‘national / 
international guidelines’ ‘clinical review’ and ‘follow up’. I scrutinised all of these 
guidelines for their recommendations about the suggested content of a regular 
review of CPAP therapy users and then extracted all the suggested 
components from the guidelines to populate an initial list. 
5.3.3.2  Pilot work to refine the list 
 
I then piloted the e-Delphi process in our local sleep medicine service with ten 
of our clinicians who were invited to add any additional components they 
considered to be important.  
5.3.4 Recruitment of an expert panel 
Delphi panels generally have fewer than 50 participants, and the majority of 
Delphi studies have included between 20-30 respondents (214).  I invited by 
e-mail, 80 international experts (including some CPAP therapy users), 





participants with clinical practice experience, physicians with academic 
expertise as well as CPAP therapy users.  My recruitment strategy involved 
inviting healthcare professionals who were actively involved in the clinical 
review of people with OSAHS who were using CPAP therapy (e.g., clinical 
academics, respiratory physicians, general practitioners, clinical nurse 
specialists / nurse practitioners, respiratory therapists, and physiologists). I 
also invited up to five individuals with OSAHS who were using CPAP therapy 
from a local sleep medicine service. All the suggestions, comments, and data 
that were collected during the study were anonymised, however, all the 
participants were offered the option of being acknowledged as participants in 
subsequent publications. 
5.4 Analysis 
I calculated the collective median scores for each component of the clinical 
review and the proportion of respondents scoring each item as 4 or 5. The 
median is the middle score for a set of data that has been arranged in order of 
magnitude. I used the median because it is less affected by outliers and 
skewed data.  Consensus was defined as ≥75% agreement for the priority 
scores of 4 or 5.   
  
Prioritised components were grouped in the following way: treatment 
acceptability; technical / CPAP issues; sleepiness assessment; treatment 
adherence; symptom resolution; assessing sleep quality; driving issues; 
quality of life; lifestyle issues / sleep hygiene.  These proritised components 
were then mapped to an initial template which could be used to facilitate a 
standardised clinical review.   
 
5.4.1 Free text comments from participants 
Participants were invited to contribute additional free-text comments in all 
rounds.  I analysed the free text comments thematically to identify the key 





5.4.2 The three rounds of the e-Delphi 
I followed the recommended consensus methodology (213, 215), and 
anticipated that it would require up to three rounds to reach consensus with a 
fourth-round planned if this was required. The data collection sheets for the 
















 An International e-Delphi exercise to define the components of a 












Role in sleep apnoea patient group / charity
Person with sleep apnoea
Annual review
Six monthly review
Save this spreadsheet to your desktop, or a folder on your computer.   If you don't do this you will lose all your responses when you close the 
spreadsheet
Checking mask fit
Checking electrical safety of CPAP unit 
Chest auscultation
Recording  Epworth Sleep Score
Verbally asking about CPAP adherence
Recording of CPAP adherence by data download via memory card
 There are three parts to the study: (1) specification of necessary components of a CPAP review, (2) specification of timing/frequency of CPAP 
review, and (3) opportunity to provide free text comments.  We request that you complete sections 1 and 2 as a minimum.
We estimate it will take 15 mins to reflect on CPAP therapy review, and complete the questionnaire.
Changing CPAP filters
Checking  body weight
Recording adherence by remote monitoring
Thank you for agreeing to help with this e-Delphi exercise.  
Listed below are the possible components of a clinical review of a patient using CPAP therapy.    
We invite you to add any additional components and/or comments that you think are important.
Checking blood pressure
Checking that any relevant Vehicle Licensing agencies are aware of the condition
Section 1. Specification of necessary components of a CPAP review.  Below are some suggestions from the literature. Please add any addition components that you think 
are important in the blank rows below our list.  We will use this to generate the list for scoring in the next round.
Checking for treatment side effects
Section 3 - Opportunity to provide free text comments that are relevant to a CPAP clinical review.
Asking about current driving status - Car/Heavy goods Vehicle license
On completion of your response please save to your desktop and return to me by email attachment to:  s1470044@ed.ac.uk
Professional role or interest in sleep apnoea:  - Please enter yes to all that apply.
Section 2 - Specification of timing/frequency of CPAP review.   This section is intended to seek opinions on how often a clinical review should take place. Please add any 











Section 3 - Additional free text comments
Checking blood pressure
Cognitive/developmental issues
Round 2 - An International e-Delphi exercise to define the components of a clinical review of 
people using CPAP therapy 
3 monthly
6 monthly
Telephone reviews at 1,4,8 weeks following starting of trial 
4 monthly
Asking about current driving status - Car/Heavy goods Vehicle license
Checking that any relevant Vehicle Licensing agencies are aware of the condition
Recording  Epworth Sleep Score
Ensuring CPAP is resolving Apnoea Hypopnoea index 
Asking about work schedule/Shift Pattern
Verbally asking about CPAP adherence/Sleep time
Recording of CPAP adherence/efficacy by data download via memory card/remote monitoring
Checking mask fit issues
Chest auscultation
Support system at home  (Help with mask on/off fitting and filling of humidifier if used) /partner engagement
Checking for treatment side effects
Checking electrical safety of CPAP unit 
Review of medical history, medication, any new co morbidities in realtion to symptoms/need for hospitalisation
Checking  patient quality of life 
Checking patient physical activity/exercise
Checking  patient quality of sleep /feeling refreshed on waking 
Asking about quality/quantity of sleep/sleep routine times
Recording the altitude where the patient lives and the altitude where the sleep study was carried out 
Checking  partner feedback / quality of life  
Ask if any problems with sleepiness while driving driving 
Patients preparedness to continue with treatment
Checking if initial symptoms for referral have improved e.g. tiredness/sleepiness/hypersomnalence/ concentration/memory
Check for control of witnessed residual snoring or apnoeas, chocking spells
Section 1. Consists of components of a CPAP clinic review generated from round 1 of the e-Delphi study. Please 
specify the importance of these with   0 = unimportant and 5 = very important.
Save this spreadsheet to your desktop, or a folder on your computer.   If you don't do this you will lose all 
your responses when you close the spreadsheet
Thank you for agreeing to help with this e-Delphi exercise.  This is round 2.
Listed below are the possible components of a clinical review of a patient using CPAP therapy.    
We now invite you to score the importance of the componets listed below with 0 being unimportant and 5 being very important
There are three parts to this round of the study: (1) Scoring the importance of the components of a CPAP review, (2) 
specification of timing/frequency of CPAP review, and (3) opportunity to provide free text comments.  We request that you 
complete sections 1 and 2 as a minimum.
We estimate it will take up to 15 mins to complete the round 2 questionnaire.
Checking  body weight
Component of the CPAP review
Examination of the nasal passage and throat
Ask about factors that help/hinder CPAP use
CPAP unit noise level
Frequency of cleaning mask interface and circuit/changing filters
Requirement  to repeat diagnostic study with significant weight loss/weight gain
Enquiring re possibility of other sleep disorders/i.e. restless leg syndrome
Advice re air travel
Nocturia/Frequency of getting up to pass urine
Fatigue and depression scale /as interfering with epworth sleep score
Requirement for humidification
On completion of your response please save to your desktop and return to me by email attachment to:  
s1470044@sms.ed.ac.uk
12-18 month review
Forced review - ie request from traffic agency/pre planned surgery or similar
Every 5 years
On demand/open access review/based on patient need
Within 3-30 days after initial CPAP introduction 
Every 2 years
Follow up via -Telemonitoring where used
Section 2 - Timing/frequency of CPAP review.   This section is intended to gain consensus on how often a clinical 
review should take place. Please indicate by putting a cross in the final column your preferred timing for routine 
checks of a patient established on CPAP











Score Median score from round 2
 
Section 3 - Additional free text comments
Within 3-30 days after initial CPAP introduction 
Every 2 years
Follow up via -Telemonitoring where used
Section 2 - Timing/frequency of CPAP review.   This section is intended to gain consensus on how often a clinical 
review should take place. Please indicate by putting a cross in the final column your preferred timing for routine 
checks of a patient established on CPAP
If poor compliance/usage seen every 6 months 
On completion of your response please save to your desktop and return to me by email attachment to:  
s1470044@sms.ed.ac.uk
12-18 month review
Forced review - ie request from traffic agency/pre planned surgery or similar
Every 5 years
On demand/open access review/based on patient need
Examination of the nasal passage and throat
Ask about factors that help/hinder CPAP use
CPAP unit noise level
Frequency of cleaning mask interface and circuit/changing filters
Requirement  to repeat diagnostic study with significant weight loss/weight gain
Enquiring re possibility of other sleep disorders/i.e. restless leg syndrome
Advice re air travel
Nocturia/Frequency of getting up to pass urine
Fatigue and depression scale /as interfering with epworth sleep score
Requirement for humidification
Section 1. Consists of components of a CPAP clinic review generated from round 1 of the e-Delphi study. Please 
specify the importance of these with   0 = unimportant and 5 = very important.
Save this spreadsheet to your desktop, or a folder on your computer.   If you don't do this you will lose all 
your responses when you close the spreadsheet
Thank you for agreeing to help with this e-Delphi exercise.  This is round 2.
Listed below are the possible components of a clinical review of a patient using CPAP therapy.    
We now invite you to score the importance of the componets listed below with 0 being unimportant and 5 being very important
There are three parts to this round of the study: (1) Scoring the importance of the components of a CPAP review, (2) 
specification of timing/frequency of CPAP review, and (3) opportunity to provide free text comments.  We request that you 
complete sections 1 and 2 as a minimum.
We estimate it will take up to 15 mins to complete the round 2 questionnaire.
Checking  body weight
Component of the CPAP review
Checking  patient quality of life 
Checking patient physical activity/exercise
Checking  patient quality of sleep /feeling refreshed on waking 
Asking about quality/quantity of sleep/sleep routine times
Recording the altitude where the patient lives and the altitude where the sleep study was carried out 
Checking  partner feedback / quality of life  
Ask if any problems with sleepiness while driving driving 
Patients preparedness to continue with treatment
Checking if initial symptoms for referral have improved e.g. tiredness/sleepiness/hypersomnalence/ concentration/memory
Check for control of witnessed residual snoring or apnoeas, chocking spells
Ensuring CPAP is resolving Apnoea Hypopnoea index 
Asking about work schedule/Shift Pattern
Verbally asking about CPAP adherence/Sleep time
Recording of CPAP adherence/efficacy by data download via memory card/remote monitoring
Checking mask fit issues
Chest auscultation
Support system at home  (Help with mask on/off fitting and filling of humidifier if used) /partner engagement
Checking for treatment side effects
Checking electrical safety of CPAP unit 
Review of medical history, medication, any new co morbidities in realtion to symptoms/need for hospitalisation
Checking blood pressure
Cognitive/developmental issues
Round 3 - An International e-Delphi exercise to define the components of a clinical review of 
people using CPAP therapy 
3 monthly
6 monthly
Telephone reviews at 1,4,8 weeks following starting of trial 
4 monthly
Asking about current driving status - Car/Heavy goods Vehicle license
Checking that any relevant Vehicle Licensing agencies are aware of the condition





Round 1:  Open round 
Round 1 was an open round to compile the list for prioritisation of components 
of a clinical review in CPAP users (Table 10). I developed a data collection 
sheet (using an excel spreadsheet), of potential clinical review components 
that were identified from my literature review of published guidelines and 
combined this with additional suggestions from our local pilot work. I emailed 
the Round 1 data collection sheet with the initial list of possible components to 
the expert panel, requesting that they add any additional components that they 
felt were important to include (Table 10). They were also asked to add any 
additional free-text comments on the initial components. I asked for their 
opinions regarding the suggested frequency of a clinical review. I collated all 
the additional suggested components at the end of Round 1 completion to 
create the final list for the scoring prioritisation consensus in round 2. 
 
Round 2:  First scoring round 
Round 2 was the first scoring round in the e-Delphi study and the panel of 
participants were asked to review the list of components that were generated 
from the free-text in round 1 and then prioritise these components using a scale 
of 1-5 (1 = unimportant and 5 = very important). The results were collated, and 
a median score was calculated for each component in preparation for round 3. 
 
Round 3:  Second scoring round 
The Round 3 data collection sheet included the median scores for all the 
components from round 2 as well as the individual participants own round 1 
score (Table 10). In round 3 the participants were given the opportunity to 
revise their scores (or not), on the priority of the clinical review components in 
the light of the median score findings from all participants of the previous round 
by again ranking each component on a score of 1 to 5 (where 1 = unimportant 
and 5 = very important). I predicted an acceptable level of agreement on 
priority components with 3 rounds however a final 4th round (following the 






Guideline review and preparation of the initial list of possible 
components. 
 
The literature review identified thirteen national / international guidelines and 
best practice statements published between 2003-2016 that made 
recommendations on the long-term management and follow-up of CPAP 
therapy users (Table 11).  From the guideline recommendations, an initial list 
of twelve components was compiled. No additional components were 
suggested by the ten local sleep medicine clinicians who participated in the 
pilot process. 
• Weight monitoring  
• BP monitoring  
• Subjective measure of sleepiness  
• Reported symptoms  
• CPAP adherence  
• Mask interphase issues 
• Pressure setting / comfort  
• Reported side effects  
• Chest auscultation  
• Technical  and safety check  
• Driving / DVLA guidance  









Table 11 National and international guidelines 






























Guideline Network, 2003 (70) 
            
National Institute for Health 
and Clinical Excellence 2008 
updated 2015 (9) 
√ √   √       √ 
BTS Impress Improving and 
Integrating Respiratory 
Services (8) 
   √ √   √  √ √ √ 
American Academy of Sleep 
Medicine 2009 (67) √  √ √ √ √ √ √  √ √ √ 
Australasian Sleep Association 
2009 (221)    √ √ √  √  √  √ 
Hellenic Society of Sleep 
Disorders  2009(222)   √   √ √   √  √ 
Spanish Pulmonology Society 
2011 (7) √   √ √       √ 
Canadian Thoracic Society 
2011 
(76) 
            
BMJ Best practice 2016 (223) 
   √ √        
American College of 
Physicians 2014 (24) √  √  √        
European Respiratory Society 
White book 2014 (6)            √ 
India Institute of Medical 
Sciences  2015 (224)             
International Geriatric Sleep 





5.5.1 International expert panel 
Of the 80 potential participants approached, 47 consented to participate from 
21 countries (Europe n=37, Australasia n=5, Asia n=3, North America n=2).  
Professionals (some represented more than one group), encompassed 
respiratory physicians (n=29), academics (n=25), journal editors (n=9), CPAP 
therapy users (n=6), specialist respiratory nurses (n=5), respiratory 
physiologists (n=3), and respiratory therapists (n=1), (Figure 6). 44 completed 
round one; 41 and 40 participants completed rounds two and three, 
respectively.  
 
Figure 6 Panel participants 
  
5.5.2 Final list of components for scoring 
An additional 24 components to include in the CPAP review were suggested 
in the free text in round one and included in the list for the scoring rounds 
making a total of 36 components (Table 10): 
• Recording Epworth sleepiness scale 
• Verbally asking about CPAP adherence / sleep time 
• Recording of CPAP adherence  / efficacy by data download via memory 




















• Checking mask fit issues 
• Chest auscultation 
• Checking for treatment side effects 
• Checking electrical safety of CPAP unit 
• Checking body weight 
• Checking blood pressure 
• Asking about current driving status - Car / Heavy goods vehicle license  
• Checking that any vehicle licensing agencies are aware of the condition 
• Review of medical history, medication, any new co-morbidities in 
relation to symptoms / need for hospitalisation 
• Checking partner feedback / quality of life 
• Checking the patient quality of life 
• Checking patient physical activity / exercise 
• Checking patient quality of sleep / feeling refreshed on waking 
• Asking about quantity / quality of sleep / sleep routine times  
• Asking about sleep schedule / shift pattern 
• Ask if any problems with sleepiness while driving 
• Checking if initial symptoms for referral have improved e.g. tiredness / 
sleepiness / hypersomnolence / concentration / memory 
• Patients preparedness to continue with treatment 
• Check for control of witnessed residual snoring / apnoeas / choking 
spells 
• Recording the altitude where the patient lives  and the altitude where 
the sleep study was carried out 
• Cognitive / developmental issues 
• Support system at home (help with mask on / off / fitting and filling of  
humidifier if used) / partner engagement 
• Examination of the nasal passage and throat 
• Ensuring CPAP is resolving apnoea hyponoea index 
• Advice re air travel 





• CPAP unit noise level 
• Nocturia / frequency of getting up to pass urine 
• Requirement to repeat a diagnostic study with significant weight loss / 
weight gain 
• Enquiring re possibility of other sleep disorders / i.e. restless leg 
syndrome 
• Fatigue and depression scale / as interfering with the Epworth sleep 
scale 
• Requirement for humidification 
• Frequency of cleaning mask interphase and circuit / changing filters 
5.5.3 Components reaching consensus threshold 
17 components achieved a priority consensus of ≥75%,  indicating agreement 
that these components were important to include in a clinical review. Eight 
components reached a consensus of ≥90% suggesting these were core 
components.  The percentage consensus for all 36 components at the end of 
round three, are listed in order of percentage agreement with the priority scores 






Components of a clinical review, listed in order of proportion 
of respondents who gave priority score of 4 or 5 





Components achieving the priority threshold for consensus (75% agreement with the priority score) 
Checking for treatment side effects 98 Acceptability 
Checking mask fit issues 98 Technical 
Recording subjective assessment of sleepiness / somnolence 
e.g. Epworth Sleepiness Scale 95 
Sleepiness 
assessment 
Recording of CPAP adherence / efficacy by data download via 
memory card / remote monitoring 95 
Adherence 
check 
Ask if any problems with sleepiness while driving 95 
Sleepiness 
assessment 
Checking if initial symptoms for referral have improved e.g. 





Checking  patient quality of sleep  / feeling refreshed on waking  90 
Assess sleep 
quality 
Ensuring CPAP is resolving the Apnoea Hypopnoea Index (AHI) 90 
Symptom 
resolution 
Asking about quality / quantity of sleep / sleep routine times 88 
Assess sleep 
quality 
Patients preparedness to continue with treatment 88 Acceptability 
Asking about current driving status - Car / Heavy goods Vehicle 
license 85 Driving 
Checking  patient quality of life  83 Quality of life 
Verbally asking about CPAP adherence / Sleep time 80 
Adherence 
check 
Requirement for humidification 78 Technical 
Frequency of cleaning mask interface and circuit / changing filters 78 Technical 
Check for control of witnessed residual snoring or apnoeas, 
choking spells 76 
Symptom 
resolution 
Asking about work schedule / Shift Pattern 76 
Lifestyle 
issues / seep 
hygiene 
Table 12 Components achieving the priority threshold for consensus (75% 
agreement with the priority score) 
Components of a clinical review, listed in order of proportion 
of respondents who gave priority score of 4 or 5 





Components not achieving the priority threshold for consensus but with >50% agreement with priority 
scores 
Review of medical history, medication, any new comorbidities in 





Ask about factors that help / hinder CPAP use 73 Technical 




Support system at home  (Help with mask on / off fitting and filling 
of humidifier if used) / partner engagement 
65 Technical 
Recording the altitude where the patient lives and the altitude 
where the sleep study was carried out  
61 Technical 
Checking that any relevant Vehicle Licensing agencies are aware 
of the condition 
60 Driving 
Requirement  to repeat the diagnostic study with significant weight 









Table 12 Components not achieving the priority threshold for consensus,  
but with >50% agreement with priority scores 
 
Components of a clinical review, listed in order of 
proportion of respondents who gave priority score of 4 or 5 




Components with <50% agreement with priority scores 
Checking  partner feedback / quality of life   48 Quality of Life 
Fatigue and depression scale / as interfering with objective 








Checking electrical safety of CPAP unit  33 Technical 












CPAP unit noise level 25 Technical 








Table 12 Components with <50% agreement with priority scores 
 
5.5.4 Themes emerging from the free-text comments 
Seven themes emerged from the free text comments:  
• The first two were regarding checking for symptom resolution and the fifth 
one was about the partner's perspective on symptom resolution.  
• The third theme was regarding the clinician’s perspective on the 
importance of monitoring adherence to CPAP therapy. 
• The fourth theme was regarding managing the technical aspects related 
to CPAP treatment. 
• The sixth theme was regarding the requirement for further general 
medical assessment and input where needed.  
• The seventh theme related to the clinician’s perspective on the frequency 





Table 13 Themes from free-text comments 
 
  
Assessment of symptom resolution 
“Assessment should be focused on whether CPAP has improved the symptoms responsible for initial 
presentation as CPAP is mainly a treatment for symptoms” (Respiratory Physician and Academic). 
“Should also have some documentation of residual AHI on treatment although I am cautious of 
putting this in as it is often a software derived number and in a significant number of cases never 
fully settles to <5.” (Respiratory Physician). 
 Assessment of sleepiness and its impact on activities including driving 
“Questioning whether CPAP is used for all sleep episodes, daytime napping, etc., and 
documentation of whether excessive sleepiness has improved” (Respiratory Physician). 
“I would take a detailed sleep history for a patient with residual sleepiness despite apparently 
effective CPAP”. (Respiratory Physiologist). 
“Professional drivers should have annual nurse review at least”. (Respiratory Physician). 
“We tend to offer 12 monthly reviews for HGV drivers”. (Specialist Nurse). 
“Professional drivers will continue to be seen yearly”. (Respiratory Nurse Specialist). 
The importance of monitoring adherence to CPAP therapy 
“Telemedicine for CPAP adherence tracking should be encouraged and reimbursed” 
(Respiratory Physician). 
“Download of the CPAP device should be performed or supplied ahead by the supplier” 
(Respiratory Physician). 
Technical issues regarding CPAP therapy 
“Checking the operational status and cleanliness of the CPAP humidifier and mask. Need for 
replacement of same”. (Respiratory Physician). 
“Some of the content of CPAP reviews, such as electrical safety testing will also depend on 
whether the machine is provided by the CPAP clinic, rented or purchased by the patient” 
(Respiratory Physician).  
Checking partner feedback and quality of life 
 “Clinical review that incorporates the patient’s bed-partner and / or other close family may be 
useful to help identify and manage any potential problems”. (Specialist Nurse). 
The requirement for general medical assessment 
“Requirement to repeat CPAP titration study or conduct a review if the download information or patient 
report is inconsistent helps with mask issues CPAP pressure etc.”. (Respiratory Physician). 
Frequency and mode of review 
“An early review after the first visit to initiate CPAP is in my view crucial for increasing the chance of 
long-term CPAP compliance.” (Respiratory Physician). 
“The frequency of a clinical review varies globally depending on local health care systems and 
providers, and professional drivers should have an annual review.” (Respiratory Physician) 
“Clinical review provides the opportunity for education / support and reinforcement of treatment “. 





5.5.5 Frequency of review 
 
There was general agreement that the timing of a review should be flexible to 
meet the clinical needs of the patient as well as being compatible with the 
healthcare delivery context.  Frequent review (face-to-face or telephone) was 
considered important to support initiation of CPAP therapy.  A consensus on 
the frequency of review once CPAP therapy was established was more varied 
among participants, with twelve to eighteen-month follow up recommended by 
the majority, although review could more frequent in those with poor 
adherence to CPAP therapy. A flexible approach to review that offered ‘open 
access’ or follow up ‘on-demand / or request’ review was prioritised by 80% of 
the participants.  Similarly, nearly half the participants prioritised the need to 
review CPAP users when there was a specific request from a traffic agency, 
or before elective surgery. Review via a telemonitoring option, where available, 
was also an acceptable option  (Figure 7). 
 
 
                   = early review                 = longer term review              = specific request for review 
 
Figure 7 Frequency of review expressed as a percentage of 
respondents 
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5.6.1 Main findings 
This is the first study to provide an international consensus on the most 
important components that should be considered when reviewing people using 
CPAP therapy. From a list of 36 components, 17 reached a consensus (≥75%), 
and were considered the most important to include during a CPAP therapy 
review. The components identified have been grouped into key categories: 
Technical aspects (n=8 components); General medical assessment (n=7); 
Sleepiness assessment (n=3); Symptom resolution (n=3); Acceptability of 
treatment (n=2); Adherence check (n=2); Assessing sleep quality (n=2); 
Driving issues (n=2); Quality of life (n=2); and Lifestyle issues / sleep hygiene 
(n=2). The need for flexible follow-up arrangements was highlighted by the 
free-text comments indicating that clinical review arrangements should focus 
on individual patient needs. I mapped these prioritised components to a 
suggested prototype template that may support clinical reviews (Table 14). I 
concluded that the clinical review of CPAP therapy users should be flexible, 
frequent in the early stages of commencing CPAP, moving to ‘on-demand’ and 
/ or remote follow-up for maintenance. This can be either face-to-face, via 
telephone, or teleconsultation with the oversight of remote telemonitoring of 
CPAP adherence and efficacy data. The findings of this study may inform 
future guideline recommendations for reviewing CPAP users.  
 
5.6.2 Strengths and limitations 
I generated an extensive list of potential components of a CPAP therapy review 
by amalgamating recommendations from current guidelines with suggestions 
from an international and multidisciplinary participant panel of clinicians and 
academics  involved in sleep medicine reviews, and also from CPAP therapy 
users. Forty participants completed all three rounds of the study; only one 
person withdrew between the two scoring rounds enabling the consensus 





There are some strengths and weakness in using the e-Delphi method in 
conducting consensus research. This methods strengths are that 
communication can take place among experts in the field that enables linking 
of existing knowledge and can enable agreement/disagreement to be 
mediated thus avoiding confrontation. Experts can contribute to the 
understanding and resolution of important unknown problems where there are 
perceived gaps in evidence based guidelines. Another strength is that the e-
Delphi does not require face-face meeting and can be conducted electronically 
on a large global scale in different time zones. Some weaknesses also exist 
with this method such as a lack of agreed standards on selection of participants 
and a lack of a universally agreed definition of consensus and interpreting and 
analysing the findings. There is also the limitation of generalising the findings 
to a wider population due to sample sizes and the differing expertise within the 
included panel. 
 
An important strength of the study is that the participants are from a range of 
healthcare backgrounds involved in the delivery of sleep medicine services, 
representing 21 countries with a broad range of economic backgrounds and 
healthcare systems. Although the number of participants recruited to the 
expert panel is larger than other similar e-Delphi studies, (229), they may not 
represent the full range of perspectives from sleep medicine clinicians / 
providers as the delivery of sleep medicine services varies widely in healthcare 
systems globally. For example in the USA, sleep medicine physicians need to 
be board certified to deliver this specialist service. In less well-developed 
countries with less mature healthcare services access to this specialist service 
may be more limited and there is a risk that the participants in the e-Delphi 
may represent much more well-developed services.  
 
There is also the consideration that the composition of the panel may have 
influenced the findings of the e-Delphi study. The e-Delphi panel comprised of 
29 Respiratory physicians, 25 academics, 9 journal editors, 6 CPAP therapy 





therapists. The Physicians/Academic/Journal editors may have been more 
likely to participate in the panel as many were active researchers in this field 
already and therefore their views may not represent those of the non-medically 
qualified participants which were of a much lower number therefore their views 
may be under represented.  The inclusion of patients in the e-Delphi also has 
some advantages and disadvantages to consider. The advantages could be 
that the patients get to have their views represented about what they think is 
important to them however as there were only 6 in the panel their views may 
also have been under represented. Perhaps conducting separate e-Delphi’s in 
these groups is a future research option, which may allow clinicians to compare 
and contrast what matters to patients regarding a clinical review. 
I also focused initially on predetermined clinical review components, derived 
from current guidelines which may have resulted in the participants being less 
open to making their own suggestions regarding their usual clinical practice. 
However, I invited free text comments throughout all three rounds of the study, 
to allow opportunities for participants to comment, and this resulted in more 
than doubling the number of components included in the scoring rounds. 
Another strength I believe is that I used the free text comments, to assist with 
interpretation and development of the initial outline review template following 
on from a structured mapping of components  (Table 13).  
 
5.6.3 Interpretation in the light of other literature 
5.6.3.1 Comparison with guidelines 
 
Current clinical guidelines regarding the review of CPAP users collectively 
suggest ten components that should be included in a CPAP review, with the 
guideline from the AASM  being the most comprehensive and identifying eight 
of twelve prioritised components (67). There is however wide variation in the 
guideline recommendations published between 2003 (70), and 2016 (78), 
highlighting the need for an international consensus on what is important to 





(e.g. asking if any problems with sleepiness while driving, objective 
assessment of sleepiness e.g. ESS, checking for any mask interphase issues), 
were strongly prioritised (>90%) in the e-Delphi study but were not always 
recommended by the guidelines. Specifically, current guidelines do not 
mention checking for resolution of the AHI despite it being given a priority 
consensus of 90%.  
 
The Veteran Affairs / Department of Defence in the USA published a  Clinical 
Practice Guideline for the Management of Chronic Insomnia Disorder and 
Obstructive Sleep Apnoea in 2019, and although the guidelines recommend 
support for adherence to CPAP and other therapies that may be beneficial and 
weight management recommendations, they do not specifically cover the 
clinical review process and components and how often this should occur  
(225).  
 
The National Institute for Health and Care Excellence is currently updating 
their guidelines regarding OSAHS, and are due to be published in early 2021, 
and the draft scoping document that was published in 2018 does mention that 
monitoring of obstructive sleep apnoea / hypopnoea syndrome, determining 
the efficacy of treatment, how to monitor and how to improve adherence is 
within the scope of this guideline (226). 
 
In 2019 the AASM published Treatment of Adult Obstructive Sleep Apnoea 
with Positive Airway Pressure: An American Academy of Sleep Medicine 
Clinical Practice Guideline. They recommend adequate follow-up, including 
troubleshooting and monitoring of objective efficacy, and usage data to ensure 
adequate treatment and adherence. This should occur following CPAP therapy 
initiation and during the treatment of OSAHS. The guidelines specifically 
mention periodic review by a qualified clinician is necessary to confirm 
adequate treatment, assess symptom resolution, and promote continued 
adherence to treatment, particularly in the early phase of CPAP initiation. They 





person-dependent, with review in the few initial weeks to months after CPAP 
acclimatisation to support adherence and assess treatment effectiveness. 
Yearly review by a trained clinician is recommended, although extended 
follow-up may be appropriate for some patients. They also recommend that in 
patients with persistent or recurrent sleep-related complaints of persistent 
difficulties with CPAP use, more frequent review may be necessary. Finally, 
they recommend objective monitoring of CPAP therapy adherence to 
complement patient reporting of difficulties with CPAP use (3). These recent 
AASM guidelines mention 9 of the 12 possible review components identified 
in previously published guidelines (Table 11). Chest auscultation and BP 
monitoring were not mentioned in the guidelines; however, these components 
could be considered to be part of clinical routine review based on the individual 
clinician’s decision as to whether this was necessary. 
5.6.3.2 Driving regulations 
 
In the UK, this prioritised component of a clinical review may reflect the recently 
updated guidance from the DVLA which states that in moderate to severe 
OSAHS subsequent licensing will require; control of the condition; improved 
sleepiness, and treatment adherence (90). A recent EU taskforce publication 
by Bonsignore et al 2020 has developed a statement to support clinicians who 
advise patients with OSAHS on fitness to drive and this may influence 
clinicians to make this component part of their routine review (45). This is an 
important finding of the e-Delphi study and driving-related issues need to be 
given a higher priority in future clinical review and guideline development. An 
Official American Thoracic Society Clinical Practice Guideline: Sleep Apnoea, 
Sleepiness, and Driving Risk in Non-commercial drivers was published in 
2013, and recommendation nine states clinicians should familiarise 
themselves with the presentations and complications of excessive sleepiness 
as well as local and state statutes or regulations regarding the compulsory 
reporting of high-risk drivers with OSAHS (227). Based on current driving 





component of a CPAP review which also applies to commercial drivers. 
5.6.3.3 Tailoring the review to the individual context 
 
The study identified a number of components that were considered as being 
less important (≤75%), suggesting these may be optional and included 
according to specific clinician judgment (Table 12), suggesting that there is a 
core of components that may always be included in a CPAP review; however, 
other components may sometimes be applicable. For example, a nurse-led or 
non-medical review may include the more highly proritised components, and 
not focus on a general medical assessment as this will have been part of the 
initial review at the point of diagnosis. In contrast in more complex CPAP 
review cases, a medical-led review may focus on other more detailed general 
medical assessment issues. 
 
5.6.3.4 Supported self-management in CPAP users 
 
Ongoing / long-term review also provides the opportunity for education, 
support, and reinforcement of the treatment rationale in CPAP users. Asking 
about quality and quantity of sleep, sleep routine times and work schedules / 
shift patterns, assessing quality of life, and reviewing patients preparedness to 
continue with treatment, all reached a priority consensus of >75%, although 
few current guidelines specifically recommend these components. This may 
reflect the clinical focus of guidelines which may overlook the nuances of how 
OSAHS affects people’s lives. The consensus gained from the e-Delphi study 
has highlighted the importance of considering including these components in 
a review. Supported self-management is not a new concept and is used in 
many other respiratory conditions. A good example is in asthma care where 
supported self-management should not be considered as optional but an 
essential component of asthma long-term care, that is personalised to meet 
the needs of an individual and assist them in optimising their condition (227, 





their condition to better self-manage, and the same principles can be applied 
to recognising deterioration in the symptomatic management of OSAHS so 
that patients take appropriate self-management action and contact their 
healthcare provider where review and intervention are required. A recent study 
by Daines et al, again related to asthma self-management concluded that 
patients reported learning intuitively how to self-manage, and clinicians should 
support and educate patients proactively (228). The same principles could be 
applied in CPAP therapy users, where attention to education and self-
management at the outset is crucial to obtaining longer-term adherence and 
management of symptoms (229). 
5.6.3.5 Practical Checks of CPAP devices 
 
The priority attached to checking practical maintenance of CPAP equipment 
depended on the organisation of sleep medicine services; in some systems, 
this was not part of a clinical review. Practical checks such as electrical safety 
checking of CPAP devices are conducted in some services by the actual 
service provider or may be a contracted out service. The manufacturers of 
modern CPAP units do not recommend that this is necessary on an annual 
basis but some organisations do an annual safety check as this is part of their 
equipment service governance process. This can often be done at the time of 
a clinical review, however, with more remote monitoring of adherence data, it 
is easy to view where there are issues that need corrected like mask fit issues 
or adjusting pressure and humidification remotely. 
5.7  Implications 
5.7.1 Templates and their pros and cons  
One option for implementing these clinical review components is to provide a 
clinical review template. While opinions vary on the use of templates in clinical 
practice, they can facilitate a structured review process and improve 
consistency of care and also reduce practice variation (230). They can support 





However, there are limitations to the use of templates; for example, they may 
not address all issues with CPAP therapy usage from a patient’s perspective 
so some flexibility in their use is important in the review. The use of templates 
to guide a CPAP review may be an attractive option for services, particularly 
for service evaluation, quality assurance, and audit purposes. However, the 
clinician needs to be cognisant of the fact that the review should remain patient 
centred, and about what matters to the patient and not simply become a ‘tick 
box’ exercise that could affect the patient / professional relationship. Building 
on the e-Delphi findings I have developed a suggested prototype template 
based on the components prioritised in the e-Delphi study that could assist 






5.7.1.2 The core components that will form the basis of the template 
Acceptability of treatment 
Checking for treatment side effects 
Preparedness to continue with treatment 
Technical aspects of therapy 
Checking mask fit issues 
Requirement for humidification 
Frequency of cleaning mask interface and circuit/changing filters 
      Subjective assessment of sleepiness 
Recording subjective assessment of sleepiness / somnolence e.g., Epworth Sleepiness Scale 
Ask if any problems with sleepiness while driving 
      Measurement of adherence to CPAP therapy 
Recording of CPAP adherence / efficacy by data download via memory card or remote monitoring 
Verbally asking about CPAP adherence/Sleep time 
       Resolution of symptoms 
Checking if initial symptoms for referral have improved e.g.,  tiredness, sleepiness, hypersomnolence, 
concentration, memory  
Ensuring CPAP is resolving the Apnoea Hypopnoea Index 
Check for control of witnessed residual snoring or apnoeas, choking spells 
Assessing sleep quality   
Checking patient quality of sleep / feeling refreshed on waking 
Asking about quality / quantity of sleep/sleep routine time 
Driving / Vehicle licensing agency issues 
Asking about current driving status - Car / Heavy goods vehicle license 
Quality of Life 
Checking patient quality of life 
Lifestyle issues/Sleep hygiene 
Asking about work schedule / Shift pattern 
Table 14 First prototype of the CPAP review template 
 
Note: This table lists the prioritised components of a review.  The vision is that 
this might be used as the basis of a (potentially computerised), template which 
would: 
• Start with an open question setting the agenda for the review (What 
does the patient wish to discuss?). 
• Act as a ‘checklist’ to prompt delivery of important components of a 
review. 
• Include space for free-text entries.  
• Be followed by a second page with the components that did not reach 





5.7.2  Implications for service models 
 
A key finding from the e-Delphi study is that there needs to be flexibility in the 
delivery of services, both in frequency and the mode of clinical review. Early 
and frequent review is recommended as a priority for new CPAP users and 
those having difficulty with adherence, or practical problems such as treatment 
side effects, and reducing to annual / biannual review when more stable and 
acclimatised to CPAP therapy. The option of offering an ‘open access’ review 
service in which the patient could determine their need for review appealed to 
80% of the respondents in the study. With the ever-increasing demand for 
sleep medicine services globally particularly in the midst of this global 
pandemic, this may be seen as an attractive option for healthcare providers. 
However, there is currently no published literature to inform this practice.  
Furthermore, with the rise in the implementation of sleep telemedicine services 
CPAP review can be facilitated with telemonitoring and overseen remotely.   
 
5.8 Conclusion 
The international expert panel agreed that the most important components of 
a clinical review of people using CPAP therapy to treat OSAHS were 
assessing: treatment acceptability; technical aspects of therapy; subjective 
sleepiness assessment; recording adherence / treatment efficacy verbally or 
by data download via memory card / remote monitoring; symptom resolution; 
driving issues; sleep quality; quality of life and lifestyle issues / sleep hygiene. 
There were diverse opinions on the optimal frequency of review but general 
agreement that relatively frequent review should be undertaken in the newly 
diagnosed patient. Long-term review will be less frequent, or potentially ‘on-
demand’, and can be provided by a range of professionals with the option of 
using telemonitoring where available. The findings of the e-Delphi may inform 
future guideline recommendations in the delivery of care for people with 






5.9 Summary of Chapter 5 
This chapter outlines the findings of the international consensus study that has 
defined the most important core components of a clinical review. I have 
mapped these components into a prototype sleep medicine review template 
that aims to assist clinicians to conduct a patient-centred, structured, and 
evidence-based clinical review. In the next chapter, I will describe a mixed-
methods evaluation of the implementation of the prototype template in three 






Chapter 6: A Mixed Methods Implementation Study of a 
Structured Sleep Medicine Review Template in the 
Clinical Setting 
In the last chapter, I described an International consensus study that defined 
the most important core components of a clinical review which I used to 
develop a prototype sleep medicine review template to guide clinicians 
conducting CPAP review for people with OSAHS. In this chapter, I will describe 
how I recruited three diverse sleep Centres in Scotland to participate in an 
implementation study of a prototype of the structured review template and to 
develop a strategy for using the template in their clinical practice (Figure 8). I 
then evaluated the use of the template in the three real-life clinical settings 
using a mixed methods research design. To inform more generally the impact 
of the implementation of the template in consultations, I explored perceptions 
of the impact on the dynamics of the consultation and specifically any potential 
disadvantages to patient-centeredness, and any potential benefits to the 













Date Age Gender 

















Are there any side effects from the treatment? 
Is the patient happy to continue treatment? 
 
Free text 
Does the mask fit correctly? 
Is humidification required / satisfactory? 


















Subjective assessment of sleepiness (Epworth Sleepiness Scale) :  
Are there any problems with sleepiness while driving? 
What are they driving: Car / Heavy Goods Vehicle? 
Free text 
 
Have witnessed snoring, apnoeas, choking spells been controlled? 
Have initial symptoms improved / resolved? 
Has CPAP resolved the Apnoea Hypopnoea Index? 
AHI:                                               
Mask Leak:                                            
Free text 
Assessing sleep 
quality / quality  
of life 
What is the quality of sleep?  Do they feel refreshed on waking? 
What are their sleep routines?   How much sleep do they get? 
Quality of life  
Free text 
Lifestyle 








Figure 8 Prototype template 
  
Additional optional review components that may be useful in some reviews 
Technical aspects 
 
Factors that help / hinder CPAP use.   Support system at home / partner engagement 
Altitude where lives / Altitude where sleep study was done 
Electrical safety of CPAP unit/ CPAP unit noise level  
 
 Review of medical history, medication review, any new co morbidities in relation to    
symptoms / need for hospitalisation 
Examination of the nasal passage and throat 
Chest Auscultation findings: 
 
Need to repeat diagnostic study with significant weight loss / weight gain 
Nocturia / Frequency of getting up to pass urine 
Cognitive / developmental issues 
 
Fatigue and depression scale / as interfering with subjective assessment of sleepiness e.g. 
Epworth Sleepiness scale    
Checking partner feedback / quality of life 
 
 Are Vehicle Licensing agencies aware of the condition?  










Quality of life 
Driving issues 
We are assessing the use of this template and would value any feedback you can give us.  
Did you find the template useful in this review?      Yes         No     Not sure  
Did use of the template increase the length of the consultation  Yes    No  
Time taken to complete during consultation ……. 
Time taken to complete after consultation ……… 
Review method: Face-to-face  telephone   videoconsultation  






Please tick box that represents your position 
Respiratory Physician/doctor               Physiologist              Specialist Nurse    
Thank you for the feedback    Name:                                                                Date: 
 
   
  
   





6.1 Templates and their role in clinical review 
The use of templates as tools to assist with the delivery of healthcare reviews 
can facilitate a structured and more guided review process and also support 
consistency of care and, have been used in clinical practice for more than two 
decades (230, 231). The use of electronic templates is widespread in general 
practice and was introduced to implement improvements in the quality of 
guideline-based care delivered for people with long-term conditions, as well as 
to standardise data collection linked to the Quality and Outcome Framework 
(232, 233). However, by directing the content of the consultation, templates 
risk overriding the patient’s agenda and have the potential for preventing them 
from expressing their concerns or may constrain the clinical review process 
(233-235).  
 
A recent study by Stanhope et al 2019 has shed further light on the impact of 
using a template-based electronic health record on person-centred care. They 
highlighted that there is a requirement to take a balanced approach to this form 
of consultation to provide some assurance that the use of electronic templates 
during a clinical review is both patient-centred and facilitates high-quality 
evidence-based care. Including an initial question in a standardised review 
template about the patient’s main concerns has been suggested as a way to 
avoid potential disadvantages and facilitate a more patient-focused review 
(236). In the secondary care setting, there is evidence that the use of a 
structured template can facilitate a safe handover of patients between clinical 
teams, and also improve patient safety measures in ward rounds by reducing 
variation and standardising practice (237, 238). There is also evidence that the 
use of a standardised surgical template improves the quality and quantity of 
documentation regarding patient information compared to freehand text and is 
preferred by health professionals and can support the reliability of the audit 
quality and control process (239, 240).  
The NHS Patient Safety Strategy was published in 2019 and central to this 





Within this document, there is reference to the patient safety incident response 
framework and introducing standard reporting templates as a means of 
reducing variation nationally (241).  
 
There has been no evidence on the use of a specific paper-based or electronic 
CPAP clinical review template until very recently. In 2020 Chakrabarti et al 
describe the use of an intelligent computerised guided decision support 
systems as a novel way to safely assess and review people with OSAHS who 
are using CPAP therapy. This system is based on the use of computerised 
templates with decision-support creating the possibility for non-sleep medicine 
specialists to conduct comprehensive guided consultation. This could support 
the entire diagnostic and management pathway and create capacity within 
healthcare systems – which the authors suggest could be valuable as the world 
recovers from the impact of the global pandemic (179). This system is not 
widely available within the UK to date. Their system offers a much more guided 
decision support pathway with safety net features within the computer program 
that can provide alerts and advice to non-specialist clinicians to support them 
to conduct an evidence-based consultation. It differs from my prototype 
template.  My template is a means of recording the content of a CPAP review 
which can be either paper-based or computer-based.  
6.2 Implementation Research 
More than a decade ago Goldsmith et al 2007 et al 2009 described 
implementation research as a method of merging both quantitative and 
qualitative data sources that if successfully brought together and considered 
in one review could promote the uptake of research findings into routine 
practice (242). The field of implementation research has evolved over recent 
years as a methodology to understand and evaluate strategies for 
implementing evidence-based interventions in the real-life clinical setting (243-
245)(248- 250). A core aim is to shorten the time it takes to translate evidence-
based practice into routine clinical practice and hasten the integration of 






A core concept promulgated by the StaRI reporting standards and reflected in 
the terminology used in this implementation study is the distinction between 
the evidence-based intervention (e.g. core components of an OSAHS/CPAP 
review), and the implementation strategy which is used to promote the use of 
the intervention (e.g. the use of a template integrated within the existing 
routines of the clinical setting (246, 247). In an implementation study, it is the 
implementation strategy that is the primary focus of the evaluation (e.g. uptake 
and the use of the template in the clinical review).  
 
Preparatory phases of implementation studies involve understanding existing 
routines and adapting the intervention and the strategies to improve local 
conditions in a specific health care delivery setting. Implementation research 
(in distinction to local quality improvement studies), seeks to create 
generalisable findings by adopting a theoretical approach and / or 
implementing in a theoretically determined range of settings (e.g. 
computerised / non-computerised clinics; mostly face-to-face / remote reviews; 
rural / urban setting). To inform more generally the impact of the 
implementation of the template in CPAP reviews, I aimed to explore the 
participating clinicians perceptions of its impact on the dynamics of the review, 
clinical autonomy, any potential benefits to the completeness of review, and 






6.3 Need for research in this area 
A search of the literature (AMED, (Allied and Complementary Medicine) 1985 
to May 2020, Embase 1974 to 2020 May 06, ERIC 1965 to January 2020, Ovid 
MEDLINE(R) ALL 1946 to May 07, 2020, Books@Ovid May 04, 2020, 
Journals@Ovid Full Text May 07, 2020, NHS Scotland Journals@Ovid) did 
not identify any publications regarding the use of a sleep medicine review 
template in routine clinical practice.  
 
6.4 Mixed methods research 
The fundamental purpose of using mixed methods studies is that merging 
quantitative and qualitative data facilitates a better understanding of the 
findings than either approach alone. The overarching purpose of combining 
these methods is to expand and strengthen a study’s conclusions and its 
contribution to the evidence base (248). I chose to use mixed methods in this 
study as the use of the differing approaches had the potential to provide a 
greater depth and breadth of study data information which I thought was not 








6.5 Aims and objectives of the implementation study 
This multicentre study used both qualitative and quantitative mixed methods 
to develop and evaluate implementation strategies and explore the use / 
applicability of the sleep medicine review template in established CPAP 
therapy users. Quantitative data aimed to assess the effectiveness of the 
implementation strategy (e.g. uptake of the template by Centre and by the 
clinician), the feasibility of using the template (e.g. time taken to complete), 
and its ease of use as an intervention (fields completed, additional fields 
required). The qualitative data aimed to explore the perceptions of sleep 
medicine clinicians on the ease of use or otherwise, and any advantages or 
disadvantages of the use of the template in patient reviews. See Appendix 10 
Implementation study protocol. 
 
Aim 
To introduce the template in three diverse sleep medicine Centres for use in 
face-to-face or remote consultations and observe implementation using mixed 
methods. 
Objectives 
I had four objectives which aligned with four phases of the study: 
1. Objective I: To develop an implementation strategy adapted to the 
routines of the different Centres. 
2. Objective II: To implement the use of templates in routine practice in 
each of the Centres. 
3. Objective III: To undertake a mixed-methods evaluation, assessing 
uptake and use of the template and exploring perceptions of template 
use. 







6.6.1 Study design  
The CPAP review template was implemented over two months in the routine 
clinical review of people with OSAHS using CPAP therapy in three diverse 
settings.  Ethical approval was obtained by the NHS Health Research Authority 
in July 2019 (Appendix 11). ACCORD was the study sponsor. I used the 
Standards for Reporting Implementation Studies (StaRI) checklist to assist in 
accurately reporting the findings of this implementation study (246, 247), 
(Appendix 12). 
6.6.2 Recruitment of Centres 
Three sleep medicine Centres in the UK consented to participate in the study. 
These Centres were selected to represent different contexts: City, Urban / 
rural, and Rural. Participation was discussed with senior clinical and / or 
management staff to gain management approval for the Centre to participate.    
 
The participating Centres clinicians were invited to use the template when they 
were conducting a review of CPAP therapy users over the study period. 
Reviews could be undertaken face-to-face, by telephone, or teleconsultation 
review according to usual clinical practice. All the clinicians from the 
participating Centres were invited to use the sleep medicine review template 
in all reviews, and Centres were asked to ensure that a blank template was 
attached to each set of records, or the templates being readily available to the 
staff undertaking the review. Clinical staff had the choice of whether or not to 
use the template in their reviews. In addition, whether the template was used 
for any individual review or whether specific components were addressed was 






6.6.3 Recruiting participants for the qualitative research 
I aimed to recruit between five and seven clinicians (respiratory physicians, 
physiologists, specialist nurses), from each Centre (in total up to 20), who were 
actively involved in reviewing people using CPAP therapy to treat OSAHS to 
participate  in a  final qualitative interview. Interviewees were selected to offer  
a maximum variation sample of professional backgrounds, frequent / 
occasional / non-users of the template.  All participants provided written 
informed consent before the interview. 
  
6.6.4 Study procedures 
In line with the four objectives (section 6.5), the study procedure followed four 
phases. The study objectives and procedures are summarised in Table 15 and 







To develop an implementation 
strategy adapted to the routines of 
the different Centres 
The implementation strategy for each site was developed during a series of site visits in discussion with the 
participating clinicians and the principal investigator. Each site had different routines and developed different 
strategies for ensuring a template was available for every consultation (e.g. attached to the clinic documentation 
or in a room where the review was being conducted.  
A Specific consideration was the choice of a paper or electronic template. The preference of the participating 
site teams was identified and materials prepared accordingly. 
II 
To implement the use of templates in 
routine practice in each of the 
Centres   
At the baseline visit to set up the study, each site was provided with anonymised templates to suit their service 
(all sites indicated their preference for a paper version) – training, explanation on completion of the template was 
provided. 
A mid-study visit to check for any problems (and potentially make any minor amendments if feasible) was 
offered if required.  Potentially this ‘visit’ could be done by telephone or teleconference. 
III 
To undertake a mixed-methods 
evaluation, assessing uptake and use 
of the template and exploring 
perceptions of template use 
Quantitative data collection 
Anonymised copies of the template were collected for analysis of uptake 
The fields completed on the template 
The overall proportion of CPAP reviews  
Qualitative exploration of clinical perception of template use (n=20 clinicians): 
The discussion covered the following questions  
What were the advantages / disadvantages of using the template in clinical practice?  
How was the template used (during the consultation as a prompt, after the consultation as a means of recording 
the review content) 
What is the impact of the template on the conduct of the review, clinical autonomy, patient centred care, and 
patient / professional relationship?. 
Are there any components that should be added or removed from the template 
IV 
To refine the template and 
implementation strategy 
Further refinement of the structured sleep medicine review template will be informed by the evaluation of the 
feedback from the semi-structured interviews and free text comments entered on the returned templates. 





6.6.5 Development of an implementation strategy adapted to the 
routines of the different Centres (Objective I) 
I planned to visit each of the Centres at least once at the onset of the study. At 
one of these initial visits, I planned to convene a group discussion of 
participating clinicians during which I would  explore perceptions of current 
arrangements, the components that they usually include in the clinical review 
of CPAP therapy users, and any benefits or concerns they may have about the 
use of a template 
• The implementation strategy for each site would be developed during 
these Centre visits in discussion with the participating clinicians. Each 
site may have different routines and develop different strategies for 
ensuring a template be available for every consultation (e.g. attached 
to the clinic documentation or readily accessible within the clinic rooms). 
• A specific consideration for the Centres would be the choice of using a 
paper or electronic template. The preference of the participating site 
teams would be identified and materials prepared accordingly. 
Data collection: Field notes would be kept of all visits (including minutes of 
any formal discussions / meetings), telephone calls, e-mails, etc. All decisions 
about implementation strategies would be documented.    
6.6.6 Implementation of the use of templates in routine practice in 
each of the Centres (Objective II) 
Implementation would be the responsibility of the Centres, but I would support 
the implementation strategy by: 
• Providing templates to suit the routines in the different services  
• Providing training and an explanation on completion of the template.  
• Offering a mid-study visit to check for any problems (and potentially 
support any minor adaptations to the template or implementation 
strategy, if required / feasible). Potentially this ‘visit’ could be done by 






Data collection: Field notes would be kept of all visits (including minutes of 
any formal discussions/meetings), telephone calls, e-mails, etc. Any 
adaptations suggested by Centres to improve implementation would be noted. 
 
6.6.7 Mixed-methods evaluation, assessing uptake and use of the 
template and exploring perceptions of template use  (Objective III)     
6.6.7.1 Quantitative data collection 
 
I planned to undertake a quantitative assessment of the effectiveness of the 
implementation strategy at promoting the uptake of the intervention (template 
use).  A process of secure collection of anonymised copies of completed 
templates for analysis would be agreed  with each Centre. Anonymised copies 
of completed templates would be collected at each site visit. Paper copies 
would be anonymised by removing any patient-specific identifiable information 
from the completed templates before collection at subsequent site visits or 
scanned and returned by NHS email. The templates would indicate the Centre, 
the clinician’s profession, and mode of review (face-to-face, teleconsultation, 
telephone), and an estimate of the time taken to complete.  
 
Data collected were: 
• The total number of templates completed at each Centre 
• The mode of clinical reviews undertaken by clinicians in the 
participating Centres as reported by the Centres   
• The clinician’s specialty that completed the template 
• The age and gender of the patients reviewed 
• The number of components completed in the templates 
• The total proportion of CPAP reviews conducted in each Centre. 
• Estimated time to complete the template during or after the review.  
For the purposes of the research, the template included a box for 
the estimated duration of the review 






6.6.8 Qualitative exploration of the clinical perception of template 
use  
 
At the end of the study, I planned to recruit between three and seven clinicians 
from each site (in total up to 20), to participate in semi-structured interviews. 
These interviews would explore how the templates were used in the clinical 
setting. I planned to audio record all the interviews and transcribe them into 
the NVIVO software program for thematic analysis.  
 
The discussion would cover the following questions (Table 16) detailed topic 
guide). 
 
Main question Additional questions Clarifying questions 
 
1. I am interested in your views on 
whether you think there is any value or 
not in using a structured template for a 
clinical review – for example, is it 
worthwhile. Do you already use one in 
your service?  
 
2. I am interested in your views of any 
evidence to support this way of 
conducting a clinical review. 
 
3. Are you aware of any evidence to 
support the use of guided templates in 
a clinical review? 
 
 
4. Was the decision to participate in the 
completion of the implementation of the 
template team led or organisationally 
led? And did you perceive there was 
any pressure to participate? 
 
 
5. Do you think you as an individual or 
your service were given adequate 
support/instruction on how to 
implement the template?  
 
6. Do you perceive any differences (even 
if you did not use the template) in the 
way that a consultation would be 
carried out as a result of using the 
template in a clinical review?  
 
•   
• If you do can you clarify what is 
different about your usual way of 
working 
•  
•  or if you do not how did using the 






Can you clarify why you think it is or 
it is not worthwhile using a template 
in a clinical review? 
•  
•  
• How well do you think the template 
was implemented over the study 





Can you clarify what additional 
support/instruction may have helped 
with the implementation of the 
template? 
 
Can you clarify what perceived 
differences would using the template 





• Can you please 
clarify what you 
mean by ....? 
• Can you please 
expand a little on ...? 
• Can you please give 
some examples of 
...? 
• In particular, what do 





7. What is the impact of the template on 
the way the clinical review is 
conducted regarding: 
• your clinical autonomy? 
• your patient/professional 
relationships? 
• patient centred care. 
 
 
8.  Are there any additional components that 
could / should be added or removed from 
the template, or how it could be improved 
 
9.  Do you think you or your service will 
continue to use the template or adapt it to 
suit your service after study completion? 
 
10. What factors do you think may have 
improved the uptake of the template in 
your department/service? 
 
11. Do you think the use of a structured 
template will modify or change the way 
that you deliver your clinical review or 
the service in the future? 
 
12. I am interested in your views about the 
team individual’s knowledge and skills 
and whether you feel the template is 
useful or not in your personal opinion 
and your style of practice / consultation 
 
 
13. I am interested in the structure of your 
service and how individual members of 
the team conduct clinical reviews of 
CPAP therapy users 
I am interested in how the MDT network 
and communicate within your service 
and how each MDT member 
contributes to developing and 
delivering the service 
   I am interested in your views on service 
evaluation and improvement and 
readiness for implementation of a 
structured review template in your 
service 
Can you clarify any additional 
impacts, either positive or negative of 





• patient centred care 
 
 
Can I ask you to clarify why any 
additional components you would like 
to see are added/removed from the 
template 
 
Please can you clarify why you may 
or may not wish to use the template 
or adapt or modify it for your service  
 
 
Can you clarify what factors may 
have helped more clinicians to 
participate in the study? 
 
If so, can you clarify why this may 
change your future practice or 
service delivery 
 
Table 16 Semi-structured interview topic guide 
 
• What were the advantages / disadvantages of using the template in 
clinical practice?  
o How was the template used (during the consultation as a 
prompt, after the consultation as a means of recording)? 
• What is the impact of the template on: 
o The way the clinical review is conducted. 





o Patient / professional relationships. 
o Patient-centred care 
o Are there any components that should be added or removed 






6.6.9 To refine the template and implementation strategy (Objective 
IV) 
This would be informed by the evaluation of the feedback from the semi-
structured interviews and free text comments entered on the returned 
templates. Further adaptation of the structured sleep medicine review template 





6.7 Data analysis 
6.7.1 Quantitative data analysis 
The analysis of the quantitative data would be limited to descriptive analysis 
and summary statistics and the key outcomes would be the effectiveness of 
the implementation strategy as assessed by: 
• The uptake of the template by the participating clinicians and sites 
(the number of templates completed at each site by the clinicians 
and the proportion of all clinical reviews). 
• The feasibility of using the template in terms of perceived time taken 
to complete the template; participants would be asked to record this 
timing at the end of the template. 
• The usefulness of the template as an intervention in terms of the 
number of fields completed and any additional fields suggested by 
participants. 
• Subgroup analysis - the use of the template in relation to the mode 
of clinical review and the background of the clinician who conducted 
the review 
 
6.7.2 Qualitative data analysis 
 
The following qualitative data would be available for analysis:  
• Initial group discussion with clinicians at participating sites (from field 
notes at initial visit) about components of the review they normally 
include in their clinical practice, and practicalities of implementing 
the use of the template. 
• Free text comments added on the anonymised templates by 
clinicians during reviews which could  provide immediate insights 
into positive / negative perceptions of review 
• Clinician / semi-structured interviews would be audio-recorded at the 





• The intention would be that these interviews would be conducted as 
soon as possible after the end of the two month study period, but 
the COVD-19 pandemic meant that data collection had to stop after 
three interviews. As soon as I was allowed to recommence research 
activities, I completed the interviews (by Microsoft teams video-
conferencing) but this was 4-5 months after the end of the study. I 
planned to conduct a thematic framework analysis of the qualitative 
data. 
• I aimed to use constant comparison, seeking a wide range of views, 
particularly seeking out contradictory views, and aimed to recruit 
participants until no new views related to the research objectives 
were expressed i.e. data saturation. 
• It was agreed that more than one researcher would extract 5% of 
the data to ensure that there was attention to the potential for and 
control for interviewer bias. 
• I aimed to use NVIVO software to thematically analyse the 
qualitative data. 
 
6.8 Framework analysis 
The Framework Method for the analysis of qualitative data has been used 
since the 1980s and is increasingly popular in medical and health research 
(249). It is a method that exists within a wide range of thematic methods (see 
section 6.9) and is described as an adaptable, organised, and precise method 
of analysing qualitative data that can facilitate transparent and clear results 
particularly with regards to theme-based and case-based analysis (250). It can 
assist the researcher to structure and assist logical thinking in an organised 
way and is a model that can direct and enable sense-making and 






I chose to use a framework analysis to interpret the qualitative study data 
because it is particularly suited to multidisciplinary health care research and it 
is not aligned to any particular philosophical, epistemological, or theoretical 
method, and can be used with a variety of qualitative methods (259). It 
facilitates a coordinated approach to qualitative data interpretation. In addition, 
the systematic process of framework analysis, and the ability for analysis to be 
completed with the help of computer software provides useful structure and 
guidance for novice researchers (249). 
 
Framework analysis uses a step-by-step process for thematically analysing 
research data and these steps are outlined in Table 17. The large volume of 
research data generated by qualitative interviews means it is vital for 
researchers to categorise the data and be able to manage the data in an 
organised way to ensure that it is available for analysis and to provide evidence 
of the research’s accuracy and reliability. It lends itself well to the evaluation of 
implementing healthcare interventions, and it can be used with a mixture of 
narrative methods of collecting data, such as interviews and focus groups 
(250, 251).  
 
There are some challenges with framework analysis. As with all thematic 
analysis, it is a lengthy process that consumes a lot of researcher resources 
and time and generates a vast amount of data (249, 252). I decided that 
framework analysis had more strengths that outweigh the challenges of this 
method and considered that it was well suited to analysing the data from the 






Stages of framework analysis (250) 
Transcription 
A good quality audio recording and, ideally, a verbatim (word for 
word) transcription of the interviews are required.  The process of 
transcription is a good opportunity to become immersed in the data 
and is strongly encouraged for new researchers. The transcription 
of the audio recordings can be uploaded to NVIVO software to 
assist with the data analysis and coding process. 
Familiarisation with the interviews 
Becoming familiar with the whole interview using the audio 
recording and any contextual or reflective notes that were recorded 
by the interviewer is a vital stage in interpretation. It can also be 
helpful to re-listen to all or parts of the audio recording before 
coding the data. 
Coding 
Coding aims to classify all of the data so that it can be compared 
systematically with other parts of the data set. After familiarisation, 
the researcher carefully reads the transcript line by line, applying a 
paraphrase or label (a ‘code’) that describes what they have 
interpreted in the passage as important. Again this can be done 
manually with a software program such as NVIVO and can be used 
to conduct the coding process. A deductive approach to thematic 
coding of the interviews is best suited where a theory is being 
tested for example the participants responses on the usefulness 
and uptake of the template in this implementation study. 
Developing an analytical framework 
 
After coding the first few transcripts, the researchers involved 
should meet to compare the codes they have applied and agree on 
a set of codes to apply to all subsequent transcripts. Codes can be 
grouped into categories (using a tree diagram if helpful), which are 
then clearly defined. For this study NVIVO was again used to 
generate the codes. This process results in generating a working 
analytical framework. 
Applying the analytical framework 
The working analytical framework is then applied by indexing 
subsequent transcripts using the existing categories and codes. 
Computer-Assisted Qualitative Data Analysis Software (CAQDAS) 
is particularly useful at this stage because it can speed up the 
process and ensures that, at later stages, data is easily 
retrievable. In this study, NVIVO software was used to analyse the 
framework. 
Charting data in the framework matrix 
Qualitative data are voluminous and a 30-minute interview can 
generate many pages of text. Being able to manage and 
summarize (reduce) data is a vital aspect of the analysis 
process. The text transcripts can be tagged automatically if you are 
using CAQDAS to manage your data. (N-Vivo version 9 onwards 
can generate framework matrices). I used NVIVO 12 which was 
able to automatically generate a coding matrix. 
Interpreting the data 
It is useful throughout the research to have a separate notebook to 
record field notes or a computer file to note down impressions, 
ideas, and early interpretations of the data. If the data are rich 
enough, the findings generated through this process can go beyond 
the description of particular findings to explanation of, for example, 
reasons for the emergence of a phenomenon, predicting how an 
organisation or in this research study multidisciplinary teams may 
be likely to instigate or continue to use the intervention in their 
future service. 
 






6.9 Alternatives to Framework analysis: Grounded theory    
There are other methods of analysing qualitative data such as grounded 
theory. Grounded theory is flexible, but also a structured methodology. It can 
be applied when there is not a lot known regarding a phenomenon, with the 
objective being to generate an explanatory concept that reveals or exposes 
characteristics of the subject of the qualitative research (253). It refers to a set 
of systematic inductive methods for conducting qualitative research aimed 
towards theory development and can follow three main types of approach: 
Classical grounded theory, Modified grounded theory, and Constructive 
grounded theory.   
 
A classical grounded theory approach is based on the Glaser and Strauss 
1967 book “The Discovery of Grounded Theory”, an approach viewed as 
theory generation rather than just an analytical method. The aim is to scrutinise 
the data and look for new theoretical insights. All data are considered in the 
process including fieldwork notes and other data that are generated. With this 
approach, it is recommended that the data generated are not examined first 
which avoids creating an early bias with the focus being to create a conceptual 
theory that may explain a relevant pattern of behaviour relevant to the research 
participants.  
 
Modified grounded theory is based on representational interactionism from a 
sociological perspective that relies on the representational sense that people 
attribute to the social interaction processes. It addresses the subjective 
meaning people place on behaviours or objects or even events based on what 
they believe is their truth. Depending on the different participant perspectives, 
a modified grounded theory might be more action-focused and may permit 






Constructionist grounded theory fully involves the role of the participant and 
researcher in the process of generating knowledge and interrogating the 
nature of the knowledge generated and theory generated. It aims to seek 
numerous perspectives or points of view and also explores and discovers 
patterns and connections among categories in the data. It encourages 
researchers to engage with various interpretations of the phenomenon of 
interest and accepts that the analysis is generated from collective experiences 
and interactions between the researchers and the participants (254, 255).  
 
I chose not to use a grounded theory approach for the qualitative data 
collection and analysis of the implementation study as it uses an inductive 
approach that is concerned with the generation of new theories or themes from 
the data. The more deductive approach of framework analysis is 
aimed at testing existing theory which in the implementation study was the 
content and structure and the use of and uptake of the structured sleep 
medicine review template in participating Centres, with the contents of the 
template already informed by the findings of the international e-Delphi 
consensus study. I aimed to understand the perceptions and practicalities of 
implementing templates in routine clinical care, not new theory generation (10).  
 
6.10 Frameworks that could inform my framework analysis 
6.10.1 The Consolidated Framework for Implementation Research  
The Consolidated Framework for Implementation Research (CIFR) is a 
theoretical framework designed to support the systematic assessment of 
multilevel implementation settings to characterise components that might 
impact implementation and its effectiveness in healthcare settings (256). A 
number of evidence-based effective interventions in healthcare services 
research are often unsuccessful in their translation into clinical practice, with 
missed opportunities for contributing to improving patient care. The CIFR can 
be used to characterise and comprehend contextual factors that may impact 





interventions. It consists of five domains that can all impact a healthcare 
intervention and is particularly suitable for rapid cycle appraisal of complex 
healthcare intervention delivery. The domains are described in Figure 7. There 
are also a number of constructs within each domain that the researcher needs 
to consider however, it is designed to be a flexible tool that the researchers 
can adapt to fit the intervention, design, factors, and research situation. 
 
 






I considered these domains when I was developing my topic guide (to ensure 
I had addressed key factors that might have determined implementation); in 
developing a coding framework; and finally in the discussion of the qualitative 






6.10.2 The Normalization Process Theory (NPT) 
 
The NPT is a sociological toolkit that can be utilised to assist researchers to 
understand the processes of developing, implementing, embedding, and 
integrating some new technology or complex intervention in healthcare  (257, 
258). The NPT proposes four conceptual elements or constructs that represent 
different methods of working patterns around implementing a new practice: 
Coherence, Cognitive Participation, Collective Action, and Reflexive 
Monitoring (258, 259). In parallel with CFIR, I considered using the NPT as a 
framework to inform coding, analysis, and interpretation of the data from the 






6.11 Steps in the framework analysis 
 
I followed the seven steps in the Framework analysis to assist me in analysing 
the qualitative data results (Table 17). After completion and thematic coding of 
the qualitative interviews using  NVIVO 12 software, I chose to incorporate the 
CFIR (260, 261), in the discussion section of this chapter. I chose to do this at 
this point as its domains of outer setting, inner setting, intervention, process, 
and participants felt like a good fit with the themes that emerged from coding 
the semi-structured interviews (Table 20). I did initially also plan to use the 
NPT framework in addition to the CFIR, however, after completing and coding 
the thematic analysis of the interview data I felt that the NPT framework was a 
much more subjective than objective way to analyse the data compared to the 
CIFR framework, therefore I chose not to use the NPT framework.  
 
6.12 Synthesis of quantitative and qualitative research data  
The limitations of qualitative and quantitative research individually in making 
sense of all forms of evidence-based healthcare have been recognised for 
almost two decades (262, 263). In only concentrating on only one of these 
methods, there is the risk that important evidence-based findings may be 
overlooked or disregarded (264). Combining the results of both quantitative 
and qualitative data can be defined as a mixed-methods approach with the aim 
being to strengthen and compensate for respective limitations of the different 
methods (131, 262).   
 
More recently there has been increasing acknowledgment that amalgamating 
both quantitative and qualitative evidence in a mixed-method combination can 
be beneficial and support the understanding of how complex healthcare 
interventions may impact in certain settings or environments. This approach 
can potentially provide a better understanding of how multifaceted 
interventions may work and for whom, in which healthcare systems and how 





implementation of a structured sleep medicine review template). I used a 
parallel-results convergent synthesis design where qualitative and quantitative 
data are analysed and presented separately with integration occurring in the 
interpretation of results in the discussion section of this chapter. This mixed-
methods approach for the synthesis of the quantitative and qualitative data can 
also use triangulation to analyse the quantitative and qualitative data 
separately and then compare the research findings to develop a complete 
understanding and oversight of the clinical effectiveness or otherwise of the 
implementation strategy and the clinicians perceptions on how the use of the 
template affected (positively or negatively) the efficiency, completeness and / 
or patient-centeredness of the review. Triangulation provides opportunities for 
convergence and corroboration of results that are derived from different 
research methods (265, 266). Each component of the study data is assessed 
for agreement (convergence), complementarities, or contradictions 
(dissonance). The interpretation of the qualitative data from the thematic 
framework analysis would be compared with the quantitative data to 
corroborate or contextualise themes that emerged from the qualitative findings 
that may inform further refinement of the review template for future 
implementation.  
 
6.13 Reflexivity  
As a novice with no previous experience in qualitative research methods the 
concept of ‘reflexivity’ was completely new to me. Reflexivity is described as a 
means of helping qualitative researchers to achieve consistency, accuracy, 
and quality in their research, and is important for defining the reliability and 
fidelity of qualitative research. All qualitative research takes place within a 
specific place and time and may involve two or more people as well as the 
person who is conducting the research.  It is essential to show transparency in 
all the components of the research so that the reader can comprehend the 
research setting or situation and its validity (266). It includes the requirement 





context of the research setting (267). Reflexivity can improve the 
trustworthiness and reliability of the research and contribute to one of five 
quality features for publishing (the others are credibility, dependability, 
transferability, and confirmability of the research findings). 
 
Critical distance and impartiality in the data analysis was a vital component to 
consider in conducting the implementation study as I was the principal 
investigator and also a practicing sleep medicine clinician with 23 years of 
experience in this speciality with my own beliefs and experience.  Therefore, 
as an ‘inside researcher,’ it was important to consider the potential impact of 
my preconceived personal biases while conducting this study. I was very keen 
to hear all the views of the participants regarding the template and how it may 
(or may not), be helpful in other sleep medicine services but recognise that my 
personal bias was a factor I needed to keep in mind throughout this 
implementation study. I actively encouraged and sought out any criticisms of 
the template from the participants during the interviews. In other respects, the 
‘inside researcher’ position was a strength, as I had a deep understanding of 
the subject area and the context in which it was delivered and I felt this was an 
advantage in linking the theoretical and the empirical parts of the study.  
 
I was also interested in exploring where service improvements may be 
possible by reducing variation, standardising processes, and sharing best 
practices, but I tried to be open to all critical comments and suggestions. 
Reflecting on the national context there is a national sleep medicine service 
improvement and remobilisation workplan ongoing in which I am involved and 
this will have influenced my understanding and questioning. It may also have 
affected responses I received as many of the interviewees would know about 
the national improvement Workplan and my role in it.  In addition, I was keen 
to share any learning from this implementation study with the national team.  
 
I had developed the structured sleep medicine template based on the 





reflexive because of the risk of preconceived bias, however, I tried to be open 
to suggestions about the structure and content of the template and its 
helpfulness or not in a clinical review and its usability. Objective IV in the study 
was to refine the template based on feedback from the participants so I felt 
that this was a really important factor in controlling my personal bias regarding 
suggestions about how the template could be improved for future use. Some 
helpful feedback and suggestions were provided that have assisted me in 
refining the template which may be used as a paper or electronic version. I 
kept a research diary, where I would record reflexive notes, impressions of the 
data, and thoughts about analysis throughout the process.  
 
I knew four of the nine clinicians who participated in the semi-structured 
interviews very well through a national sleep medicine network and this will 
have affected the interviews in that I already had a personal relationship with 
these individuals, and also had some prior knowledge of how their services 
were delivered. This may also have introduced some ‘scope drift’ in the way in 
which the topic guide was used and how the interviews were conducted. One 
positive reflective consideration is that this also made the interviews feel very 
comfortable and it did allow a relaxed and open-ended style of asking 
questions. Following on from the first three interviews I was able to have a 
discussion with my co-researchers about the content of the first three 
interviews and how I needed to be more reflexive in my future interviews and 
this helped me to develop the topic guide further to address the research 
objectives in which I was interested.  This assisted me in the final six interviews 
which generated more useful and richer qualitative data content. 
 
I also needed to recognise and take into account the ongoing potential for bias 
as the study progressed and continue to apply critical reflection to ensure the 
relevance of the data collected and the appropriateness of the analysis 
methods I used to develop the themes that emerged from the study. Good 
record-keeping at all stages of the study was conducted by keeping field notes 





well as any emails with the study participants to maintain a transparent and 
consistent view of the data collection and interpretation. I also compared and 
contrasted similarities and differences from the interviews which were assisted 
by the use of the NVIVO software in the analysis of the responses from 
interviewees to ensure differing opinions / views were captured as reliably as 
possible in the thematic analysis. I also continuously engaged with my co-
investigators throughout the study to reduce the potential for personal research 
bias as much as possible.  
 
The initial two semi-structured interviews were the first time that I had 
conducted qualitative interviews. Although I used a topic guide to assist with 
the interviews, after transcribing these first interviews I could see that I tended 
to speak too much about my clinical service and experience and did not ask 
the participants to expand on some of the responses they gave me.  This will 
have influenced how they responded to the questions and may have reduced 
divergent opinions as interviewees aligned with my views. A factor that may 
have improved my qualitative interview techniques prior to commencing the 
study would have been to ask one or two of my colleagues to participate in a 
recorded interview to allow me to develop a more reflexive approach to the 
semi-structured interviews. A total of nine semi-structured interviews, one 
start-up group discussion, and the free-text comments on the templates were 
transcribed and analysed by following the framework analysis process 
described in Table 17. It was evident that in the later six interviews that more 
themes were emerging that I think reflects these final semi-structured 
interviews were of a higher quality as I developed more reflexivity in my 




Another reflection is that I conducted the first three interviews before the SaRs-
Cov-2 pandemic stopped research activities. This meant I had very limited data 





confirmability of the research findings to the point that conducting a thematic 
analysis would not have been possible. However, due to a respite in the 
pandemic in July 2020, I was able to conduct the final six interviews using the 
secure NHS Microsoft teams teleconsultation facility. These final interviews 
enabled the implementation study to meet the study objectives.  Reflecting on 
the use of Microsoft teams to conduct these interviews, it was a very positive 
experience for me as the participants all consented to have their interview 
audio recorded via Microsoft teams and this made the interview transcription 
process easier, clearer, and smoother to complete.  
 
A final reflective observation is that of maintaining the confidentiality of the 
sites and the participants identity as the country in which this study was 
conducted is small, however, there are several similar City sites, Urban / rural 
and Rural sleep medicine services throughout the country that reduced the risk 






6.14 Impact of COVID 19 on the study 
Despite a carefully planned implementation study protocol, due to the arrival 
of the Coronavirus global pandemic in the UK on the 28th February 2020, this 
resulted in a delay in qualitative data collection however I was able to meet the 
aims of the study protocol (Appendix 10). I was able to complete the final six 
interviews in July 2020 due to some respite in the pandemic, and I believe that 
despite this the qualitative and quantitative data will be able to meet the four 
study objectives. These final later interviews were conducted almost five 
months after completion of the study which may have impacted on the recall 
of the experience of those who used the template, although it had the 
advantage that I was able to determine that one site continued to use the 
template beyond the study perhaps indicating that there may be some 
sustainability of the intervention either in paper or electronic form in future 







6.15  Results 
I recruited three Centres to participate in the study: Centre one – City, which 
was a large tertiary sleep medicine service, Centre two, Urban / Rural also a 
city-based sleep medicine service but also serving a large rural catchment 
area and Centre three Rural, covering a mostly remote and rural wide 
catchment area. The Centres will be referred to as City, Urban / Rural, and 
Rural in the results section.  
  
The City Centre was a large mostly urban-based sleep medicine Centre that 
serves a population of around 800,000. This was a large and well-established 
city-based sleep medicine service within a dedicated unit where diagnosis and 
treatment of a range of sleep disorders are conducted. The multidisciplinary 
team consisted of respiratory physicians, speciality doctors, physiologists, and 
nurses. 
 
The Urban/Rural Centre was a sleep medicine service serving a population 
of around 400,000 in a large city but with a very wide rural catchment area and 
geography again being a significant challenge in delivering services. The 
multidisciplinary team at this site also consisted of respiratory physicians, 
speciality doctors, physiologists, and specialist nurses. 
 
The Rural Centre was a sleep medicine service serving a population of around 
310,000 in a remote and rural region with significant geographical challenges 
for clinicians and patients to travel to deliver and receive services in the remote 
clinic sites as well as in the main Centre. Again the multidisciplinary team at 
this site also consisted of respiratory physicians, speciality doctors, 






6.15.1 Objective I To develop an implementation strategy adapted 
to the routines of the different Centres 
Visits were conducted face-to-face or virtually at all three participating Centres 
to establish the local routines of these services to develop tailored 
implementation strategies. Specific practical considerations were how to 
ensure a template was available for use during reviews (e.g. attached to the 
clinic documentation or readily available within the clinical environment to 
complete during the review). The City Centre and the Urban / Rural Centre 
were conducted by face-to-face visits and the Rural Centre was conducted 
using video consultation. All sites chose to use a paper version of the template.  
These could be anonymised (patient name and CHI number blanked out) 
before copies of the templates were made available for the evaluations.    
 
City Centre:  Developing the Implementation strategy 
 
I was invited by the Lead respiratory consultant to present my research 
protocol at a multidisciplinary team (MDT) meeting with approximately 20 
clinicians, and eight clinicians indicated they were interested in using the 
templates (three consultants and five registered nurses).  I was given the e-
mail addresses of the interested participants and I arranged to provide the 
study resources electronically.   
 
Following the MDT meeting, I met with four of the nurses from the sleep 
medicine department for an initial group discussion. They were based within 
the sleep medicine unit and conducted sleep medicine clinical reviews 
regularly both in the ward and the outpatient clinic setting.  These four nurses 
provided written consent to allow me to audio record the group discussion 
which involved asking the participants what they normally did within a sleep 
medicine review using a topic guide. I also made field notes.  I wanted to learn 
about the routines within the department and how they normally structured a 
clinical review. I explored perceptions of current arrangements, the 





users, and any benefits or concerns they may have about using the template. 
We discussed the best way to facilitate the completion of the templates at the 
time of the clinical review and how to collect these anonymised templates after 
study completion. The nurses agreed that they would attach the paper 
templates provided to the clinical notes, and they would keep the anonymised 
templates securely within the department until the next site visit when I would 
collect them.   
 
The completion of the template was in addition to the paperwork they already 
had to complete so they were concerned that this may extend the time of their 
consultations. They normally wrote their clinical reviews in long-hand text and 
then also had to enter this in the electronic care record so I understood how 
implementation at this site might be impacted by the additional work of 
completing the template.  I felt that this was a good start to the implementation 
study however I had very little time with the consultant medical staff due to 
clinic workload and I noted that I would need a further site visit to facilitate their 
engagement. 
 
I was also able to meet with the Service lead for the department who agreed 
that she would speak to the team and encourage them to use the template. I 
was informed that the department was already undergoing a service redesign 
and improvement plan as there were very long waits for diagnosis and 
treatment of OSAHS and commencing CPAP therapy. I was able to conduct 
an initial discussion with one of the Consultants early in the study by telephone 
and he also agreed to use the template however he was then redeployed to 






Urban/Rural Centre: Developing the Implementation strategy 
 
A start-up visit group discussion was undertaken with a specialist nurse and 
one respiratory consultant. The specialist nurse completed all the clinical 
reviews for CPAP and NIV patients and the consultants mostly saw the new 
patients and did not conduct any CPAP reviews. The specialist nurse already 
used a template in her clinics however was happy to use my template for the 
duration of the study. She commented that the content of my template was 
very similar to hers except hers was structured differently and she used 
separate templates for CPAP and NIV reviews. Severe train delays impacted 
our scheduled appointment time; therefore, the initial group discussion was a 
bit too short to have a full discussion about what the specialist nurse included 
in her clinical review and we agreed that we could continue the conversation 
at a later date. This was clarified at the final interview. It was agreed that 
completed templates would be anonymised and scanned and emailed to me 
by secure NHS mail. It was clear that this was very much a nurse-led service 
at this site and the consultants were unlikely to use the template.   
 
Rural Centre: Developing the Implementation Strategy 
The first visit was conducted by teleconsultation using NHS Near Me with two 
respiratory physicians and two specialist nurses who all agreed on the use of 
templates.  A member of the administrative team was tasked with providing a 
template for all the consultations and collating the anonymised templates for 
return by collection in person or by registered post at the end of the study.  It 
was agreed by the Lead respiratory consultant that they would commence the 
study the first week in January for eight weeks. A template would be made 
available for all the clinical reviews and the decision was team led by the Lead 
respiratory physician. It was also highlighted that this service was also looking 
at service redesign and they were keen to participate in this study as the 
template was ready for use and could support their local initiative.  There was 





6.15.2 Objective II To implement the use of templates in routine 
practice in each of the Centres 
 
The study was implemented in the three Centres between October 2019 and 
closed in March 2020. (Appendix 13 outlines the site visit schedules and field 
notes from these visits).  
 
City – Progress with implementation   
The City Centre was the first site to participate and two mid-study site visits 
were conducted during the implementation phase. 
 
I attended a site visit where I sat in on a morning clinic with one of the 
consultants to understand the medical clinic routine and spoke to the clinic 
outpatient staff to see how they might assist with attaching the templates to 
the case notes for completion. This was agreed however, no templates were 
completed and there was no medical participation in the study at this point. 
Another mid-study visit was conducted where I attended the ward team 




No mid-site visit or telephone support was required at the Urban / Rural Centre.   
 
Rural  






6.15.3 Objective III To undertake a mixed-methods evaluation, 
assessing uptake and use of the template and exploring 
perceptions of template use 
6.15.3.1 Final data collection Centre visits 
 
City fourth visit 8-2-20  
A further visit was conducted again meeting with the department manager and 
several other nursing team members did agree to participate at this fourth visit 
however, the Coronavirus made an appearance in March 2020 and the 
priorities for all respiratory teams was to focus on patient care of those affected 
by COVID 19. This would also have required a protocol amendment to extend 
the study time and all studies were halted by ACCORD at this time. 
Urban/Rural Final Telephone review 12-2-20  
A final structured recorded interview with one respiratory nurse specialist who 
completed the study was conducted by telephone following informed consent. 
The quality of the interview was much reduced by not being able to pursue a 
video consultation as the technology was not working properly that day. I did 
take extensive field notes as well as recording the interview which helped to 
capture most of the content of the semi-structured interview and I was invited 
to telephone this participant if I needed to clarify anything regarded the 
recorded interview content.  
Rural final visit   
Email correspondence from the Lead respiratory physician from the 13th March 
2020 confirmed that they had completed the study as planned however due to 
the arrival of the COVID 19 pandemic they were asked by their NHS board to 
cancel non-urgent visitors to the hospital so a final face-to-face visit to 
undertake the semi-structured interviews was not possible. I sent the final 
semi-structured interviews topic guide to the participants on the 4th April 2020 
and I suggested in this email correspondence that the final interviews could be 
conducted by video consultation and this was achieved with two specialist 





which they all consented to be audio recorded.  The completed templates were 
returned to me by registered post for the quantitative data analysis.  
6.15.3.2 Quantitative assessment of the effectiveness of the 
implementation strategy 
                                                                                                                                                                                                                                                                                                                                                       
Assessment of the effectiveness of the implementation strategy (e.g., uptake 
of the template by site and by clinician). There were a total of 520 clinical 
reviews in which the template could have been used across the three Centres, 
and 219 completed templates were returned for data analysis suggesting that 
the template was used in 42% of the reviews.    
 
This proportion varied between Centres: 
The City Centre returned 58 templates completed by three nurse specialists; 
26% of 224 CPAP reviews. The Urban / Rural Centre returned 12 templates 
completed by one specialist nurse; 13% of the 96 CPAP reviews.  The Rural 
Centre returned 137 templates completed by specialist nurses plus 12 
competed jointly with a respiratory physician; 75% of 200 CPAP reviews. 
 
Where recorded there were 169 face-to-face reviews, 30 were video 
consultation reviews and 20 were telephone reviews (Figure 10). One Urban / 
Rural and one Rural Centre were already using teleconsultation CPAP review 








Figure 10 Mode of review 
 
6.15.3.3 The feasibility of using the template (e.g. time taken to 
complete) 
 
The average time taken to complete the template when this was done during 
the review with the patient present was fourteen minutes (132 respondents) 
and the average time to complete the template after the patient left the review 
was four minutes (123 respondents), (Figure 11). Forty out of 219 (18%) 
participants responded that it increased the overall review time.  Where 
recorded the average time to complete the template was 14 minutes during 























Figure 11 Average time in minutes taken to complete the template 
 



















During review After review














Of the 219 templates completed 154 (70%) were male, the average age of 
patients was 60 years (SD 12.6). Adherence was recorded in 204 / 219 (93%) 
participants,14 of which had no recorded adherence, 28 had < four hours per 
night adherence and 168 had > four hours per night adherence. Nine patients 
had OSAHS but were not using CPAP therapy.  
 
The fields completed on the template were; treatment acceptability 216 / 219 
(99%), technical aspects 210 / 219 (96%), subjective assessment of 
sleepiness 211 / 219 (96%), ESS 209 / 219 (95%), symptom resolution 170 / 
219 (78%), AHI 70 / 219 (32%), sleep quality and quality of life in 214 / 219 
(98%). Of the 210 using CPAP, mask leak issues were recorded in 69 / 210 
templates (33%), The lifestyle section of the template was completed in 194 / 
219 (89%) with the additional/optional fields completed in 162 (74%). Driving 
issues were completed in 213 / 219 (97%). Weight, height, BP, and oxygen 
saturation were recorded in 138 (63%), 96 (44%) ,123 (63%) and 35 (18%) 
respectively.  
 
Several of the specialist nurses reported that it was not possible to get 
adherence and efficacy data from older CPAP machines via telephone / 
teleconsultation review. The section asking the clinician to indicate whether or 
not the template was useful was completed for 181 (83%) consultations.  On 
148 (68%) occasions the clinician regarded the template as ‘useful’ and seven 
responded ‘not sure’ where this was completed (with two responding that it 
was their first time using it and they were unfamiliar with it). Only 12 (0.05%) 
indicated that the template was not useful and eight of these were in NIV 
reviews.  Figure 12 represents the percentage of fields completed in the 
template. There were comments about adaptation to the template in the free 
text comments which will also be addressed in the qualitative data analysis 
(Table 18). The additional optional fields were considered less useful (Figure 





Table 18 Free text comments on the template 
Free text comments on the templates 
A separate NIV template would be preferred 
We would adapt the template to record diagnosis, current settings, device, interface 
The plan would probably be to have a separate template for the NIV clinic. 
Not everything is applicable for an NIV clinic 
Finding navigating document is getting easier throughout the clinic 
First attempt at using the template for review 
Took longer than normal at the beginning but this is to be expected 
In the clinic, we retained the data card for download and then posted it back to the patient 
Finding the template really useful in sleep clinics 
Finding that getting easier throughout clinic 
First attempt at using template review took longer than normal, but this will be expected.  
We are unable to obtain apnoea-hypopnea index and mask fit from some of our older device in the clinic 
so have retained data card for download and then to be posted back to the patient afterwards 
Unfortunately, the patient had not been using correctly throughout and there was no data, and she has 
not been receiving any therapy 
Box for patient further appointment or discharged for open access review would be helpful 
Possible outcome should also be included as a box 
First time use so unfamiliar with the template. 
Reminded me to start patient on humidification. 
Layout of questions would be helpful as my personal preference only. 
Straightforward appointment with patient who has previously struggled, but is now managing well and 
moved open discharge 
More used to using template now but completing this did take extra time as I have to put information 
now on the track system as well may 
Be useful for patients in outpatient department & this can be guided by the template rather than text 
You do not need to put on track in the outpatient department 
Layout of questions could be different from my personal preference 
Diagnosis box on the sheet would be helpful 
We are used to completing the template now and only completing the relevant 
Questions patient on long-standing CPAP with previous good compliance 
Free text boxes could be bigger 
First time I have used template – took longer 
For an NIV review – I do not feel that this template is suitable 
I do not feel that this template works for an NIV review 
Need to add free text into form from NIV machine tidal volume, minute ventilation, R/R, AHI 
Sort of worked – Longer clinic time needed 
Getting used to template, only using questions relevant to patient and self 
Only completed what needed for individual 





6.15.4 Qualitative exploration of clinical perception of template use 
Nine participants (five specialist nurses, one service lead and three respiratory 
physicians), provided semi-structured interviews. Two interviews were 
conducted face-to-face, one via telephone, and the other six used Microsoft 
TEAMS with their consent gained before recording the interviews. Table 19 
outlines the characteristics of the participants. 
 
 Profession Male / Female Duration in post 
Centre 1 
Specialist  Nurse Female >10 years 
Specialist  Nurse Female >10 years 
Physiologist Female >10 years 
Centre 2 
Physician Male >10 years 
Physician Male >10 years 
Specialist Nurse Female >10 years 
Centre 3 
Physician Female >10 years 
Specialist Nurse Female >2 years 
Specialist Nurse Female >2 years 
Table 19 Characteristics of participants in recorded interviews 
 
A Summary of emerging themes from the thematic analysis of qualitative data 






Themes Sub Themes 
1 
Use of a structured template in the 
clinical review of CPAP users 
 
Structure / content of the template 
and adaptation 
evidence for use of a structured 
sleep medicine template 
template value, worthwhile, helpful, 
useful 
2 
Impact of the template on clinical 
autonomy, patient-professional 
relationships, patient centred care 
Impact on clinical autonomy 
impact on patient-professional 
relationship impact on person-
centered care 
3 Decision to participate 
Organisational or team led / pressure 
to participate 
uptake of the template 
support and instruction 
continue to use the template in the 
future 
4 
Impact on any differences in way the 
consultation was conducted as a 
result of using the template /impact 
in efficacy of review 
Impact on different ways of working, 
standardisation / structured review / 
equity / reducing 
variation/consistency 
impact of template on the time of 
consultation 
5 
Impact of the template on service 




Impact of the template on the service 
- multidisciplinary team working / 
team knowledge and skills / 
education and training 
   






6.15.4.1 Theme 1 - Use of a structured template in the clinical review of 
CPAP users 
 
Six specialist nurses used the template in their clinical reviews and one site 
was already using their clinic review template.  As the CPAP reviews were all 
nurse-led services in the Centres for the majority of cases, the respiratory 
physicians that were interviewed did not use the template in their reviews 
which were generally more complex problems as opposed to routine reviews. 
The physicians were aware of template use as they were available to the 
specialist nurses for additional support and more complex case discussion if 
required. There was a comment from one Respiratory physician that using a 
template guided approach where there were several nursing staff conducting 
reviews could facilitate a more structured way of doing things and may be a 
more reliable way of capturing the necessary information. There was variation 
in the way that CPAP reviews were conducted in the three Centres however, 
there was general agreement that structured templates were a tool that can 
assist clinical review.  
 
RNS 3  - “We have our own template which is pretty similar in the content to 
yours”. 
RNS 5 - “ We used to have our own template that we followed but it wasn't 
nearly as in-depth as your one. For instance, we didn't ask questions about 
sleep hygiene. We always ask them do they sleep well but not specifically 
‘What time do you go to bed?’ and ‘What time do you get up?’. ………. we 
found we out more about the patient and more out of the clinic review”.  
RP 2 - “I think the template is useful on the basis that certainly in our service, 
most of our patient interactions and clinical service, is actually delivered by 
nursing staff and a variety of them so having a more structured way of doing 
things that means that it will be a more reliable way of capturing the necessary 
information”. 
RP 3 - “So, I didn't directly use it with the patients. I used it for gathering 





direct users in our service were our nursing staff”. 
 
Structure / content of the template and adaptation 
The feedback in the interviews and the free text comments on the returned 
templates offered some useful comments about the structure and content of 
the template and how it could be refined. A common comment was that 
separate CPAP and NIV templates were needed as the review of CPAP and 
NIV users contains different components. One Centre said they did not find 
the template useful for NIV reviews and they did not use it for this purpose, 
which supports the case for having two separate templates. The comment 
about having a component on the NIV template regarding discussing 
anticipatory care planning is a very important point as often these patients have 
considerable comorbidities and are much more at risk of admission to hospital 
when a clear summary of this information would be useful.  
 
Additional space for free text comments and including the diagnosis, outcomes 
from the review and a follow-up plan, and adding partners’ comments were 
also raised by the specialist nurses as a means of improving the template and 
making it more user-friendly. There were some comments about some of the 
content (e.g. chest auscultation was not carried out by nurses or ear nose and 
throat examination), being less relevant to a nurse-led CPAP review and that 
these could be removed and also a comment about including a section to 
record the device used, settings and mask interphase.  
 
There was feedback that some of the older devices do not prove information 
on the AHI and mask leak as they do not have the inbuilt capacity for remote 
monitoring that newer devices can do in real-time, via a web-based platform. 
An important point made by two of the respiratory physicians was that an 
electronic template embedded in the patient’s electronic health record could 







RNS 1 - “We would adapt the template to record diagnosis, current settings, 
device, and mask interface and include a place to record the outcome and I 
have written comments on the completed template too”. 
SL 1 - “And in terms of adaptations, I know that staff we're talking about having 
somewhere to put partners, comments as well……….”  
RNS – 3 “We didn't find it so useful for NIV patients, basically because we 
asked different questions to them”. 
RNS 4 -“The plan would probably be to have a separate template for NIV clinic. 
Not everything is applicable on the template for an NIV clinic”. 
RNS 5 -“Data capture. So, it asked for the AHI and some of our machines do 
not record this,…So, we just wanted to have space to see what kind of machine 
they had, and what type of mask they use and the pressure settings too”. 
RP 3 - “I think we would have two separate ones because the nurses found it 
very useful as it existed for their CPAP reviews and didn't describe that they 
changed their structure of doing their clinic”. 
RP 3 - “ Oh, I'm going to just go back to the additional component question. 
Now, this is less relevant to CPAP review but the one thing we feel that we 
should be doing in an NIV clinic with the more complex patients is making sure 
we do anticipatory care planning, so, I think from what I remember, that there 
wasn't a box for that……….”. 
 
 
Evidence for use of a structured sleep medicine template  
None of the clinicians reported any awareness or knowledge of any published 
evidence on the use of a structured clinical template in a CPAP review, apart 
from the fact that one of the interviewees was aware of my previous work in 
preparation for the study. Three of the participants were members of the e-
Delphi panel. 
 
SL 1 - “I don't think I would be able to specifically name any published 
templates that are used within Sleep services. I do know that there's a lot going 





and particularly with the getting it right first-time proposal that's being initiated..” 
RP 1- “No, I’ve not seen any evidence and I’ve not really looked for any”. 
RP 2 -“ Well, only really the stuff that you have sent me for the purpose of your 
research………”. 
 
Template value, worthwhile, helpful, useful 
Regarding the theme of whether the template was of value, useful, helpful, 
worthwhile, there was general agreement among the specialist nurses, service 
lead, and the respiratory physicians that the template was beneficial in 
conducting a CPAP review as a way of structuring and also standardising the 
consultation, enabling a consistent and reliable approach to capture the 
necessary information. Highlighting diversity in practice and styles of clinical 
review, one respiratory physician thought that more senior, experienced staff 
didn’t need a template to guide their consultation, whilst another considered 
that structured templates were very useful. It was considered that junior 
clinicians and new staff might learn from the process of using a structured 
template for the review. Also, it was felt that it could be used as a prompt to 
ensure that key elements relevant to a CPAP review were not missed, such as 
driving status and type of driving licence held which is of particular importance 
for vocational drivers.  
 
RNS 2 -“ Finding the template really useful in sleep clinics”. 
RNS 5 -“ As well as asking about you've got your witnessed snorting, apnoeas 
and choking spells being controlled, I think just being able to jog your memory 
to ask all these questions that are specific to the review was really good as 
well. So, yeah, I found it brilliant”. 
SL 1 -“ I do think that it does hold a lot of value within any service and not just 
within sleep medicine……… It's something that I would see being of a lot of 
value within the service here and some of the reasons that I've taken a note of 
is that everything is centralised within one document”. 
RP 1 - “I would say some kind of proforma for a large team who [are] all trying 





consistency to the approach in safety and all the rest of it………………”. 
RP 1-“ I think obviously the more senior people probably don't need a template. 
But as I said earlier, it's helpful just to probably make it more efficient for them 
actually. But for junior folk or new people coming into the service, I think it's 
useful to have these structured templates so you can learn more quickly what's 
important and what's not. At the same time, still, deliver the same care for the 






6.15.4.2 Theme 2 - Impact of the template on clinical autonomy, patient-
professional relationships, patient centred care 
 
Impact on clinical autonomy 
All the interviewees responded that the template did or would not impact 
negatively on their clinical autonomy or their consultations, and there was an 
appreciation that it promoted a more structured and thorough consultation. It 
was described as a tool to assist with the consultation process by one 
respiratory physician and that ‘it does not do the job for you’. He also 
commented that it was important to focus on the patient and not the template 
in a clinical review to maintain that patient-clinician relationship and focus on 
delivering person-centred care. One respiratory physician considered that it 
probably impacted positively in terms of guiding the review and there was also 
feedback from two of the RNS’s that they felt it improved their clinical reviews. 
However, one respiratory physician was concerned about a potential negative 
impact of the template on clinician autonomy though he did not think that it 
would personally affect him. Only one of the respiratory physicians used the 
template in 12 joint consultations therefore it’s not possible to explore in any 
detail whether clinical autonomy of the medical staff would have been affected 
by the use of a template.  
 
RNS 2 -“ It did not change the way I did the review but the good thing about it 
was that going through it and having a chat with the patient it highlighted what 
we had covered in the consultation …………. so it made sure it was a bit more 
of a thorough consultation ….”.   
RNS 3 -“No I didn't think it affected my autonomy or the consultation by using 
the template and I use a very similar template with similar content. So no, I 
don't think it changed the way I conducted my consultation”. 
RNS 4 -“I think it improved the review and we loved this template and I think 
it's made our consultations better. We thought we were doing pretty good 
anyway, but it definitely was more thorough and I think it improved our 





RNS 5 - “I think I would say that it probably improved as well. And I don't think 
it affected my autonomy. I think it just probably made things a bit more 
thorough, actually”.  
RP 1 -“As a clinician, it shouldn't really impact too much. I mean, you're just 
using it as a tool to help you get through your work. It's not it's not doing the 
job for you. And you still have to understand why you're asking the 
questions………… So, I don't think it really impacts clinical autonomy 
negatively anyway”. 
RP 3 -“So, my clinical autonomy, I don’t feel that it takes away from that 
because you can still work around a template. It doesn't alter your patient-
professional relationship……… And we've discussed already about the patient 
centred care is maybe just to bring in that question about what matters to them 
in the consultation”. 
 
Impact on patient /professional relationship 
Regarding the theme of the impact of the template on the patient-professional 
relationship, there was general agreement that the use of the template did not 
impact negatively on the patient-professional relationship, and that it may 
provide some reassurance for the patient that the review was more inclusive 
and thorough.  However, there was a perception by one respiratory physician 
that the use of the template could have a negative impact on the relationship 
if it was used as ‘a tick box’ exercise and prevented a focus on the patient 
sitting in front of them. Again as only one respiratory physician used the 
template in 12 joint consultations it’s not possible to explore in any detail 
whether the patient / professional relationship in the medical staff would have 
been affected by the use of the template. 
 
RNS 5 -“A positive impact, definitely a positive. ………...and I think they 
probably felt a bit more included”.  
SL 1 -“I would like to think that the patients would see that everything is being 
covered and see that as a positive. And again, it comes back to making sure 





consultation is as full as it could be… … And I think that would probably 
reassure the patients more as well that everything was being conducted as 
fully as possible”. 
RP 1 - “I suppose it depends on how you use it. I mean, if you just have it in 
front of you and just look at the form and tick a box, then the relationship might 
break down. But you still get the same information from people having a long 
conversation, which I think it depends on the individual for that one”. 
RP 3 -“It doesn't alter your patient-professional relationship. And we've 
discussed already about the patient centred care is maybe just to bring in that 






Impact on person-centered care 
Most participants described a positive impact of the template on patient-
centered care, particularly the specialist nurses with one commenting that it 
supported a holistic review. One of the physicians highlighted the importance 
of adapting the consultation to what matters to the patient and not focusing 
entirely on the template. The opening question of the template about the 
patient’s agenda and what they wanted to discuss was seen as a positive way 
to begin the review, and some of the RNS’s felt that it improved the review for 
both parties. As with the previous two subthemes as only one respiratory 
physician used the template in 12 joint consultations, it’s not possible to 
explore in any detail how template use by medical staff would have impacted 
person-centered care.  
 
RNS 3 -“ addressing what is important to the patient in practice is central to my 
consultations, I feel the template supports a holistic review ”. 
RNS 4 -“ certainly the very first question, actually, and when you know what 
the patient wants to discuss and how do they have any concerns.  I thought 
that was a great way to start in consultation……… We're starting off our 
consultations with is there anything you want to discuss first or do you have 
any concerns with your treatment which we wouldn’t have done previously”. 
RNS 5 -“ I think I say would that the review probably improved as well. And I 
don't think it affected person-centered care. I think it just probably made things 
a bit more thorough, actually.  
LS 1 -“ Absolutely a positive. And as discussed earlier on, I'm quite in favour 
of minimising variation in patient outcomes and offering equity in all standards 
of patient care. So it's definitely a positive for me”.  
RP 1 -“ I suppose it's as the template is asking the right questions and puts the 
patient at the centre of the consultation …………”, 
RP 2 -“ I mean, I think it's important to adapt a consultation to suit the patient 
in front of you, everyone’s different and that's a skill that not just doctors but 






6.15.4.3 Theme 3 - Decision to participate in the implementation study  
 
Organisation or team led/pressure to participate 
The decision to participate was made at organisational level and individuals in 
the departments were free to decide whether, or not, to use the template in 
any or all of their consultations.  This played out differently in the three Centres.  
One of the Centres (Rural) had a much greater uptake of the template and this 
may reflect leadership and championing of the implementation study. All the 
interviewees responded that they did not feel there was any pressure to 
participate in the study despite the fact that all the participants were known to 
me except two of the specialist nurses.  
 
Uptake of the template 
There was a comment from the service lead at the City Centre that if they had 
decided to use this as an alternative to their current documentation process 
and to use the template as a whole department trial for a period of time rather 
than having the staff complete the template in addition to their usual 
continuation sheets that would probably have improved uptake. One of the 
respiratory physicians at the Remote / Rural Centre commented that, in 
retrospect, he and his colleague could have been more involved in the study, 
but that this option had not been clear to them at the initial start-up visit. The 
Centre with the largest uptake was in the process of beginning to undertake 
service redesign at the time of the first start-up meeting and they were engaged 
in wanting to try out new ways of working. This Centre however felt the 
template was only suitable for CPAP reviews and a separate one for NIV 
reviews would be preferred.  There was a whole team buy-in to participating in 
the study in this Centre and so there was a readiness from the whole team to 
explore the potential of the template in their service improvement work.  
 
One Centre used its own template already and this was likely a factor in the 
lower uptake in this Centre. The low uptake of the template in the respiratory 





they do not conduct many CPAP reviews as this was a nurse-led service in all 
three Centres and the respiratory physicians focused on more complex cases 
therefore as experienced physicians may not feel that they need to use a 
structured template to guide their review. If I were undertaking a future study 
with a refined template, I would take more time to explain the importance of 
getting multi-disciplinary feedback from the whole team and would place more 
emphasis on the importance of medical staff participation.  
 
The RNS’s who used the template commented that they did so because they 
were keen to try new ways of working. Other comments from the RNS’s were 
it was not applicable to use the template at the short three-month review 
however it was used for every other CPAP clinic review.  
 
RNS 4 -“ I think because x is new in the past two years and I've only been in 
the service maybe three and a half years, so we're still quite new. So, we're 
quite happy to take part and try new things. But I think when you have been in 
the job a long time, you're more resistant to change. But we certainly didn't feel 
pressurised ……….”. 
LS 1 - “So I don't think that there was any pressure for anybody to be involved 
in the study and those that did wanted to participate did. Those that didn't did 
not. And that was purely an individual choice. So nothing was ever imposed or 
forced upon any of the staff members. And I would say that there was probably 
a little bit of both in terms of it being organizationally led. So encouragement 
for myself but also a decision within the individuals themselves to want to try 
this.” 
RP 3 -“So, it was team led and no pressure. You didn't put any pressure on 
us? It was very much we were keen to embrace the use of templates, 
particularly because you've done all the work”. 
RNS 4 -“ And what x said earlier about the 3-month reviews we would not use 
it then as it just a quick 10-minute consultation but the patients that are new 
going on treatment.”. 





patients, all of our clinics. And then once we had sampled it with the NIV 
patients we did not use it for that but we used it for all our sleep clinics”.  
LS 1 -“ I think that the only thing that comes to mind is if we had decided to 
use this as an alternative to the documentation that we would usually scan into 
the patient notes. So if we decided to do this as a trial for a period of time, 
perhaps, and, you know, rather than having staff do this as well as usual 
continuation sheets and things that they would send for scanning, and I think 
that that may be one of the things that probably would have improved uptake 
if we had decided to ask everybody to do this as potentially a pilot”. 
RP 3 -“So, I think the nurses embraced it as soon as we said we would do it, 
which I think was the beginning of January. I'm fairly sure it was well 
implemented. I didn't hear any mutterings or anything. I think it was embraced”.  
 
Support and instruction 
Regarding the sub-theme of support and instruction, there was general 
agreement that all the Centres were happy with the level of support and 
instruction on the use and completion of the template that was provided at the 
start-up visits and any subsequent visits. Two of the Centres had a start-up 
visit face-to-face with one Centre using NHS Near Me teleconsultation 
 
RNS 4 -“We are really lucky in that if there are any problems, we've got each 
other and the senior sleep Nurse and the consultants and we've got was a 
huge support………...”. 
RNS 5 -“No, we didn’t get stressed about it. And the fact that we just kind of 
thought, well, as you read through all of this, it’s quite self-explanatory. And 
once we just got used to doing it and just kind of flowed……………”. 
S L 1-“ And I don't think that that support was just upfront either, I feel that that 
was something that was ongoing. And I felt that you regularly touched base to 
find out how things were going………. And certainly from, you know, support 
from your end, I would say that that was more than adequate and excellent all 
the way through”. 





meeting, once we decided on the date, which was the crucial thing to embrace 
it, that we didn't and I certainly didn't need to provide any further 
support………….”. 
 
Continue to use the template in the future 
One Centre continued to use the template beyond the study period, and all the 
Centres have requested to see a refined version of the template with the 
intention to potentially incorporate these refined templates into service 
improvement projects and also explore electronic template options in some 
Centres as well.  
 
RP 3 - “So, I've waited really for your feedback, before we've done anything 
with it. But I think I'd be quite interested to know what you find from the study 
before we implement it. Yes, very much. We'd like to implement it”. 
RNS 4 - “But it's definitely something we would want to continue to use and 
are still using for our Sleep patients”. 
SL1 - “I think that we would probably like to introduce a template like this within 
the service, particularly now that we have been forced to conduct remote 
management of our patients and remote set up of our patients. And I think that 
it just gives us that good guide to follow during a consultation, particularly over 







6.15.4.4 Theme 4 - Impact on any differences in way the review was 
conducted as a result of using the template /Impact in efficacy of review 
 
Impact on different ways of working  
Comments regarding the impact of the template on ways of working varied but 
were generally positive. The specialist nurses did not think that it impacted on 
the way the actual review was conducted, and two from the same Centre felt 
that it was really helpful in guiding the review. In contrast, one Centre used the 
template in addition to their usual documentation and all the nurses reported 
that it extended the consultation time initially, although this was less of an issue 
once they became familiar with the template. One respiratory physician 
commented that the use of a template may facilitate a more economical way 
of working with the large volume of clinical work in sleep medicine review 
services. Some commented that the use of the template could facilitate a 
patient-focused review and that it did not negatively impact on usual ways of 
working.  
 
One respiratory physician highlighted that differences in medical and nursing 
training might affect how the approach to a review, commenting that nurses 
may be more guideline and process-oriented as the nursing profession is more 
process-driven. There was also a comment from the same respiratory 
physician that in sleep medicine the review process is more formulaic 
compared to a lot of other conditions and is much easier to define and quantify, 
and so it probably lends itself much more to the use of a template than other 
conditions. Additionally, the same individual commented that having a more 
protocolised or focussed way of conducting clinical reviews with less 
experienced staff was an important factor. Another respiratory physician 
commented that particularly with the arrival of the Coronavirus pandemic and 
the significant impact of COVID 19 on clinical review services there would have 
to be more remote reviews implemented, and the template may help clinicians 






RNS 1 -“It did not change the way I did the consultation; I did not do it when I 
saw the patient at first and I waited and did it afterward.  Some of the content 
was irrelevant and I did not use it as it was not appropriate.” 
RNS 2 - “Once I got a bit more familiar with it I took it in with me and although 
I would usually ask the patient how are you getting on and then make the time 
to lead to the chat …………..and I found it quite useful to actually take in with 
me as I got more familiar with it”. 
RNS 3 -“No I didn't think it affected my autonomy or the consultation by using 
the template and I use a very similar template with similar content, So no, I 
don't think it changed the way I conducted my consultation”.  
RP 1 -“I suspect COVID will be changing the way we deliver our service much 
more, that's going to do a lot more remote stuff. So actually, it may actually 
help focus the mind if you're doing telephone or video clinics. You don't 
necessarily get the same, you certainly don't get the same signals when you're 
on the phone to somebody for a clinic, as you do either on video or face to 
face. So, it actually might provide a bit more focus than just a rambling 
conversation, actually”. 
RP 2 -“I am not sure what the answers to that is, I mean, I think there is a 
difference between doctors and nurses generally in how we approach things. 
Training is a bit different. Nurses are much more taught to follow guidelines 
and rules and processes, whereas while we are increasingly having to do that 
too, but there is a need for doctors to, for the benefit of patients, to have the 
courage and confidence, sometimes to go outside the box. I think sleep is a bit 
different because it is so formulaic compared to a lot of other conditions. It is 
much easier to define, quantify and so it probably lends itself much more to 
the use of a template approach like this than other conditions does”. 
RP 2  - “It is high volume clinical work and so a template like this might facilitate 
a more economical way of delivering a service because of the numbers 
involved and the volume of referrals that we get”. 
RP 3 -“You do miss out questions, because quite often when you're trying to 
lead the patient, so it is a patient-focused interview. Then you can get side-





Standardisation / structured review / equity / reducing variation / 
consistency 
Themes regarding the impact of the template on the clinical review and patient 
care were positive in terms of describing reduced variation in practice, 
standardising the clinical review process, and providing structure and 
consistency to the process. Also reducing paperwork and having all the 
information in one document was seen as beneficial. Having free text options 
to input information and incorporation of the Epworth sleepiness scale was 
also helpful with comments about having everything centralised in one 
document. There were also comments about supporting new staff and 
inexperienced members of the team to keep them on track and ask the right 
questions, using a consistent way of recording CPAP treatment outcomes. The 
respiratory physicians had differing opinions on template use and one 
commented that it may be more helpful in larger services to support 
consistency in a review. One physician commented that the free text box at 
the beginning of the template helped focus on what matters to the patient and 
it could assist with consistency in the review.  
 
RNS 2 -“It would be a good idea for us all to be following the same protocol it 
would be easier………... The structure might be different for different services 
it might suit our service different to your service”.   
RNS 5 -“I find that with me being quite new to the service then it was just a 
really nice sort of structure to conduct your review of the person. And how x 
was saying about finding out more about the quality of peoples sleep and 
things that we don't necessarily ask so much in-depth normally clinic about it”.  
LS 1 -“And certainly I think that it holds a lot of value in the form of reducing 
variation. So you're not missing anything out and you know, you are 
standardising, patient care essentially, and that everybody has the same 
equity and will help to minimize variation and the outcomes within that”. 
LS 1 -“What I like about the template is just that you know we use an awful lot 
of paperwork and it's all sent for scanning into the patient notes. And it's nice 





that's one of the things I like about it. I quite like as well is that there are free 
text section options and I do like the part with the Epworth score being included 
within the template as well because usually we do that as a separate piece of 
paperwork and I like that it’s all incorporated within the one document ”. 
RP 2 -“If we're using more inexperienced people and a wider group of people 
will help to have something like this, to keep them on track, to asking the right 
questions and consistent way of recording outcomes from treatment”. 
RP 3 -“So the free text, gave you the opportunity to feedback in real-time rather 
than trying to remember at the end when you do a semi-structured review. So, 
I think that free text box was clear”. 
RP 3 - “And I get to the end of the review and go I didn’t ask that because I've 
been trying to listen and let the patients direct the review. So, I guess that's 
where the advantage might be that if you can still do or bring in the template 






Impact of template on the duration of consultation 
 
Regarding the impact of using the template on the consultation duration, there 
was negative feedback because it extended the duration of the review due to 
a number of factors. The first was that it was a new way of working for the 
RNS’s and they were unfamiliar with the layout of the template; once they 
became familiar with the use of the template most of them said it did not 
increase the time of the review. The second factor that increased the time of 
the consultation in two participants was that they had to complete their usual 
paperwork as well as the template, so this did extend the time of the 
consultation. However, the lead for that service observed that if the template 
was the only source of documentation then this could save time. The service 
lead also said that if the template was implemented in the future it would be 
the sole documentation that the staff members would be using and it wouldn't 
be seen as something additional. There were also some negative comments 
regarding the use of the template in NIV users in that one RNS felt it was not 
suitable for an NIV review suggesting the need to have a separate template 
for CPAP and NIV reviews. One respiratory physician agreed that the template 
was not suitable for NIV reviews. 
         
RNS 1 -“More used to using template now but completing this did take extra 
time as I have to put information now on the TrakCare system as well”. 
RNS 2 -“We all have different ways of working when there are umpteen of us 
but the fact that we have to write enough for the secretaries to type a letter and 
they are not at the moment au fait with working with this, but if in the future if 
they were happy to come up with a letter from this then you could just sit and 
do this at the clinic but I found it easier just to do this when we're up here in 
the ward because you have a longer consultation time to type up your notes 
so I did add a bit of time but if it was the only documentation that you had it 
would save you time”. 
RNS 3 -“ It took a bit longer initially to complete because of the different way 





structured differently but has similar content”. 
RNS 3 -“We do have different templates for if it's a CPAP/NIV and an Airview 
review. I don't think it changed the way I conducted the consultation and as I 
got used to it, I was quicker and I don't think it changed my routine practice”. 
RNS 4 -“ So the first week it took about fifteen minutes roughly and then as the 
weeks went on, we were noticing we were writing on the back of the form, the 
box at the bottom. It was taking us less and less and less time as we got used 
to it”.  
RNS 5 -“We really got into the format of it so we didn’t need to constantly look 
at the template for your next question. But after a few patients, it was pretty 
much just taking the same amount of time as before. Yes. It didn't take us any 
longer than previously. But for NIV it did take a bit longer initially”.  
LS 1 -“ I think that the template itself was favoured and that the feedback from 
the team members was they felt that it was time consuming only because they 
had to fill out the standard documentation that they usually would in addition 
to the template as well. ………”. 
RP 3 -“When we used your template, the nurses bring it through and we were 
filling it in, yours did not extend the review using the template. It certainly did 
not extend the CPAP reviews and I don't think they felt it did for the NIV. It was 
just they couldn't use the template in its completeness for an NIV review”. 
 
6.15.4.5 Theme 5 - Impact of the template on service evaluation/ service 
improvement/service structure 
 
There were some comments that the template could impact positively on 
service delivery by creating more efficiency and better patient outcomes. The 
Service lead thought this was of particular importance if the template were the 
sole documentation to be completed in the review, whether this is face-to-face 
or by teleconsultation. She also highlighted due to the impact of COVID 19 the 
requirement to rapidly deploy teleconsultation and remote monitoring solutions 
to minimise face-to-face contact that the template would be beneficial in this 





electronic template could be developed that could be integrated directly into 
the health record, reducing the requirement to dictate formal letters and reduce 
administrative processes. All the services were severely disrupted by the 
pandemic and they were all looking at ways to remobilise their services and 
the template impact use and uptake was a very small factor in service 
redesign.  
 
RNS 2 -“ I think it would be useful to use the template at the clinic downstairs 
if you just had the one template.  Because we don’t dictate the letters, we have 
to type it all out and that is the only documentation and then it all has to go into 
a letter which is your only record”. 
RNS 2 -“ The first thing I thought was as are moving to more telephone-based 
consultations that the plan for the future if that patients are going to be initially 
reviewed over the phone I think this will be invaluable then.  It is a bit more 
difficult to have that rapport over the phone that you have face to face with 
somebody.  You can give them a call and go through the template then it 
means we will definitely cover everything”. 
LS 1 -“ I think it holds a lot of value and I think that at the moment, while 
services are starting to remobilise post-CoVID pandemic there's a greater 
requirement to look at the way that we offer services to patients and how these 
things can be integrated into different ways of working, essentially which will 
now essentially be remote”. 
LS 1 -“ I think that there is a place for a nurse or physiology-led clinics and it's 
something that we hope to implement at some point within the future. And 
we've started a framework for that with physiologist clinics of patient results 
just now. So yes, we will continue to use the template, and that's something 
that we'll look at implementing here in the future”. 
RP 1 -“ I think the key thing for this is to try and get the template integrated into 
some electronic format,  our previous patient templates are all paper, we need 
to not have as much paper but certainly for these sorts of interactions just to 
be able to do it electronically”. 





replace potentially doing a clinic letter because we uploaded your clinic 
template as our record to sky store. So, at the moment, we didn't make that 
final change to not doing the letter. We still did the letter on top where if you 
got that right, that we'd hope that we would actually reduce our administrative 
processes”. 
 
6.15.4.6 Theme 6 - Impact of the template on the service - 
Multidisciplinary team working / Team knowledge and skills / education 
and training            
 
Based on the responses from the participants there is clear evidence on the 
value of MDT working for all members of the team whether this is formal or 
informal meetings. Two of the sites found that formal MDT weekly meetings 
were a good way to support the whole team providing the opportunity for 
shared learning, consistent and collaborative working, whole team support, 
and this governance approach was appreciated by the service lead and the 
RNS’s. With the rapid role out of Microsoft teams and NHS Near Me during the 
COVID 19 pandemic, this has supported remote consultation for the teams in 
more remote and rural services, and there were also comments that the 
template may be useful for education and training purposes of newer members 
of staff, however more senior specialist nurses may find the template less 
useful. Regarding this wider theme of service impact and MDT working the 
refined template may be of use to some services which relate to achieving 
Objective IV of the study and refining the template. 
 
 
RNS 3 -“ If I am struggling with a difficult patient the Respiratory physicians will 
obviously see them on request.  The consultants will dictate their letters to go 
to GP and they do not use the local template at all”.  
RNS 4 -“ So, we have a consultant who comes up regularly from another 
hospital and we do a weekly Teams MDT with him, with all our new patients. 






RNS 5 -“ And we're really lucky in that if there are any problems, we've got 
each other and the senior sleep Nurse and the consultant and we've got a 
huge support………….”.  
SL 1 -“ Although we take the patient results to the MDT for discussion with the 
doctor, it's not just for discussion with the doctor, but very much from input from 
everybody as well. And we regard all staff members to be extremely 
knowledgeable and value everybody's input. So it is very much a team network 
….”. 
SL 1 -“ The template is something that could certainly be incorporated into 
training and as part of evidential reviews for training as well, and to make sure 
that staff are as knowledgeable as you can be using it”. 
RP 2  -“We did initially have an MDT, and then it is kind of fell by the wayside. 
So, we do it very informally. So basically, we work in close proximity to where 
the sleep nurses work and the physiologists work and if there are issues, they 
come and tap on our door. ………….”. 
RP 3 -“And also, the other thing that's lovely about NHS Near me is that you 
can get trainees doing it now. And they can send a link to me so that I come 
into the review remotely. So, you can have your three-way remote review. And 
that is working well. ………. It would have been interesting if we had been 
doing this during CoVID”. 
RP 3 -“ With your remote monitoring capability sleep medicine could not be 
better set up to do this. This is just the thing where it's going to make a 
difference. So, one of my team has even kept going with NIV reviews even 
though I had to come out of doing clinics for NIV, she's kept going on her own 







6.16.1 Statement of principal findings 
All participating sites engaged with developing an implementation strategy and 
the template was used in 26%, 13%, and 75% of consultations in City, 
Urban/Rural, and Rural Centres respectively with varying uptake of the 
templates in two Centres. 
  
The quantitative data fields completed in the returned templates in this real-life 
implementation study align closely with the consensus results achieved in the 
international e-Delphi study (10), apart from recording the AHI and mask leak 
which was considered of lesser importance by the implementation study 
participants. Free text feedback on the completed templates suggested that 
clinicians perceived that templates aided a thorough and holistic consultation 
and that it was helpful / useful and easy to use with familiarisation. It was not 
possible in some cases to get data from older CPAP machines via telephone 
/ teleconsultation and users suggested that additional free text space for the 
model of CPAP / NIV device used, tidal volume, minute ventilation, respiratory 
rate, and AHI should be added to the refined templates.   
 
There were six main themes from the qualitative data (Table 20).  The template 
was regarded as being a useful tool to assist a clinical review, though clinicians 
suggested that the structure and content of the template could be revised with 
the addition of fields to include device type and mask interface, diagnosis, 
follow-up arrangements, and additional noteworthy outcomes of the 
consultation. The template was not reported to adversely affect the way the 
clinical review was conducted or perceived clinical autonomy, patient / 
professional relationships, and patient-centred care.  
 
The decision to participate in the study was organisational and team lead with 
individuals able to decide for themselves whether to use the template. There 





been improved with wider departmental and clinician participation, and if there 
was no requirement (in one Centre) for additional data entry. The uptake of the 
template was particularly high in one Centre where the timing of the study 
coincided with local service improvement work,  All Centres felt that they were 
given sufficient support and instruction regarding requirements for the study 
and one site was continuing to use the template. All the Centres have 
requested to see the refined template. 
 
Participants were clear that there was no negative impact of the template on 
clinical autonomy, patient-professional relationships, or patient-centred care.  
In general, comments suggested that the template standardised ways of 
working and reduced practice variation. The use of the template initially 
extended the consultation time, however with familiarisation in its use this was 
less problematic. In the City Centre where the template was an additional task, 
this extended the duration of the consultation, though it was noted that this 
could be resolved by adopting a refined template as the sole means of 
capturing the content of a CPAP review. As a means of increasing and 
optimising the time allocated for conducting a review the option to ask the 
patient to complete some aspects of the template prior to the consultation 
could be a consideration in any future research. For example completion of the 
epworth sleep score and the section at the top of the template on what the 
patient wants to discuss may help with  a more patient focussed review making 
best use to the time allocated for this.  
 
There were comments regarding the positive impact of the template on CPAP 
reviews by creating more efficiency, particularly if the template was the sole 
means for completion in the review. An electronic template that could be 
integrated directly into the clinical portal was suggested and this is already 







The template was considered to support valued MDT working, team 
knowledge and skills / education and training, and shared learning, whole team 
support, and governance being appreciated by the service lead and the RNS’s. 
Other comments were with the rapid role out of Microsoft Teams and NHS 
Near Me during the pandemic, the template supported remote consultation for 
the teams in more remote and rural services. There were comments that the 
template may be useful for education and training purposes.  
 
6.16.2 Strengths and limitations 
I Followed implementation research framework 
I followed an implementation research framework and used the StaRI checklist 
to ensure that I was following agreed standards for reporting the 
implementation study findings. I distinguished but also focused on both the 
evidence-based intervention and the implementation strategy. In combining 
the quantitative and qualitative data using a framework analysis approach to 
develop the thematic analysis, and subsequent development of the six main 
themes and then using the CIFR domains to discuss the findings of the study 
has allowed an in-depth analysis of the study results. 
 
Robust development of the intervention 
I developed the review template based on a search of global guidelines, 
recommendations, and best practice statements on what should be included 
in a CPAP review plus the findings from the international e-Delphi study. One 
of the strengths of this research is that no other publications address the most 
important components to review in CPAP therapy users in the real-life setting.  
In combining the findings of the international e-Delphi study with the 
quantitative and qualitative results from this implementation study, both 
contribute to an evidence-based approach to the use of a template in 







Codesign of the implementation strategy with the Centres 
The aim of the initial visit to each Centre was to ‘co-design’ the 
implementation strategy to explore basic things such as did the Centres want 
the template in a paper or electronic format; how were they going to ensure 
that templates were readily available within the clinic setting and if there had 
been any other strategies that might have helped support the 






Mixed methods enabled triangulation 
Using mixed methods enabled triangulation whereby I was able to analyse the 
results of the data using multiple approaches to enhance the credibility of the 
implementation study findings and compensate for any weaknesses in the 
study methodology. The quantitative data on the template fields completed 
resonate with the e-Delphi consensus results regarding what are the most 
important components to include in a clinical review. By combining the 
quantitative and qualitative data using a framework analysis approach to 
develop the thematic analysis and subsequent development of the six main 
themes, and then using the CIFR domains to discuss the findings of the study 
has allowed an in-depth analysis of the study results.  
 
Uptake and potential use of a refined template 
The uptake of the template in the rural Centre was much more successful than 
the other sites and this may because this Centre was already planning service 
redesign and there was a strong leadership focus with the whole MDT being 
keen to try new ways of working. The lesser uptake in the other two Centres 
may be due to the fact one Centre already used their own template and in the 
City Centre, there was a requirement for double data entry with no additional 
clinical time allocated to facilitate this. The reasons for no medical staff 
participation in template use may be multifactorial, firstly all the CPAP reviews 
were nurse-led services, and secondly, I may not have been explicit about the 
medical team using the template at the developing the implementation strategy 
stage. One of the physicians interviewed said that experienced senior 
physicians did not need to use a template in a review and this may be a factor 
in no medical staff using the template.  The fact that the study was conducted 
over the winter period when pressures are greatest for respiratory teams may 
also have been a factor in the Centres with lesser uptake. Trying to engage 
more senior physicians in participation may require a different approach or 






There is the potential for a refined template or templates to be utilised in 
increased telephone and teleconsultation reviews in the coming years as 
telemedicine use is adopted more widely in services during and beyond the 
pandemic. The ability for services to have oversight of telemonitoring data in 
CPAP and NIV users is already embedded in routine clinical practice nationally 
and internationally and combined with the use of a structured clinical review 
template may support the delivery of safe, person-centered care that is 
effective, economical and environmentally friendly for future sleep medicine 
services to adopt.  
 
Data saturation 
I aimed to recruit up to 20 clinicians from three Centres, conducting up to 15 
semi-structured interviews at the end of the study which would have allowed 
me to conduct a more robust qualitative thematic framework analysis of the 
recorded and transcribed interviews. Regarding data saturation, I believe this 
was achieved in the specialist nurse interviews as no new themes were 
presented during the final interviews. Typically data saturation often requires 
a much larger sample size in qualitative studies however this was a group of 
specialist nurses who were very familiar with this speciality and conducting 
nurse led reviews and may therefore have represented a much more 
homogenous group allowing data saturation in a much smaller group. 
However, I am unable to say that I reached data saturation in the physician 
interviews as none of them used the template and the interviews were already 
delayed due to COVID 19 and there was no time to do this in my already 
delayed PhD. 
 
Limited diversity amongst interviewees 
Having a larger group of medical interviewees or other clinicians could have 
resulted in the planned qualitative analysis methods providing much richer 








COVID-19 and delayed interviews 
The final six interviews were completed in July 2020 - five months after study 
completion in February 2020. There is the potential for those that used the 
template to perhaps not recall their thoughts on the use or the content of the 
template, however, there was the facility within the template for immediate 
feedback via the free text comments that I was able to analyse. 
 
Use of a theoretical framework  to aid interpretation  
By using the CFIR and its five main domains of Outer setting, Inner setting, 
Intervention, Process, and Individuals involved to explore the six main themes 
from the interviews this has enabled me to be more organised, consistent, and 
inclusive in systematically reporting the qualitative findings of the 
implementation study.  
 
Reflexivity 
Section 6.14 covers reflexivity in much more detail however some key points 
on reflexivity are noteworthy. I knew many of the interviewees as long-standing 
professional colleagues over a number of years which both opened doors and 
made discussion easier and can be considered a strength, however, this may 
also have prevented me from asking some questions that may have identified 
basic issues with template use in CPAP reviews. A limitation is that I developed 
the template and had been using it in my clinical practice for some time 
therefore thus believed in it and this may have resulted in my personal bias 
being a factor in the interviews. 
 
Developing experience 
I was inexperienced in qualitative research at the beginning of the study.  
However, I have undertaken a three-month qualitative research module with 
the University of Aberdeen before undertaking this study and have read 
extensively on qualitative research methodologies as well as seeking and 





qualitative researcher may mean I have missed some important themes, 
particularly in the early interviews when I was still learning the skills of 
undertaking qualitative interview techniques, however, the later interviews 
were substantially improved. 
6.16.3 Discussion of the CFIR domains in relation to 
implementation study results                
 
I chose to also use the CIFR domains to assist with the discussion of the 
results of the implementation study (Figure 9) as the five domains of Outer 
setting, Inner setting, Individuals involved, Intervention, and Process can all be 
used to interpret the implementation study findings (261, 268). I considered 
the CIFR framework and its domains to be a good fit to discuss the qualitative 
data results and themes and to inform understanding of the various factors that 
influenced the success (or otherwise), of the implementation strategy.    
 
6.16.3.1 Outer setting 
 
Definition (261, 268): Outer setting includes the features of the external context 
or environment that might influence implementation. Four constructs are 
included in the outer setting (e.g., external policy or influences and incentives). 
 
There is a national remobilisation of sleep medicine services improvement 
work steam underway to assist services in a recovery plan in the midst and 
beyond this pandemic. As this work-plan progresses any new national service 
incentives, developments, or initiatives such as the wider use of 
teleconsultation and telemonitoring services and the development and 
implementation of this template (electronic or paper-based), may influence and 
support new ways of working and delivering services. 
 






Definition (261, 268): Inner setting, which includes features of the 
implementing organization that might influence implementation. Twelve 




I recruited three Centres that represented three distinct sleep medicine 
services, City, Urban /Rural, and Rural to gain an insight into how these 
different settings may impact on and be able to inform and meet the study 
objectives. All of the Centres had very well-established sleep medicine 
services with the lead collaborators in each site all being consultant respiratory 
physicians. Two of the Centres, City, and Rural were already planning future 
service redesign when I initially made contact with them pre-study to seek their 
interest in participation because of their very long waiting times to have a 
diagnostic test for OSAHS, and then to commence CPAP therapy. This may 
be a factor in that they were perhaps more receptive to participating in the 
study. The Urban/Rural Centre was imminently facing recruitment issues due 
to senior specialist nurse staffing changes and this site had already used their 
own templates (one for CPAP and one for NIV reviews), which may reflect the 
lower uptake of the template in this Centre.  
 
All the participating Centres had very experienced staff within their teams, 
however, all the CPAP reviews were all nurse-led services where physicians 
did not see these patients unless there was a degree of complexity outside the 
scope of practice of the specialist nurses requiring physician oversight. 
Furthermore, a long-established national network of sleep clinicians met on a 
biannual basis for clinical education and peer support pre-COVID 19 and this 
was a real advantage in recruiting the sites to participate again allowing all the 
study objectives to be met. The 18-week target of diagnosis of OSAHS to 
treatment set by the government was not achievable in any of the Centres with 






The delay in being able to undertake the qualitative interviews provided an 
opportunity to explore sustainability.  In the remobilisation of all sleep medicine 
services in the midst of the first and second wave of the pandemic in the 
participating Centres, there was a clear interest in having sight of the refined 
template in both a paper and electronic format indicating an interest or 
readiness for further implementation. The deployment of video consultations 
(rapid deployment of NHS Near Me), and more use of the remote monitoring 
capabilities in newer CPAP and NIV devices have been accelerated both 
locally and supported from the Government healthcare perspective as a 
response to the pandemic. It is clear from the thematic analysis of the 
qualitative data that working in a standardised and evidence-based way that 
reduces variation and supports best evidence-based practice and person-
centred care is valued by clinicians and patients alike. 
 
6.16.3.3 Characteristics of Individuals Involved 
 
Definition (261, 268): Characteristics of individuals involved in implementation 
that might influence implementation. Five constructs are related to 
characteristics of individuals (e.g., knowledge and beliefs about the 
intervention). 
 
The three participating Centres all has specialist nurse-led CPAP review 
services, and the respiratory physicians did not routinely conduct CPAP 
reviews but focused on reviewing the more complex patient who were using 
NIV. In the Rural Centre with the highest uptake of templates expectation from 
the lead clinician may have been a factor in achieving this greater uptake, 
however, participation in the study was seen as a very positive experience by 
all the participants and reflected in the themes, sub-themes and the free text 
comments in Table 18. In the Urban Centre, there were a larger number of 
staff who initially indicated their interest in using the template however, the fact 





a negative factor in the lower participation at this site where extra work was 
being asked of them, and this may explain the lower uptake at this site.  
 
The individuals involved and their personal attributes contributed to the 
implementation strategy achieving all of its objectives. There was clear and 
transparent evidence of joined-up MDT working in all the participating Centres.  
This is an important factor as MDT working is widespread across the NHS and 
a team atmosphere that facilitates whole team involvement, with task 
allocation can support improvements in healthcare delivery and is a key factor 
to ensuring team decisions are implemented (283). This was evident in all the 
Centre visits I conducted (there were good team interactions with myself and 
all the team members expressing their views regarding participation in the 
study),  during the implementation phase of the study (Objective II), and also 
in the participant interviews about the impact of the template on the service.  
Multidisciplinary team working / team knowledge and skills / education and 
training and their interest in seeing and potentially implementing a refined 
template post-study (Objective II and IV).  
 
Leadership is an important factor in the adoption and uptake of evidence-
based healthcare improvement initiatives, and the NHS invests significant time 
and resources in leadership development for health professionals. Good 
leadership is central to team effectiveness, from a clinical and financial 
performance perspective, and for implementing and improving innovative 
healthcare solutions (276, 277). Service redesign initiatives were already 
underway in all the Centres and the teams were all in a state of readiness and 
open to new ways of working. The negative impact of the template in terms of 
increasing the consultation time initially in all the Centres was more 
problematic at the City Centre because of a requirement to maintain the ‘old’ 
way of working. This could be mitigated by adopting the refined template in an 
electronic format as the sole means of recording the CPAP review content, 
thus reducing paperwork and supporting the Scottish Governments TEC 





who used the template did not feel that it impacted their clinical autonomy or 
on the patient / professional relationship in any significant way and used it as 
a tool to guide a structured and thorough consultation. The Centre that had the 
highest uptake of the template reported that the template had a positive impact 
on their review process, and they felt that their reviews were of a better 




Definition  (261, 268): Intervention characteristics, which are the features of an 
intervention that might influence implementation. Eight constructs are included 
in intervention characteristics (e.g., stakeholders’ perceptions about the 
relative advantage of implementing the intervention, complexity). 
 
Although widely used in other contexts, the literature review did not reveal any 
evidence of a specific structured sleep medicine review template, and the 
participants were not aware of any evidence to support this format of 
conducting a CPAP review.  However, two Centres used their own template or 
had done so previously and many other services likely use their own template 
to guide such a review, although this has not been translated into any formally 
published evidence. The comments regarding the structure and content of the 
template will facilitate the adaptation of the template for further evaluation or 
trialability. Also supported by the participants responses regarding whether the 
template was of value, useful, helpful, worthwhile, there was general 
agreement among the specialist nurses, service lead, and the respiratory 
physicians that the template did not add any additional complexity to a  review. 
It was viewed as beneficial in conducting a CPAP review as a way of 
structuring and also standardising the review using a more consistent and 
reliable approach to capture the necessary information. This is also the case 
for other conditions such as asthma where templates can facilitate a patient- 





and also addresses the patient agenda (228, 229). 
 
There was a comment that more senior staff may not need to use a template 
in their CPAP consultation which may be reasonable in relation to the clinical 
autonomy and variation in clinicians’ consultation styles.  However more junior 
staff and new staff may learn from the process of using a structured template 
for the review, and larger teams may benefit from this approach in terms of 
consistency, reducing variation, and supporting safer care (228, 237). Also, it 
was felt that the template could be used as a prompt to ensure that key 
elements relevant to a CPAP review were not missed such as driving status 
and the type of driving licence held which is of particular importance for 
vocational drivers.  
 
Regarding the impact on clinical autonomy, all of the interviewees were clear 
that the template did not impact negatively on their clinical autonomy or their 
consultations and there was positive feedback that it assisted a more 
structured and thorough consultation and it was described as a tool to assist 
with the consultation process. For many of the interviewees, it impacted 
positively in terms of guiding the consultation, and there was also feedback 
from two of the nurse specialists that they felt it improved their clinical reviews.  
 
The only costs related to the intervention was in terms of time to conduct the 
study with no further developmental costs to the NHS as an electronic version 
of the refined template could easily be integrated into the electronic healthcare 
records, and the technology is already in place at NHS boards to support this 






6.16.3.5 Implementation process 
 
Implementation process, which includes strategies or tactics that might 
influence implementation. Eight constructs are related to the implementation 
process (e.g., engaging appropriate individuals in the implementation and use 
of the intervention, reflecting, and evaluating). 
 
Objective I -  I aimed to involve the Centres in developing the implementation 
strategy.  I was able to work with each Centre at the initial visit and any 
subsequent visits to decide on the best strategy to support the implementation 
of the template within their teams.   
 
Regarding Objective II - Implementation,  I conducted two semi-structured 
interviews; face-to-face with two specialist nurses pre COVID 19, one 
telephone interview with a specialist nurse, and six video teleconsultations 
using Microsoft TEAMS with one service lead, two specialist nurses, and three 
respiratory physicians. Additionally, one initial recorded group discussion with 
two specialist nurses, and the free-text comments entered on the completed 
templates were also included in the coding of the data to develop the themes 
outlined in section 6.15.4. I had originally aimed to conduct between 10-20 
semi-structured interviews across all the sites however this was not possible 
despite extending the recruitment time for the study to the end of February 
2020 to engage more participants. The main factor in not achieving more 
interviews was that in the three Centres all CPAP reviews were nurse-led 
services and then the additional impact of the appearance of SARS-CoV-2 
virus in the UK in early 2020  meant I could not extend the study period further.  
 
Following discussion with my co-authors, we agreed to attempt to analyse the 
very limited qualitative data I had; however, it was apparent that the qualitative 
data did not meet the aims and objectives of the study. Following a further 
discussion, I contacted the participating Centres to ask if any of the clinicians 





hospitalised affected individual cases were low at this point.  Using secure 
Microsoft teams I was able to conduct a further six semi-structured interviews 
that generated greater qualitative data for the thematic analysis. I used NVIVO 
software to undertake the thematic analysis and generated six main themes 
described in the results section 6.15.4  and Table 20. I used the StaRi checklist 
recommendations for implementation studies to measure what standards I 
have met with the results achieved (Appendix 12). The earlier section 6.13, 
regarding the need for reflexivity, outlines how I tried to be as reflexive as 
possible at all stages in the study and the evaluation of the study results. 
 
The highest uptake of the templates was in the Rural Centre with 149 / 200 
(75%) completed templates returned for analysis. Several factors are likely to 
have facilitated this higher uptake at this site.  The first being the fact that the 
principal collaborator at this site was the Lead respiratory physician in the 
service, and the second being they also have a research interest. Thirdly,  this 
service was currently in the process of looking at service redesign and they 
indicated at the first virtual site visit that they were open to trying out new ways 
of working. Another factor in this higher uptake of the template is that the two 
specialist nurses at this site were relatively new to the speciality and were keen 
to try out new ways of working. The City was the largest Centre and returned 
58 / 224 (26%) completed templates for analysis by three specialist nurses. 
They had to complete the templates in addition to their usual documentation 
practice and this was a negative factor that impacted on increasing the time of 
their consultations. None of the respiratory physicians in the City Centre 
participated in the completion of the template, however, there was interest in 
participation. Several factors may have impacted this. CPAP reviews were 
nurse-led and the respiratory physicians reviewed only the more complex 
patients. The second factor was that the study was conducted over the winter 
and respiratory services face many conflicting winter pressures that may have 







This highlights the importance of engagement with a lead collaborator at each 
Centre and the need for a local champion to be closely engaged in the study 
which was the case in the Rural Centre. Recent publications have consistently 
found that the role of champions is an important influence in how effective 
implementation can be achieved and their role in supporting, promoting, 
influencing, and motivating teams through implementation by overcoming 
possible resistance that the intervention may provoke in a healthcare setting 
(276, 277). The Urban / City Centre returned 12 completed templates for 
analysis. They had their own template in place already and this may have 
impacted the number of templates returned from this Centre. 
 
 
6.17 Interpretation of findings in relation to previously 
published work  
Contents of a CPAP review 
When compared to national and international guidelines published between 
2003  -  2016 (6-9, 24, 67, 70, 76, 78, 209, 221, 224), the e-Delphi did identify 
additional components that could be included in a CPAP review that were not 
always included in these guidelines. For example, specifically asking if any 
problems with sleepiness while driving, measurement of the ESS, weight, and 
blood pressure monitoring, checking for any mask interphase issues which 
were strongly prioritised (>90%), in the e-Delphi study but were not always 
recommended by the guidelines. Asking about quality of life, and quantity and 
quality of sleep, asking about work schedule / shift pattern working, 
preparedness to continue with CPAP therapy, and the requirement for 
humidification was all prioritised as >75%, but were not specifically included in 
these guidelines. Also, these guidelines do not mention checking for resolution 
of the Apnoea / hypopnoea index despite it being given a priority consensus of 
90%.  Only one guideline published by the AASM in 2019 mentions 9 of the 12 





2016. The findings from the e-Delphi study regarding the core components of 
a CPAP review may inform future guidelines to perhaps focus more on a 
patient-centred clinical review that includes the prioritised core components 
identified in the e-Delphi study and what matters to the patient. 
 
DVLA and driving regulations 
The e - Delphi identified the requirement to focus on asking about sleepiness 
when driving as an extremely important component at a clinical review 
(proritised at 95%), for patients with OSAHS. This is supported by the DVLA 
website advice on excessive sleepiness and driving, the BTS position 
statement on driving in OSAHS 2018, and European task force findings 2020 
(45, 90). The importance of discussing driving-related issues was also 
prioritised as a core component of the review in the implementation study 
where this field was completed in 98% of the 219 returned templates. In 
combing the results of the e-Delphi and the Implementation study giving driving 
issues a high  priority (95% and 98% respectively), then future guidelines may 
wish to take this into account and provide more clarity for clinicians conducting 
CPAP reviews. The ERS Statement on Sleep Apnoea, Sleepiness and Driving 
Risk published in 2020 does provide supporting statements to assist clinicians 
in assessing fitness to drive (45). 
 
Role of templates 
The use of templates within both primary and secondary care to support 
structured review is not a new concept and there are pros and cons in their 
use (233, 234).  The cons are that template-based reviews may override the 
patient agenda with the risk of becoming a tick box exercise that does not 
necessarily support a patient-centred review about what matters to them and 
may inhibit communication (237). The pros of using templates are the review 
can be more structured for the healthcare clinician conducting the review, 
supporting more consistency and reducing variation in practice whilst also 
focusing on disease-specific guideline-based care (233, 235). In taking a 





review that includes an opening question regarding what the patient wants to 
discuss in the review can support both a patient-centred review that also 
includes the most important components to include in the review based on the 
e-Delphi consensus study finding and current guidelines. The specialist nurses 
that used the template in the study agreed that it did support a structured 
review, that did not affect patient-centred care or their clinical autonomy. Other 
Centres may use their own templates for CPAP review; however, this is the 
first CPAP review template to be developed using an international e-Delphi 
consensus to inform the review content with the clinicians in the 




Who can do CPAP reviews 
A number of respiratory clinicians can do CPAP reviews however this is 
becoming a primary nurse specialist-led, physiology led or clinical scientist-led 
service as the respiratory physicians tend to see the more complex cases who 
may be using NIV and require more medical oversite. There is evidence to 
support that review outcomes are similar for consultant and nurse-led reviews, 
and a simplified nurse-led model of care has demonstrated non-inferior results 
to physician-directed care in the management of symptomatic moderate-
severe OSAHS while being less costly (175, 212). This was certainly the case 
in the three Centres in the implementation study. The increased prevalence of 
OSAHS means more people are using CPAP and sleep medicine services 
need to find innovative ways to continue to support routine reviews. The data 
from the implementation study suggest that a template enables nurses and 







Use of templates and training for health care professionals  
The use of templates to support an evidence-based review that also supports 
training and education for new specialist nurses and more junior staff is an 
important consideration for healthcare services (269). Electronic medical 
records that use standardised templates for clinical reviews are replacing 
paper-based systems globally and may offer clinical educators and healthcare 
trainees a platform to support effective healthcare education (269, 270). 
Implementation of standardised guideline-based structured templates during 
the training of junior medical staff and other MDT members are likely to 
improve compliance to guidelines and promote and protect patient safety and 
person-centred care (269). The refined structured CPAP review template will 
require further evaluation at a wider service level to determine if it supports 






6.18 Summary of Chapter 6            
This chapter describes the results of a mixed-methods implementation study 
of a structured sleep clinic review template in three diverse clinical settings in 
the UK. The quantitative data from the completed templates indicates that the 
content and structure of the template and fields completed match well with the 
findings of the e-Delphi study. The qualitative research interviews facilitated 
the development of six main themes which allowed a more in-depth 
understanding of the participants views of the use and potential future use of 
the template in this speciality. In applying a mixed-methods approach to this 
implementation study I was able to achieve the study objectives. 
 
Feedback regarding the template is generally positive, however, its structure, 
content, and layout need to be refined utilising the feedback and comments 
from the participating clinicians. This study is the first of its kind to evaluate the 
use of such a template in the real-life clinical setting. The use of structured 
templates may reduce variation and standardise practice in nurse-led sleep 
clinic reviews and there should be further studies conducted with a revised 
template (electronic), based on the results of this study. Within the current 
context of the global COVID 19 pandemic, the use of a structured sleep clinic 
review template may assist future service provision and reduce variation in 
practice. With standardisation of practice, more telephone and teleconsultation 
will become the norm to reduce face-to-face reviews and reduce the risk of 






Chapter 7: Contributions to clinical practice and 
implications of PhD findings 
This PhD has focused on three distinct but interlinked pieces of research: 
 1) A systematic review that investigated the role of telemedicine and 
teleconsultation in people with OSAHS (168).  
 2) An international e-Delphi Consensus study to determine the most important 
components to include in a CPAP review (10). 
3) A mixed methods Implementation study of a structured clinical review 
template in CPAP therapy reviews in the real-life clinical setting. 
 
7.1 Systematic Review 
The systematic review in chapter four of this thesis concluded that by 
combining both telemonitoring and teleconsultation no safety concerns were 
raised in the five studies that met the inclusion criteria, and that adequately 
powered, well-designed trials were required to establish whether the 
combination of real-time telemonitoring and remote teleconsultation is a 
clinically viable and cost-effective option for CPAP therapy users. Since this 
review was published in 2017, a number of other studies have been published 
that negated the need to conduct a further RCT combining these interventions. 
In 2020 a metanalysis by Chen et al of telemonitored care versus usual care 
demonstrated significantly greater adherence with CPAP therapy when 
telemonitoring was used (271).   
 
Teleconsultation and telemonitoring solutions in the delivery of sleep medicine 
reviews have existed for two decades. They have been implemented at pace 
in the last five years with the advent of more advanced technology, new 
legislation, and clinical governance to support this model of clinical care (4, 
The emergence and ongoing global COVID 19 pandemic has forced sleep 
medicine providers to deliver more teleconsultation clinics and telephone 
clinics for CPAP therapy users to avoid face-to-face consultation where 





of the participants in the implementation study and the need to sustain the use 
of remote consultations (Chapter 6). An article published in the BMJ by 
Greenhalgh et al 2020, has outlined how telephone and teleconsultation can 
be conducted during COVID 19 (273). The same principles can equally be 
applied to teleconsultation combined with remote monitoring of CPAP therapy 
users. There would now appear to be a race for services globally to implement 
virtual care solutions at pace in preparation for subsequent waves of COVID 
19 and beyond to maintain safe, effective, and person-centred services to 
people using CPAP therapy (274).  
 
On completion of the systematic review in the light of the further published 
studies supporting the use of telemonitoring and teleconsultation, I decided to 
focus on defining the most important components to include in a CPAP clinical 
review (whether face-to-face or remotely).  
 
7.2 The International e - Delphi study 
The international e - Delphi study (Chapter 5) was completed by 40 participants 
who were practicing clinicians (physicians / academics, specialist nurses, 
physiologists, and service users). This is the first study to seek consensus from 
an expert panel on what components are considered priorities and the most 
important to include in the review of CPAP users and how often this should 
occur. The 17 prioritised consensus components generated from the e-Delphi 
study were used to develop a prototype structured CPAP review template that 
was utilised in the final mixed methods implementation study (Chapter 6), in 
three diverse sleep medicine Centres. There was a clear gap in the published 
evidence base for the benefits or disadvantages of introducing a structured 
CPAP review template, and the final implementation study in this PhD aimed 






7.3 A mixed methods Implementation study of a structured 
clinical review template in CPAP therapy reviews in the real-
life clinical setting 
The implementation study (Chapter 6), combined quantitative and qualitative 
methods to observe the implementation of the prototype template in CPAP 
reviews. There was overall good uptake of the templates in the three 
participating Centres. Completed templates showed that clinicians (mostly 
nurses), had used most of the fields prioritised by the e-Delphi expert panel. 
One Centre had a much higher uptake of template use, probably because 
there was a clinical lead at this site who developed a robust implementation 
plan supported by an administrative member of the team. The semi-structured 
interviews showed that the template facilitated a structured, standardised 
review, reducing variation in practice, and was not perceived to affect clinical 
autonomy or person-centred care.  The use of the template did not impact on 
how the review was conducted though it extended review time in one Centre 
where double data entry was required. From a service perspective, the 
template was perceived as improving efficiency and promoting better patient 
outcomes whether in face-to-face reviews or teleconsultations. In addition, the 
template was seen as potentially contributing to multidisciplinary team working 
and might be useful for education and training purposes. Adaptations to 
structure, content, and layout were suggested.   
 
7.4 Implications 
7.4.1 For people with OSAHS using CPAP therapy 
The studies in this PhD have implications for how care is provided for people 
living with OSAHS who are using CPAP therapy.   
• Telemedicine-based options are established as an option for clinical 
reviews that can reduce the requirement to travel for face-to-face reviews, 
and by providing care closer to home or from their place of residence, 






• By establishing the core components of a CPAP review, and the 
subsequent development and refinement of a structured template in CPAP 
reviews, people who are using CPAP therapy may benefit from a more 
person-centered review that includes the core components identified by 
international consensus, and also what matters to them in a clinical review.  
 
7.4.2 For professionals and clinical services 
The findings of these PhD studies also have implications for professionals and 
providers of clinical services : 
• The use of a structured review template reduces variation among clinicians, 
supports standardised practice and the perceived delivery of person-
centred care that is based on current guidelines and best practice.  
• Templates may support learning and development in new or less 
experienced members of staff. 
• Templates can be used in paper or electronic format, may reduce 
administrative processes, and be more time-efficient if it is the sole method 
for recording the content of a CPAP review.  
• From a service perspective, this would support efficiencies within services 
and free up time to focus on current clinical service pressures.  
• By reducing variation in the delivery of healthcare in the NHS this has a key 
role in the way resources are best used to provide the best value for service 
users and organisations alike, placing the nursing profession at the 
forefront in a position to identify and reduce unwarranted variation across 
services.  
 
I have now refined two templates based on the participants’ feedback for future 
use (Figure 13) and have shared this with the participating sites and the 
national improvement team working group who are working with clinicians to 







7.4.3 For policy-makers 
The findings of these PhD studies have implications for policymakers: 
• The potential for harnessing and embedding new remote monitoring 
technologies that enable optimisation of CPAP treatment is an important 
priority for the NHS and its policymakers to deliver better and safer care 
pathways and services in patients with underlying OSAHS. The British 
Thoracic Society has provided detailed guidance for sleep and ventilation 
services and advises the uses of teleconsultation and telephone review as 
preferable to face-to-face review in this current climate and beyond. It is 
apparent that policymakers in the UK and Globally will have to rapidly 
deploy telemedicine solutions and the evidence base and the technology 
to do so is already in place in many services nationally and internationally.  
• Policymakers are interested in managing variation and quality improvement 
within healthcare and the development of a structured review template 
based on the e-Delphi consensus supports this process. 
• Templates may facilitate skill-mix, enabling less experienced staff to safely 
review CPAP users, thereby relieving the pressure on increasingly busy 
sleep medicine services.    
• In refining the template for future use, it remains to be seen if it will be 
adopted as a potential solution in CPAP review services more widely in 
Scottish sleep medicine Centres. 
 
7.4.4 For research 
The systematic review and subsequent RCTs established that the use of 
telemedicine (telemonitoring and remote consultation), is a central component 
within sleep medicine service delivery that can provide person-centred care 
that is safe and efficient for both service users and clinicians. Collectively, 
current national and international guidelines do not clearly define what a 





take place. The core components of a clinical CPAP review established by the 
e-Delphi consensus study may influence future practice guidelines.  
Future research may: 
• Evaluate the clinical and cost-effectiveness of using the template in CPAP 
reviews (face-to-face or remotely). 
• Assess the skill mix enabled by using a template with a clinical service. 
• Explore the educational potential of the review template for new or less 
experienced staff. 
 
7.4.5 Objective IV Refining the template 
I received enough feedback and comments to meet the final objective IV of the 
implementation study, which was to refine the template. The feedback from 
those that used the template was generally positive with additional 
suggestions. I made two versions of the template, one for CPAP reviews and 
one for NIV reviews. I added the option to record the diagnosis and the mode 
of consultation to both templates, and the follow-up plan with additional space 
for more free-text comments. I also added the machine type, mask interphase, 
and pressure settings to both templates. I removed the capillary and arterial 
blood gas options and the transcutaneous carbon dioxide measurement from 
the CPAP template. I also added a section to record any anticipatory care plan 
to the NIV template as was suggested by one of the interviewees. Apart from 
these minor refinements, the two templates are very similar. Figure 13  outlines 
the refined CPAP and NIV templates. I have shared the refined template with 













Date Age Gender 














Face to face review               
Telephone review       
















Are there any side effects from the treatment? 





Does the mask fit correctly? 
Is humidification required/ satisfactory? 




















Objective assessment of sleepiness (Epworth Sleep Score) :  
Are there any problems with sleepiness while driving? 




Have witnessed snoring, apnoeas, choking spells been controlled? 
Have initial symptoms improved/resolved? 
Has NIV resolved the Apnoea Hypopnoea Index? 
AHI:                                                  Mask type: 
Mask Leak:                                      Machine and settings:  













What is the quality of sleep?  Do they feel refreshed on waking? 
What are their sleep routines?   How much sleep do they get? 
Quality of life  
Free text 
 










Factors that help/hinder NIV use.   Support system at home/partner engagement 
Altitude where lives/ Altitude where sleep study was done 
Electrical safety of NIV unit/ NIV unit noise level  
Review of medical history, medication review, any new comorbidities in relation to 
symptoms/need for hospitalisation 
Examination of the nasal passage and throat 
Chest Auscultation findings: 
 
Need to repeat diagnostic study with significant weight loss/weight gain 
Nocturia/Frequency of getting up to pass urine 
Cognitive/developmental issues 
 
Fatigue and depression scale /as interfering with subjective assessment of sleepiness e.g. 
Epworth Sleep Score 
Checking partner feedback / quality of life 
 
 Are Vehicle Licensing agencies are aware of the condition?  












Quality of life 
Driving 
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Face to face review               
Telephone review       

























Are there any side effects from the treatment? 





Does the mask fit correctly? 
Is humidification required/ satisfactory? 




















Objective assessment of sleepiness (Epworth Sleep Score) :  
Are there any problems with sleepiness while driving? 




Have witnessed snoring, apnoeas, choking spells been controlled? 
Have initial symptoms improved/resolved? 
Has NIV resolved the Apnoea Hypopnoea Index? 
AHI:                                                  Mask type: 















What is the quality of sleep?  Do they feel refreshed on waking? 
What are their sleep routines?   How much sleep do they get? 
Quality of life  
Free text 
 










Factors that help/hinder NIV use.   Support system at home/partner engagement 
Altitude where lives/ Altitude where sleep study was done 
Electrical safety of NIV unit/ NIV unit noise level  
Review of medical history, medication review, any new comorbidities in relation to 
symptoms/need for hospitalisation 
Examination of the nasal passage and throat 
Chest Auscultation findings: 
 
Need to repeat diagnostic study with significant weight loss/weight gain 
Nocturia/Frequency of getting up to pass urine 
Cognitive/developmental issues 
 
Fatigue and depression scale /as interfering with subjective assessment of sleepiness e.g. 
Epworth Sleep Score 
Checking partner feedback / quality of life 
 
 Are Vehicle Licensing agencies are aware of the condition?  












Quality of life 
Driving 
























 The three studies outlined in this thesis add to the evidence base for 
undertaking regular review of CPAP therapy users and telemedicine is an 
option for conducting a review combined with remote monitoring. The 
international e Delphi consensus study identified important components that 
may be recorded in a CPAP review and this informed the development of a 
structured review template. Implementation of the template was achieved in 
three Centres and all the objectives of the final study were met. The template 
was considered to provide structure to both face-to-face reviews and 
teleconsultations with a potentially important role in training staff and 
standardising care. One Centre continues to use the refined template in their 
service in an electronic format and it is hoped that wider adoption will be 
considered in other services. 
 
Teleconsultation has been centre stage in the midst of a global pandemic for 
routine CPAP reviews, and electronic templates adapted to fit local services 
and clinical teams routines could support standardised, evidence based, safe 
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Proposed Project (State research question and topic area, and briefly describe method/ data. Specify also countries 
in which data will be collected.): 
Defining the essential components of a clinical review of people using Continuous Positive Airway 
Pressure (CPAP) therapy: protocol for an international e-Delphi consensus exercise 
Murphie P, Little S, McKinstry B, Pinnock H. 
 
The need for consensus and potential components of a clinical review in those using CPAP therapy 
National and international guidelines on the management of people with OSAHS using CPAP recommend regular 
reviews.  However, we conducted a literature review in August 2016, and it is evident that current guidelines do 
not state explicitly what are the essential components of a clinical review of people with OSAHS using CPAP 
therapy, and how often a review should take place. There is a need to gain a consensus in order to inform future 
service delivery.  
Aim 
To use an international e-Delphi consensus process to identify and prioritise the essential components of a clinical 
review of a patient who uses CPAP therapy to treat OSAHS, and to agree how often this review should take place. 
Methods 
We will follow standard consensus methodology to undertake a national and international e-Delphi exercise. 
Recruitment of an expert panel. 
We will recruit an international expert panel of approximately 30 people to achieve the aims of the e-Delphi 
exercise (i.e. to gain a consensus on the essential components of a clinical review in people with a diagnosis of 
OSAHS on CPAP therapy).   It will be important to include representation which encompasses international 
perspectives from clinicians who are actively managing people with OSAHS, as well as those with academic 
expertise in this condition and people using CPAP. 
 
Our recruitment strategy will therefore be to invite: 
• Healthcare professionals (e.g. Respiratory Physicians, General Practitioners, Clinical Nurse Specialists, Nurse 
Practitioners, Physiologists who are actively reviewing people with OSAHS on CPAP therapy) to participate in the study. 
• Clinical academics working in this field 
• People with OSAHS recruited from patient organisations  
 
We will e-mail potential members of the expert panel (using e-mails addresses in the public domain for 
professionals; via patient organisations for expert patients), inviting them to participate.  The invitation will include 
a description of the process, the anticipated timescale, and estimated commitment.  The three rounds of the e-
Delphi will be: 
1. An open round in which participants will suggest components they consider to be important in a review 
2. A first scoring round in which participants will score the importance of the candidate components 
3. A second scoring round in which the median scores from the second round are fed back and participants are invited to 
re-consider their score.  












1. Bringing the University into disrepute 
Is there any aspect of the proposed research which might bring the University into disrepute? NO 
2. Data protection and consent 
Are there any issues of DATA PROTECTION or CONSENT which are NOT adequately 
dealt with via established procedures?  NO 
These include well-established sets of undertakings. For example, a ‘No’ answer is justified only if: 
a. There is compliance with the University of Edinburgh’s Data Protection procedures (see 
www.recordsmanagement.ed.ac.uk); 
b. Respondents give consent regarding the collection, storage and, if appropriate, archiving and destruction 
of data; 
c. Identifying information (eg consent forms)  is held separately from data; 
d. There is Caldicott Guardian approval for (or approval will be obtained prior to) obtaining/ analysing NHS 
patient-data. 
e. There are no other special issues arising about confidentiality/consent. 
 
3. Study participants 
a) Will a study researcher be in direct contact with participants to collect data, whether face-to- 
face, or by telephone, electronic means or post, or by observation? (eg interviews, focus groups, 
questionnaires, assessments) YES 
 
4. Moral issues and Researcher/Institutional Conflicts of Interest 
Are there any SPECIAL MORAL ISSUES/CONFLICTS OF INTEREST? NO 
a. An example of conflict of interest for a researcher would be a financial or non-financial benefit for 
him/herself or for a relative of friend. 
b. Particular moral issues or concerns could arise, for example where the purposes of research are 
concealed, where respondents are unable to provide informed consent, or where research findings 
could impinge negatively/ differentially upon the interests of participants. 
c. Where there is a dual relationship between researcher and participant (eg where research is undertaken 
by practitioners so that the participant might be unclear as to the distinction between ‘care’ and 
research). 
5. Protection of research subject confidentiality 
Are there any issues of CONFIDENTIALITY which are NOT adequately handled by 
normal tenets of confidentiality for academic research?  NO 
These include well-established sets of undertakings that should be agreed with collaborating and 
participating individuals/organisations. For example, a ‘No’ answer is justified only if: 
a. There will be no attribution of individual responses; 
b. Individuals (and, where appropriate, organisations) are anonymised in stored data, publications and 
presentation; 
c. There has been specific agreement with respondents regarding feedback to collaborators and publication. 
 
6. Protection of research subject confidentiality 
Are there any issues of CONFIDENTIALITY which are NOT adequately handled by 
normal tenets of confidentiality for academic research?  NO 
These include well-established sets of undertakings that should be agreed with collaborating and 
participating individuals/organisations. For example, a ‘No’ answer is justified only if: 
a. There will be no attribution of individual responses; 
b. Individuals (and, where appropriate, organisations) are anonymised in stored data, publications and 
presentation; 
c. There has been specific agreement with respondents regarding feedback to collaborators and publication. 
b) Answer this only if qu. 3 above = ‘YES’: 
In ethical terms, could any participants in the research be considered to be ‘vulnerable’? 
e.g. children & young people under age of 16,  people who are in 
custody or care (incl. school), a marginalised/stigmatised group 
Please tick one: 







1. Protection of research subject confidentiality 
Are there any issues of CONFIDENTIALITY which are NOT adequately handled by 
normal tenets of confidentiality for academic research?  NO 
These include well-established sets of undertakings that should be agreed with collaborating and 
participating individuals/organisations. For example, a ‘No’ answer is justified only if: 
a. There will be no attribution of individual responses; 
b. Individuals (and, where appropriate, organisations) are anonymised in stored data, publications and 
presentation; 
c. There has been specific agreement with respondents regarding feedback to collaborators and publication. 
 
2. Potential physical or psychological harm, discomfort or stress 
a. Is there a FORSEEABLE POTENTIAL for PSYCHOLOGICAL HARM or 
STRESS for participants?  NO 
b. Is there a FORSEEABLE POTENTIAL for PHYSICAL HARM or 
DISCOMFORT for participants?  NO 
c. Is there a FORSEEABLE RISK to the researcher?  NO 
Examples of issues/ topics that have the potential to cause psychological harm, discomfort or distress and 
should lead you to answer ‘yes’ to this question include, but are not limited to: 
relationship breakdown; bullying; bereavement; mental health difficulties; trauma / PTSD; violence or 
sexual violence; physical, sexual or emotional abuse in either children or adults. 
 
3. Duty to disseminate research findings 
Are  there  issues  which  will  prevent  all  relevant  stakeholders*  having  access  to  a  clear,     
understandable and accurate summary of the research findings if they wish? NO 
* If, and only if, you answered ‘yes’ to 3 above,  ‘stakeholders’ includes the participants in the research 
 
Overall assessment 
➢ If every answer above is a definite NO, the self-audit has been conducted and confirms the 
ABSENCE  OF  REASONABLY FORESEEABLE  ETHICAL RISKS – please tick box 
This means that regarding this study, as currently self-audited,  no further ethical review actions 
are required within Usher. However, if in the coming weeks/months there is any change to the 
research plan envisaged now (and outlined above), the study should be re-audited against a Level 1 
form, because  it may be that the change made negates the absence of ethical risks signed off here. 
➢ If one or more answers are YES, then risks have been identified and prior to commencing 
any data collection formal ethical review is required - either: 
 by NHS REC (NB copy of ethics application and decision letter to be sent to Usher Ethics); 
or 
 if not to be formally reviewed by NHS REC, then Usher level 2/3 ethical review required. 
[If either 4 is ‘yes’ or 3b is ‘vulnerable’ then it is possible level 3 review is required.] 
 
Two copies of this form should be taken for inclusion in the final dissertation/thesis and the original 
should be returned to the Usher Ethics administrator. 
           Phyllis Murphie                                                                  Hilary Pinnock 
Student Name Supervisor Name 
Student Signature Supervisor Signature * 
* NOTE to supervisor: The Usher Ethics Subgroup will not check this form (the light touch Level 1 form means we have 
insufficient detail to do so). By counter-signing this check-list as truly warranting all ‘No’ answers, you are taking responsibility, 
on behalf of Usher and UoE, that the research proposed truly poses no potential ethical risks. Therefore, if there is any doubt on 
any issue, it would be a wise precaution to mark it as ‘uncertain’ and contact the Ethics Subgroup as to whether a level 2 form 







                                CENTRE FOR POPULATION HEALTH SCIENCES  
  
Research Ethics Application - Level 2/3  
Due ethical process/’approval’ is required for all research projects carried out by staff or 
students in the Centre for Population Health Sciences (CPHS).   
Prior to completion of any forms, applicants should familiarise themselves with the ethical review process within CPHS 
- http://www.cphs.mvm.ed.ac.uk/intra/research/ethicalReview.php     
All research projects require at least a completed and signed Level 1 form.  In the case of a PG student applicant, 
any form required needs to be completed under the oversight of the student’s supervisor.    
This Level 2/3 form should be used for all projects that have been identified, by the Level 1 Self-Audit form, as requiring 
formal ethical review  - i.e. level 2 / 3, within the three-tier system of ethics approval set out by the School of Health 
in Social Science Research Ethics Committee.    
The completed form should be submitted to the CPHS Subject Area Research Ethics Group-   
   All level 2/3 applications should be submitted via the CPHS  Ethics administrator -  
cphs.ethics@ed.ac.uk    
  For PG research and masters students the application should also be copied to the PG Administrator - 
cphs.pg@ed.ac.uk   
Research must not proceed before ethical approval has been granted.  For this reason you are advised to: a) 
  Submit your application well in advance of any required date of approval, particularly for level 3 
research;  
b)  Acknowledge any potential for ethical concern, even minimal, and use your responses on the form, 
and additional documentation submitted with the form, to address this, detailing steps to be/being taken to 
minimise discomfort/ distress.  
  
Name of Applicant:    Phyllis Murphie  
If applicant is a PG student:           Name of  
Supervisor  
Confirm supervisor has checked completion of form  
If UG/MPH, also give Student Exam number  
Professor Hilary Pinnock  
Please tick if yes   
  
Project Title:  Defining the essential components of a clinical review of 
people using Continuous Positive Airway Pressure (CPAP) 
therapy: protocol for an e-Delphi consensus exercise  
 
  
Funding body:  Self-funded  
Level of review requested  (2 or 3)  2  
Expected timescale for the research  6 months  
Date this ethics application submitted:  18-1-17  
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List those who will be involved in conducting the 
research,  including names and positions (e.g. ‘PhD 
student’)  
  
Phyllis Murphie - PhD Student  
Dr Stuart Little - Respiratory Physician  
Professor Brian McKinstry - Professor Primary Care EHealth  
Professor Hilary Pinnock - Professor of Primary Care 
Respiratory Medicine  
  
  
LEVEL 2 / 3 ETHICAL REVIEW  
OVERVIEW of documentation provided in support of your application *     
You are advised to submit copies of: consent form, participant information, questionnaire, interview guide, vignettes, 
disclosure, GP letters etc  
For any such additional documents submitted, please enter below the document names - Please ensure ‘names’ 
listed below match the actual names of the doc-files. It us helpful to admin / review if document names indicate content 
in their initial text (e.g. staff interview guide, participant interview guide), with additional detail coming towards the end 
(e.g. version number, date etc).  
Document name  Tick ✓  Document name  (enter – & add rows if needed)  Tick ✓  
Level 1 Ethics Form - e - Delphi - 181-
17 -Rev1  
√  e-Delphi excel spreadsheet - Ver - 1  √  
Level 2 ethics form -e-Delphi Rev 1 
18-1-17  
√  Participant invitation email  √  
e-Delphi protocol - Rev1 18-1-17  √  Ethics resubmission letter -18-1-17  √  
Letter to participants Rev 1- 
highlighted 18-1-17  
√      
 * We do not accept paper documentation so, if necessary, please scan all documents into electronic format for 
submission to CPHS Ethics Group.  Please keep a copy of all documentation for your records.  
STRUCTURE OF REST OF FORM  Sections:      Item numbers       
Page (on blank form!)  
 Risks to, and safety of, researchers  1 – 3  2  
 Risks to, and safety of, participants  4 – 7  3  
 Research design  8 – 22  3  
 Data protection  23 – 33  5  
How to complete form:    
Please give some response to every item. The response boxes will expand as you complete them.   
Where a Yes/No response choice is offered, please delete as applicable.  If the answer to such a question is ‘Yes’, 
you must elaborate i.e. give details as to how this issue will be addressed to ensure that ethical standards are 
maintained, and/or provide a case as to why the concern does not prevent ethical approval being given.    [For 
information/background about ethical issues in research, please refer to ethics resources made available on CPHS 
Ethics website (URL on page 1) and on H drive (path    H:\Research support docs\Governance\Ethics).]    
The more comprehensive the detail/ explanation given in and with the form, in particular regarding the key ethical 
issues (vulnerable participants, recruitment/consent process,  data collection method, confidentiality/anonymity), the 
quicker should be your receipt of ethical opinion. Forms that do not contain sufficient detail will be returned, incurring 
delay.  
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RISKS TO, AND SAFETY OF, RESEARCHERS NAMED IN THIS APPLICATION 
Do any of those conducting the research named above need appropriate training to enable them to conduct the 
proposed research safely and in accordance with the ethical principles set out by the College? 
NO   
PM has read the ethical principles set out by the College to enable conducting the proposed research in accordance 
with these ethical principles.  
PM has had previous experience with conducting research within her NHS role, however her previous GCP training 
has expired. Although not required for this research project PM has enrolled for a GCP training course on the 23 rd 
February 2017 at Edinburgh University as this will be required for future research in her PhD. 
Are any of the researchers likely to be sent or go to any areas where their safety may be compromised, or they may 
need support to deal with difficult issues? 
NO 




RISKS TO, AND SAFETY OF, PARTICIPANTS  
4.  Regarding whether  any participants are children or protected adults: (protected adults are those in receipt 
of registered services  - i.e. care, health, community care or welfare services)    
Note:  Any researcher  who will have contact in Scotland with children, or protected adults, requires approval from 
Disclosure Scotland – see   http://www.disclosurescotland.co.uk/index.htm    
 Does this study require Disclosure Scotland approval for any of its researchers?       If yes, please  ✓  
              If yes, ethical approval will be subject to documentation confirming Disclosure Scotland approval.  
  
5.  Could the research induce any psychological stress or discomfort in participants?  
NO  
6.  Does the research involve any physically invasive or potentially physically harmful procedures?  
NO  
7.  Could this research adversely affect participants in any other way?  
NO   
   
RESEARCH DESIGN  
8.  Does the research involve living human subjects specifically recruited for this research project      If 
‘no’, skip items 9 to 22 i.e. go to next section (Data Protection, item 23 onwards)  
YES   





We aim to recruit approximately 30 participants to complete an e-Delphi consensus process.   To achieve this we will 
invite up to 50 international experts, including up to five expert patients recruited from a patient public involvement 
panel.    
This sample size has been selected because Delphi panels are generally under 50;1 and the majority of Delphi studies 
have included between 20-30 respondents.  To obtain an international consensus with a broad range of participants we 
will invite 50 people with a view to recruiting at least 30 to the process.   
1  Avella, J. R. (2016). Delphi panels: Research design, procedures, advantages, and challenges. International  
Journal of Doctoral Studies, 11, 305-321. Retrieved from http://www.informingscience.org/Publications/3561    
10.  What criteria will be used in deciding on inclusion/exclusion of participants?  
 Participants will be an international range of policymakers, guideline writers, leading academics in the field, 
expert patients, and specialist healthcare professionals who are involved in the clinical review of people with 
obstructive sleep apnoea hypopnoea syndrome who are using continuous positive airway pressure treatment.   
Participants will be identified by their publications, prominent role in conferences, professional bodies or 
guideline committees.   We will approach patient groups (e.g. the European Lung Foundation – European Patient 
Ambassador Participation group) to identify lay advisors for the expert group.   
11.  How will the sample be recruited? ( e.g. posters, letters, a direct approach- specify by whom)  
 Professional participants will be recruited by a covering email (from PM – principal investigator) with information 
regarding the purpose of the e-Delphi study and an attached word document that will outline the study 
requirements for potential participants. All professional participants’ emails and contact details are in the public 
domain.  
Patients will be recruited via their organisation.   
Reminder e-mails will be sent within 2 weeks for non-respondents.  
12.  Will the study involve groups or individuals who are in custody or care? - such as students at school, self-
help groups, residents of nursing home   
 NO  
13.  Will there be a control group?  
 NO  
14.  What information will be provided to participants prior to their consent? (e.g. information leaflet, briefing 
session)  
 YES  An email letter will be sent to all participants explaining the purpose of the e-Delphi study, and exactly 
what participation will involve.   Contact details (for PM) will be provided to enable potential participants to 
request further information.      
15.  Participants have a right to withdraw from the study at any time.               
Please ✓  to confirm that participants will be advised of their rights, including the right to continue receiving 
services if they withdraw from the study.  
16.  Will it be necessary for participants to take part in the study without their knowledge and consent?       
(e.g. covert observation of people in non-public places)  
 NO  
17.  Where consent is obtained, what steps will be taken to ensure that a written record is 
maintained?  
 The e-Delphi is an electronic format, so there will not be any paper records.  The first part of the 
first round spreadsheet will include a section that requires the participants to indicate that they have 
received information and consent to participate in the e-Delphi study by entering ‘Yes’ in the 
appropriate column.    
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18.  In the case of participants whose first language is not English, what arrangements are being made to 
ensure informed consent?  
 The e-Delphi will be conducted in English, the international language of academic conferences and publications.   
It will therefore not disadvantage the professional members of the team.   The expert patients will need to be 
able to communicate in English to complete the process.   This is a PhD project and we do not have budget to 
pay for translation.  
19.  Will participants receive any financial or other benefit from their participation?  
 NO  
20.  Are any of the participants likely to be particularly vulnerable, such as elderly or disabled people, adults 
with incapacity, your own students, members of ethnic minorities, or in a professional or client 
relationship with the researcher?  
 NO  
21.  Will any of the participants be under 16 years of age?  
 NO  
22.  Will any of the participants be interviewed in situations which will compromise their ability to give 
informed consent, such as in prison, residential care, or the care of the local authority?  
 NO   N/A:  there are no interviews planned  
 
DATA PROTECTION   
23.  Will any part of the research involve audio, film or video recording of individuals?  
NO  
24.  Will the research require collection of personal information from any persons without their direct consent?  
NO  
The only personal information collected will be contact details (for use in conducting the process) and information 
about professional role as provided by the participant.  
25.  How will the confidentiality of data, including the identity of participants (whether specifically recruited for 
the research or not) be ensured?  
Only the research team named above will have access to the identity of the participants.  This is required in order 
to a) send reminders to non-responders; b) feedback individual’s median scores for the second scoring round; c) 
send a copy of the publication to the participants.   
 All electronic data will be in a secure folder on the UoE shared space only accessible by the staff named above.   
All respondents will be identified by a code on all data. No hard copies of the study data will be kept. The participants 
will not be identified by name – only their professional/lay background will be reported in results. 
26.  Who will be entitled to have access to the raw data?  
Only the research team (PM and her supervisors HP, BMcK).  
27.  How and where will the data be stored, in what format, and for how long?  
Data will be stored electronically in a secure UoE folder only accessible to PM, and HP, BMcK. It will be retained for 
the duration of the study, and thereafter be archived according to University regulations for 5 years.  
28.  What steps have been taken to ensure that only entitled persons will have access to the data?  
MVM IT staff have permitted electronic access only to those staff named above.  Access to a folder on the UoE 
shared drive will be set up which is accessible to PM, HP and BMcK.  
29.  How will the data be disposed of?  
In accordance with the UoE Research Data Management policy May 2011.  
30.  How will the results of the research be used?  
CPHS Subject Area Ethics Subgroup of SHSS Research Ethics Committee  Feb 2015                                                                                                                              






This e-Delphi is a crucial component of PM’s PhD, in which she is developing a telehealth intervention to deliver 
routine reviews for people using CPAP for OSAHS.   In the absence of clear guideline recommendations for what 
should be included in a review, the e-Delphi will provide the required consensus to inform a telehealth review.   
We will present abstracts, publish the results in a peer reviewed journal.  The findings will be of interest to guidelines 
which currently to not make clear recommendations about CPAP/OSAHS reviews.  
31.  What feedback of findings will be given to participants?  
A copy of the peer reviewed publication will be emailed to the participants, with a lay summary.   
32. Is any information likely to be passed on to external companies or organisations in the course of the research?  
NO  





















05 June 2017 
 
 
Ms P Murphie 
 
Dear Phyllis 
THE UNIVERSITY of 
EDINBURGH 
Centre for Population Health 
Sciences 
THE USHER INSTITUTE of 
POPULATION HEALTH SCIENCES 
AND INFORMATICS 





Tel: +44 (0)131 650 3237 




Re: Defining the essential components of a clinical review of people using Continuous 
Positive Airway Pressure (CPAP) therapy: protocol for an e-Delphi consensus exercise 
 
The Usher ethics committee have reviewed the additions to the documentation for your ethics 
application for the above study, to cover Round 2 of the Delphi process planned. 
Ethics approval for the above study is hereby extended up to and including the second round 
of the Delphi survey process. 
However, as you know, the Ethics committee have not seen the survey forms for subsequent 
stages (or what is most likely, the third and final stage). Therefore you are granted only 
conditional approval for the subsequent stage(s). Once each of these survey forms in turn is 
ready, and you submit same to the Committee, full approval of these stages should be a 
formality, and speedy, since it will be only the form that needs to be checked. There should be 
no data collection for any of the subsequent stages until the relevant survey form has been 
submitted and approval given. 
 
Please be aware that this ethical approval is in respect of the protocol and methods as described 
in the documents submitted to the committee (with amended documents superseding 
predecessors). If there is in the future a change to the study design/protocol/methods, you 
should check whether this means your level 2 application form needs to be revised, and submit 
to the committee (via me), any documents that have been revised (study 
materials/protocol/level 2 form), using tracked changes. You should make clear in your 
covering email whether: 
(i) you are requesting ethical review of a study amendment; or 
(ii) you are not sure whether such is needed and, in the first instance, would like the 











Ethical Review Group : http://www.cphs.mvm.ed.ac.uk/intra/research/ethicalReview.php (Staff & PGR Students only) 
 














01 August 2017 
 
Ms P Murphie 
Dear Phyllis 
Centre for Population Health 
Sciences 
THE USHER INSTITUTE of 
POPULATION HEALTH SCIENCES 
AND INFORMATICS 





Tel: +44 (0)131 650 3237 




Re: Defining the essential components of a clinical review of people using Continuous 
Positive Airway Pressure (CPAP) therapy: protocol for an e-Delphi consensus exercise 
 
The Usher ethics committee have reviewed the additional documentation that you have 
submitted for your ethics application for the above study, to cover Round 3 of the Delphi 
process planned. 
Ethics approval for the above study is hereby extended up to and including the third round of 
the Delphi survey process, that is for the full study. 
 
Please be aware that this ethical approval is in respect of the protocol and methods as described 
in the documents submitted to the committee (with amended documents superseding 
predecessors). If there is in the future a change to the study design/protocol/methods, you 
should check whether this means your level 2 application form needs to be revised, and submit 
to the committee (via me), any documents that have been revised (study 
materials/protocol/level 2 form), using tracked changes. You should make clear in your 
covering email whether: 
(i) you are requesting ethical review of a study amendment; or 
(ii) you are not sure whether such is needed and, in the first instance, would like the 


















Ethical Review Group : http://www.cphs.mvm.ed.ac.uk/intra/research/ethicalReview.php (Staff & PGR Students only) 
 
The University of Edinburgh is a charitable body, registered in Scotland, with registration number SC005336 












Appendix 9 e-Delphi study published in the Journal of  



















































































































































































































































































Appendix 12 Standards for Reporting Implementation Studies: the StaRI checklist for completion 
 
The StaRI standard should be referenced as: Pinnock H, Barwick M, Carpenter C, Eldridge S, Grandes G, Griffiths CJ, Rycroft-Malone J, Meissner 
P, Murray E, Patel A, Sheikh A, Taylor SJC for the StaRI Group.  Standards for Reporting Implementation Studies (StaRI) statement.  BMJ 2017;356:i6795 
The detailed Explanation and Elaboration document, which provides the rationale and exemplar text for all these items is:  Pinnock H, Barwick M, 
Carpenter C, Eldridge S, Grandes G, Griffiths C, Rycroft-Malone J, Meissner P, Murray E, Patel A, Sheikh A, Taylor S, for the StaRI group.  Standards 
for Reporting Implementation Studies (StaRI). Explanation and Elaboration document. BMJ Open 2017 2017;7:e013318 
Notes:   A key concept of the StaRI standards is the dual strands of describing, on the one hand, the implementation strategy and, on the other, the 
clinical, healthcare, or public health intervention that is being implemented.  These strands are represented as two columns in the checklist. 
The primary focus of implementation science is the implementation 
strategy (column 1), and the expectation is that this will always be 
completed.    
The evidence about the impact of the intervention on the targeted 
population should always be considered (column 2) and either health 
outcomes reported, or robust evidence cited to support a known beneficial 
effect of the intervention on the health of individuals or populations.   
The StaRI standards refers to the broad range of study designs employed in implementation science.    Authors should refer to other reporting 
standards for advice on reporting specific methodological features.  Conversely, whilst all items are worthy of consideration, not all items will be applicable 


























  “Implementation strategy” refers to how the intervention was 
implemented 
  “Intervention” refers to the healthcare or public 
health intervention that is being implemented. 
Title and abstract 
Title 1 123 Identification as an implementation study, and description of the methodology in the title and/or keywords 
Abstract 2 123 Identification as an implementation study, including a description of the implementation strategy to be tested, the evidence-based intervention 
being implemented, and defining the key implementation and health outcomes. 
Introduction 
Introduction 3 125 Description of the problem, challenge or deficiency in healthcare or public health that the intervention being implemented aims to address. 
Rationale 4 125 The scientific background and rationale for the implementation 
strategy (including any underpinning theory/framework/model, how it is 
expected to achieve its effects and any pilot work). 
125 The scientific background and rationale for the 
intervention being implemented (including evidence 
about its effectiveness and how it is expected to 
achieve its effects). 
Aims and 
objectives 




6 131 The design and key features of the evaluation, (cross referencing to any appropriate methodology reporting standards) and any changes to 
study protocol, with reasons 
Context 7 132 The context in which the intervention was implemented. (Consider social, economic, policy, healthcare, organisational barriers and facilitators 
that might influence implementation elsewhere). 
Targeted ‘sites’ 8 132 The characteristics of the targeted ‘site(s)’ (e.g. 
locations/personnel/resources etc.) for implementation and any 
eligibility criteria. 
132 The population targeted by the intervention and 
any eligibility criteria. 
Description 
 
9 134 A description of the implementation strategy 134 A description of the intervention 
Sub-groups 
 
10 NA Any sub-groups recruited for additional research tasks, and/or nested studies are described 
Methods: evaluation 
Outcomes 11 135 Defined pre-specified primary and other outcome(s) of the 
implementation strategy, and how they were assessed.  Document any 
pre-determined targets 
135 Defined pre-specified primary and other 
outcome(s) of the intervention (if assessed), and how 




12 135 Process evaluation objectives and outcomes related to the mechanism by which the strategy is expected to work 
Economic 
evaluation 
13 NA Methods for resource use, costs, economic outcomes and analysis 
for the implementation strategy 
NA Methods for resource use, costs, economic 





Sample size 14 NA Rationale for sample sizes (including sample size calculations, budgetary constraints, practical considerations, data saturation, as appropriate) 
Analysis 
 
15 137- 138 Methods of analysis (with reasons for that choice) 
Sub-group 
analyses 
16 NA Any a priori sub-group analyses (e.g. between different sites in a multicentre study, different clinical or demographic populations), and sub-
groups recruited to specific nested research tasks 
Results 
Characteristics 17 149 and 153 Proportion recruited and characteristics of the recipient population 
for the implementation strategy 
158 Proportion recruited and characteristics (if 
appropriate) of the recipient population for the 
intervention 




19 182 and 186 Process data related to the implementation strategy mapped to the mechanism by which the strategy is expected to work 
Economic 
evaluation 
20 NA Resource use, costs, economic outcomes and analysis for the 
implementation strategy 
NA Resource use, costs, economic outcomes and 
analysis for the intervention 
Sub-group 
analyses 
21 NA Representativeness and outcomes of subgroups including those recruited to specific research tasks 
Fidelity/ 
adaptation 
22 186 Fidelity to implementation strategy as planned and adaptation to 
suit context and preferences 
186 Fidelity to delivering the core components of 
intervention (where measured) 
Contextual 
changes 
23 148 Contextual changes (if any) which may have affected outcomes 
Harms 
 




25 182 Summary of findings, strengths and limitations, comparisons with other studies, conclusions, and implications 
Implications 26 190 Discussion of policy, practice and/or research implications of the 
implementation strategy (specifically including scalability) 
190 Discussion of policy, practice and/or research 
implications of the intervention (specifically including 
sustainability) 
General 
Statements 27 Appendix 7 Include statement(s) on regulatory approvals (including, as appropriate, ethical approval, confidential use of routine data, governance 






Appendix 13 Site visit schedule and fieldnotes  
 
Site 1 - start-up visit - 4/10/20 - Reflective diary regarding implementation study visit 
Site one - 4th of October 2019. Large Urban sleep medicine centre. 
 
The group discussion on the dedicated sleep medicine Unit involved asking the 
participants what you normally do within a sleep medicine review.  I wanted to learn 
about the routine within the department and how they normally structure a clinical 
review.  
I was invited to present my research protocol to the entire department at the 
multidisciplinary meeting and there were a number of people who indicated they were 
willing to participate in the study.  I was given by e-mail addresses of the interested 
participants are I arranged to provide the study documentation electronically.  8 
clinicians indicated they would participate in the study, 3 consultants, and 5 nurses. 
Following the multidisciplinary meeting, I met with four of the nurses from their sleep 
medicine department for an initial group discussion.  These members of staff are 
based within the sleep medicine unit and they conduct sleep medicine clinical reviews 
regularly.  Four of the nurses consented to participate in the implementation study at 
this first start-up visit. 
We discussed the best way to facilitate the completion of the templates at the time of 
the clinical review and how to collect these anonymised templates after study 
completion. The nurse would use the templates in ward-based clinical review and 
keep the templates in a secure office until I was able to collect them.  I felt that this 
was a good start to the implementation study however I had very little time with the 
consultant medical staff due to clinic workload and  I knew that I would need a further 
site visit to facilitate their participation. 
I was able to conduct an initial discussion with one of the Consultants on 4/10/20 by 
telephone and he also consented to participate in the study however he was then 
redeployed to another service and did not participate further. 
 
5/11/19 - Site 1 – second visit – I attended a second site visit where I sat in on a 
morning clinic with one of the consultants to understand the medical clinic routine and 
spoke to the clinic outpatient staff to see how they may assist with attaching the 
templates to the case notes for completion and this was agreed, however, no 
templates were completed and there was no medical participation.  
 
22/11/20 Site 1 – third visit – I attended the ward team meeting again requesting 
further medical and nursing staff participation and several medical staff members and 






14/1/20 – Site 1 – forth -  final visit for two nurses who completed the study. Final 
face-to-face recorded semi-structured interviews with 2 of the specialist nurses who 
completed the study. 
 
At this visit, I also met with two of the Respiratory Clinician and further team members 
requesting their participation in the study as I had already extended the study due to 
slow recruitment at site 1.  Both consultants agreed to participate and further copies 
of the templates were provided to be attached to the clinic notes sheets for completion 
during the clinics.  
 
8-2-20 – Site 1 visit 5 - A further site visit was conducted 8/2/20 again meeting with 
the department manager and several of the extended members of the nursing team 
who agreed to participate – however no further templates were completed and 
returned. And at the end of February 2020, COVID 19 appeared and there was no 
further participation from site 1. 
 
4/11/2019 – Site 2  
 
 Start-up visit- Group discussion was undertaken with Specialist Nurse and 
Respiratory Consultant.  The specialist nurse completes all the clinical reviews for 
CPAP and NIV patients and the consultants mostly just see the new patients. The 
specialist nurse uses her own template in her clinics however was happy to use the 
template for the duration of the study.  The meeting was cut short due to train delays 
therefore the initial group discussion was too short to have a full discussion about 
what was included in the clinical review and we agreed that we could continue this 
conversation at a later date in the study.  
 
12/2/20 – Site 2 – Final Telephone visit 
 
Site 2 – Final structured recorded interview with 1 Respiratory Nurse specialist who 
completed the study was conducted by telephone as winter work pressures prevented 
me from visiting the site in person.  The quality of the interview was much reduced by 
not being able to a video consultation that day as the technology was not working 
properly and attend anywhere was not working properly that day.  I did take extensive 
field notes as well as recording the interview which helped to capture most of the 








Site 3 - 4-12-19 Start-up visit 
This was conducted by teleconsultation using NHS near me with 2 Respiratory 
Physicians and two specialist nurses who consented to participate in the study.  A 
member of the administrative team was tasked with providing a template for the 
consultations and collating the anonymised templates for return by registered post at 
the end of the study.  It was agreed by the Lead Respiratory Consultant that they 
would commence the study the first week in January for a period of 8 weeks.  Email 
correspondence from the Lead Respiratory physician from the 13th March 2020 
confirmed that they completed the study as planned however due to the arrival of 
COVID 19 they were asked by the NHD board to cancel non-urgent visitors to the 
hospital so a final face to face visit to undertake the semi structured interviews was 
not possible. It was suggested in this email correspondence that the final interviews 
could be conducted by video consultation also however this was not possible due to 
redeployment of myself to the respiratory ward in our hospital due to COVID 19. The 
completed templates were returned to me by registered post for the quantitative data 
analysis. I sent the final semi-structured interviews topic guide to the participants on 
the 4th April 2020 with a request for online completion if they could find time to do this 



























Appendix 14  Awards during PhD 
 
 
 
 
 
 
